Involvement of Cytochrome P450 1A in the toxicity of aryl hydrocarbon receptor agonists : alteration arachidonic acid metabolism and production of reactive oxygen species by Schlezinger, Jennifer J.
INVOLVEMENT OF CYTOCHROME P450 1A IN THE TOXICITY OF ARYL 
HYDROCARBON RECEPTOR AGONISTS: ALTERATION OF ARACHIDONIC ACID 
METABOLISM AND PRODUCTION OF REACTIVE OXYGEN SPECIES 
by 
Jennifer Joy Schlezinger 
B.S. Biology 
Boston College, Chestnut Hill, MA, 1992 
SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE 
DEGREE OF DOCTOR OF PIDLOSOPHY 
at the 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 
and the 
WOODS HOLE OCEANOGRAPHIC INSTITUTION 
August, 1998 
© Jennifer Joy Schlezinger 
All rights reserved. 
The author hereby grants to M.I.T. and W.H.O.I. permission to reproduce and 
distribute copies o(_this thesis document in whole or in part. 
Signature of Author-:..__ 
Joint Program in Biological eanograpfW~ 
Massachusetts Institute of Te nologyJWoods Hole Oceanogral'fric Institution 
Certified by . _ _ 
John J. Stekeman, THesis Suoervi [' 
Accepted by~.------------------------­
Mark E. Hahn, Chair 
Joint Committee for Biological Oceanography, 
Massachusetts Institute of Technology/Woods Hole Oceanographic Institution 
2 
Involvement of Cytochrome P450 lA in the Toxicity of Aryl Hydrocarbon 
Receptor Agonists: Alteration of Arachidonic Acid Metabolism and 
Production of Reactive Oxygen Species 
By 
Jennifer Joy Schlezinger 
submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy 
ABSTRACT 
Two cytochrome P4501A-dependent mechanisms of aryl hydrocarbon receptor 
(AhR) agonist toxicity were examined in the marine teleost scup (Stenotomus chrysops), 
alteration of arachidonic acid (AA) metabolism and production of reactive oxygen species 
(ROS). 
In scup hepatic microsomes, cytochrome P450s including CYP1A and CYP2B-like 
proteins catalyzed regioselective metabolism of AA to eicosatrienoic and 
hydroxyeicosatetraenoic acids. Benzo[a]pyrene (BP) treatment induced liver microsomal 
AA metabolism, but that effect varied with season. Endogenous AA epoxides were 
recovered from scup liver, heart, and kidney, and their composition in the liver was altered 
by treatment with BP or 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
In scup and mammals, the formation of ROS was stimulated by binding of 
3,3',4,4-tetrachlorobiphenyl (TCB) to CYP1A, apparently CYP1Al. Attack of that ROS 
inactivated scup CYP1A. ROS release and inactivation of CYP1A were stimulated only by 
substrates of CYP1A that are slowly metabolized. In vivo, 3,3',4,4',5-
pentachlorobiphenyl (PeCB) potently induced CYP1A mRNA, protein and catalytic activity 
at low doses (0.01-0.1 mg/kg), suppressed induction of CYP1A protein and catalytic 
activity at a high dose (1 mg/kg) and transiently induced oxidative stress in scup liver. The 
suppression of CYP1A induction was organ-dependent, with hepatic CYP1A being most 
susceptible to inactivation. The results suggest that ROS could be involved in the in vivo 
suppression of scup liver CYP1A by planar halogenated aromatic hydrocarbons. 
The reactive oxygen sensitive transcription factor, nuclear factor-KB (NF-KB), was 
characterized in scup. An NF-KB consensus binding sequence bound specifically to 3 
proteins in scup liver, heart and kidney. One protein was recognized by an antibody to 
mammalian p50. Injection alone appeared to activate NF-KB. BP did not increase the 
activation ofNF-KB, and PeCB activated NF-KB in only 1 of 2 experiments. 
Last, CYP1A induction in endothelial cells of the American eel (Anguilla rostrata), a 
site which may be particularly susceptible to alterations in AA metabolism and ROS 
production, was described. Eel liver CYP1A responded to BP, 13-naphthoflavone and 
TCB in a dose-dependent fashion, and induction was correlated with hepatic inducer 
concentration. Endothelial CYP1A was inducible in a number of organs and was 
metabolically active. In the rete mirabile, penetration of endothelial CYP1A induction 
increased with increasing dose of AhR agonists, corresponding with an increase in inducer 
concentration. A transition from endothelial to epithelial staining occurred in the gill, heart 
and kidney at high inducer doses. 
Thesis Supervisor: John J. Stegeman. Title: Senior Scientist, WHOI 
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CHAPTER 1 
Introduction and Background 
17 
INTRODUCTION 
The overall goal of this research was to investigate mechanisms of toxicity of aryl 
hydrocarbon receptor agonists, with particular emphasis on planar halogenated aromatic 
hydrocarbons (pHAH). These studies explored two potential cytochrome P450 !A-
mediated mechanisms of toxicity, alteration of arachidonic acid metabolism and production 
of reactive oxygen species. Further, cytochrome P450 lA induction in a sensitive cell 
type, endothelium, was examined following either experimental or environmental 
exposure. 
Polychlorinated biphenyls (PCB) are ubiquitous contaminants of the global 
environment. Produced mainly for the electrical industry from the 1940's to the 1970's, 
their production now is banned. PCBs, along with dioxins and dibenzofurans, comprise 
the group of compounds know as halogenated aromatic hydrocarbons (HAH). The planar 
HAH congeners are considered to be the most toxic. While the toxicity of planar HAHs 
(pHAH) is recognized and thought mainly to be a function of their interaction with the aryl 
hydrocarbon receptor (AhR), the mechanisms of this toxicity are unclear. 
Mono-oxygenase enzymes, particularly cytochrome P450s, are considered to be 
one of the major defense mechanisms against the toxicity of xenobiotic compounds. 
Cytochromes P450 (CYP), a superfamily of enzymes, is responsible for the synthesis and 
degradation of many endogenous compounds, as well as for the metabolism of many 
foreign compounds. These enzymes catalyze a wide range of reactions including aromatic 
and aliphatic hydroxylation, epoxidation, N, 0, and S dealkylation and N, S, and P 
oxidation. In general the addition of oxygen to xenobiotic compounds increases their 
water-solubility and thus allows for increased excretion. Most xenobiotics are metabolized 
by CYPs in families 1-4. In particular, cytochrome P4501A (CYPlA) has been 
characterized for its induction and regulation by foreign chemicals via the AhR. 
Paradoxically, the interaction of substrates with CYPlA also may result in 
increasing the toxicity of these chemicals. First, oxidative metabolism by CYP contributes 
to toxicity by activating promutagens and procarcinogens such as benzo[a]pyrene or 
aflatoxin B1. Second, studies in fish and mammals have suggested that treatment with 
CYPlA inducers increases the metabolism of arachidonic acid (AA) in vivo. These 
metabolites have a variety of diverse physiological functions, and alteration of AA 
metabolism following CYPlA induction may have important physiological consequences. 
Third, pHAH treatment is associated with AhR-dependent oxidative stress. Binding of 
slowly metabolized substrates by CYPlA may uncouple the catalytic cycle, resulting 
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release of reactive oxygen species (ROS) that could attack any member of the cellular 
machinery. Thus CYPlA may contribute to toxicity by activating chemicals, modifying 
metabolism of endogenous signaling molecules and producing reactive oxygen. 
CYPlA is found in a wide range of tissues and cell types. It is thought that most 
metabolism of xenobiotic compounds is carried out in the liver by CYPlA. However, 
studies have shown that endothelium in vertebrates from fish to mammals is a ubiquitous 
site of very strong induction of CYPlA by halogenated and non-halogenated aromatic 
hydrocarbons. CYPlA found in endothelial cells may represent a significant proportion of 
CYPlA found in organisms as a whole. Because the endothelial cells line all blood vessels 
and actually form the capillaries, it raises the question of what significance induction of 
CYPlA in these cells may have. 
19 
STRUCTURE, FUNCTION AND REGULATION OF CYTOCHROMES 
P450 
The cytochromes P450 are a superfamily of mono-oxygenase enzymes. CYPs are 
found in a wide variety of life forms, including bacteria, fungi and plants, as well as 
animals. There are 115 gene families, 37 of which occur in animals (Nelson, 1997). 
CYPs with less than 40% amino acid sequence identity are placed in different gene families; 
those with 40-55% identity are placed in different subfamilies. The diversity of this gene 
superfamily is reflected by the vast array of chemicals, endogenous and exogenous in 
origin, which are substrates for these enzymes. 
In general, CYPs are hydrophobic, membrane bound, heme proteins found in the 
endoplasmic reticulum of many cell types. The orientation of CYP in the membrane is still 
debated. Studies agree that the protein is localized toward the cytoplasmic face. Nelson 
and Strobel (Nelson and Strobel, 1988) hypothesized that a CYP is held in the membrane 
by an amino terminal hairpin loop, with the globular part of the protein extending into the 
cytoplasm. The substrate binding site faces the membrane in this model with the heme 
oriented parallel to the membrane. Edwards et al. (Edwards et al., 1991) proposed a model 
in which there is only a single stranded anchor of 20-30 residues with the globular portion 
of the protein in the cytoplasm, the heme being perpendicular or near perpendicular to the 
membrane. They also suggest that a portion of the globular protein may rest on the 
membrane itself. Still others suggest that there are fo'ur transmembrane domains and that 
the active site is within the membrane (Black and Coon, 1986). 
The CYP active site contains one iron protoporphyrin IX prosthetic group formed 
by four pyrole rings and one iron atom. This is where the dioxygen molecule is bound, 
reduced and activated (McMurry and Groves, 1986). Unlike other hemoproteins, the CYP 
heme has a 5th ligand, a cysteine-thiolate (Black and Coon, 1986). This 5th ligand causes 
the unusual absorbance maximum at 450 nm. When the thiolate bond is disrupted, P450 is 
converted to the inactive P420 form (Parkinson, 1996). Knowledge of active site structure 
is limited because of the inability to crystallize membrane-bound proteins; however, the 
stereospecific nature of substrate oxidation suggests that the substrate orientation is 
constrained within the active site (Miwa and Lu, 1986). 
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Figure 1: The catalytic cycle of cytochrome P450. From: (Parkinson, 1996). 
The reaction mechanism of CYP consists of a series of interactions with oxygen 
and a substrate (Figure 1). In the resting state, the heme iron of the prosthetic group is in a 
low spin state (Fe3+). Once the substrate is bound, the iron is converted to a high spin 
state and to a redox potential that favors reduction. Substrate binding is probably the first 
step in most CYP cycles; however, rapid CYP reduction also can occur in the absence of 
substrate (Guengerich and Johnson, 1997). The iron is reduced by electron transport from 
the flavoprotein NADPH-cytochrome P450 reductase. Oxygen binds. Addition of a 
proton and a second electron converts the complex to a peroxide. Donation of the second 
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electron is the rate limiting step in the mechanism. The oxygen-oxygen double bond is 
cleaved by the introduction of a second proton. A substrate radical is formed, hydroxylated 
and released (Stegeman and Hahn, 1994). Therefore, one oxygen atom oxidizes the 
substrate while the other atom is reduced with two electrons to form water. 
Electron transfer is essential to CYP function. Because NADPH is the major 
source of electrons and is a two electron donor, the electron transfer enzyme must be able 
to accept two electrons but donate only one electron at a time to CYP. NADPH-
cytochrome P450 reductase is a membrane-bound flavoprotein which contains equimolar 
amounts ofF AD and FMN and donates the first, if not both, electrons to CYPs. FAD is 
located close to the NADPH binding site and accepts the electron from NADPH. FMN is 
located near the CYP interaction site and passes the electron to CYP (Kurzban and Strobel, 
1986). The rate of reduction of CYP can be increased 5-10 fold upon substrate binding 
(Ingelman-Sundberg, 1986). The second electron also may be donated to CYP by 
cytochrome b5, through cytochrome b5 reductase and NADH (Ortiz de Montellano, 1986). 
Cytochrome P450 enzymes form two different regulatory classes. One class 
metabolizes endogenous substrates and the other metabolizes exogenous substrates, 
including xenobiotics. As a result there is a fundamental difference in the way that these 
two classes of enzymes are regulated. Constitutively expressed CYPs may be induced by 
endogenous or exogenous compounds; however, enzyme levels are generally maintained 
optimally for the maintenance of a particular function (Waterman et al., 1986). 
Constitutively expressed CYPs include CYP1A2, CYP2A6, CYP2B6, CYP2C, CYP2D6, 
CYP2E1 and CYP3A (Gonzalez and Lee, 1996). Those CYPs which metabolize 
exogenous compounds are inducible and respond to inducers with increased protein levels 
and catalytic activities. These changes in protein level are usually a result of changes in 
mRNA levels. These CYPs are induced by a wide variety of compounds (Table I). 
CYPs can be regulated transcriptionally or post-transcriptionally. 3-
Methylcholanthrene (MC) induction of CYP1A2 is associated with mRNA stabilization 
(Kimura et al., 1986). Phenobarbital (PB) induces transcription of CYP2B1 and CYP2B2 
(Waxman and Azaroff, 1992). Increases 1n CYP2E1 mRNA following diabetes occur due 
to mRNA stabilization (Porter and Coon, 1991). However, following exposure to acetone, 
CYP2E1 protein stabilization occurs because of phosphorylation prevention (Song et al., 
1986; Eliasson et al., 1990). CYP3A can be induced either by transcriptional activation 
with dexamethasone (Schuetz et al., 1984) or by protein stabilization with macrolide 
antibiotics (Watkins et al., 1986). Clofibrate induces transcriptional activation of CYP4A; 
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this may be mediated by the peroxisome-proliferator-activated receptor (Hardwick et al., 
1987). Thus, regulation is inducer-, as well as, CYP- specific. 
TABLE I 
I d n uctJ.on o f 1 se ecte dCYP bf T (F rom: ann tes gene su s tegeman an dHah 1994) n, 
Gene family Selected 
and Protein Prominent substrates Common Inducers Mechanisms 
subfamily members 
CYPlA lAl PAH, planar PCB, PAHs, planar PCBs, Mostly 
7 -ethoxyresorufin BNF, chlorinated dioxins transcriptional 
andfurans 
1A2 Acetanilide, estradiol, PAHs, planar PCBs, Transcriptional, post-
caffeine BNF, chlorinated dioxins transcriptional 
and furans, ISF 
CYP2B 2Bl Barbiturates, steroids Barbiturates, non-planar Transcriptional 
PCBs, DDT 
CYP2E 2El Ethanol, Ethanol, ketones, Transcriptional, post-
alkylnitrosamines starvation, diabetes transcriptional 
CYP3A 3Al Steroids PCN, DEX, macroli4e Transcriptional, post-
(6B-hydroxylase) antibiotics transcriptional 
CYP4A 4Al Lauric acid, arachidonic Clofibrate, phthalates, Transcriptional 
acid PCBs 
Abbreviations: 
BNF B-naphthoflavone DEX dexamethasone 
DDT dichlorodiphenyltrichloroethane !SF isosafrole 
P AH polynuclear aromatic hydrocarbon PB phenobarbital 
PCB polychlorinated biphenyl PCN pregnenolone-a-carbonitrile 
TCDD 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin 
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For CYP1A1, induction is a receptor-mediated process. The aryl hydrocarbon 
receptor (AhR) is a cytosolic protein containing a ligand binding subunit and two heat 
shock proteins. Recently, the hepatitis B virus X-associated protein 2 also has been shown 
to be associated with the unliganded AhR (Meyer et al., 1998). Agonist binding to the 
AhR initiates CYP1A1 induction. The sequence of events is as follows (Hankinson, 
1995). 1. The inducer diffuses into the cell. 2. The inducer binds to the AhR protein. 3. 
The ligand receptor complex is converted to a DNA binding form via the dissociation of the 
heat shock proteins, translocation to the nucleus, association with the AhR nuclear 
translocator (ARNT) protein and phosphorylation. 4. The ligand, receptor, ARNT 
complex binds to the enhancer DNA, known as the dioxin response element (DRE). 
Multiple DREs may be present in the promoter region of CYP1A (Lusska et al., 1993). 5. 
The enhancer DNA is activated. The enhancer is activated by several possible mechanisms, 
including altered DNA configuration, histone modification, or recruitment of additional 
proteins. 6. The nucleosome is disrupted allowing increased accessibility of the 
transcriptional promoter. The transcription factor binds to the promoter and enhances 
mRNA and protein synthesis. This sequence of reactions leads to increased levels of 
CYP1A in the cell. 
CYPs may be regulated by physiological parameters, as well. In mammals, the 
CYP2A, CYP2C, CYP3A, and CYP4A subfamilies are expressed in a sexually 
differentiated fashion (Sundseth et al., 1992a; Sundseth and Waxman, 1992b). The 
differences in expression have been attributed to the pulsatile versus continuous release of 
growth hormone in males and females. Suppression of hepatic P450 content and activity 
during gonadal development in females, and release of that suppression after spawning, 
occurs in many teleost species (Pajor et al., 1990; Gray et al., 1991; Andersson and Forlin, 
1992; Elskus et al., 1992). CYP1A, CYP2B-like and CYP3A-like proteins are suppressed 
by estradiol treatment or during natural maturation of female fish (Pajor et al., 1990; Gray 
et al., 1991). Estradiol regulates CYP1A at a pre-transcriptional level (Elskus et al., 1992). 
Sexually differentiated expression of CYP2K mRNA and protein also has been attributed to 
hormonal regulation (Buhler et al., 1994). 
Even environmental factors, such as temperature, can influence CYP content. In 
some species, cold acclimatized fish have higher CYP metabolic rates than warm 
acclimatized fish (Carpenter et al., 1990). In killifish (Fundulus heteroclitus), warm 
acclimatized fish have higher CYP1A content and EROD activity; however, cold 
acclimatized fish maintain elevated CYP1A mRNA and protein levels for longer periods of 
24 
time. The data suggest that it is a post-transcriptional temperature affect (K.loepper-Sams 
and Stegeman, 1992). The regulation of CYPs is not directed simply by inducers, but is 
influenced by a large variety of internal and external variables. 
CYTOCHROMES P450 IN TELEOST FISH 
While this study focuses on the CYP1A subfamily, it is important to note that other 
CYP gene families exist in fish. Procedures including protein purification, immunological 
reactivity and amino acid sequencing have been used to identify and classify different CYP 
genes in fish. This has lead to the description of fish CYP genes in subfamilies 1-4: 1(A), 
2(B,E,K,M,N,P), 3(A), 4(T) (Stegeman, 1987; Kaplan et al., 1991; Stegeman, 1993; 
Buhler et al., 1994; Yang et al., 1996; Falckh et al., 1997; Oleksiak et al., 1998a; Oleksiak 
et al., 1998b). CYP from the ll(A), 17, 19, and 26 subfamilies also have been identified 
in fish (Sakai et al., 1992; Tanaka et al., 1992; Takahashi et al., 1993; White et al., 1996). 
Most of these CYP forms have been isolated in rainbow trout (Oncorhynchus mykiss); 
however, several subfamilies have been described in scup (Stenotomus chrysops), cod 
(Gadus morhua) and killifish as well. In particular, CYP1A has been found in all fish 
species that have been examined to date (Stegeman and Hahn, 1994). 
While the CYP1A subfamily in mammals is represented by two members, CYP1A1 
and CYP1A2, most fish are thought to have only one CYP1A subfamily member. In 
mammals, CYP1A1 metabolizes polynuclear aromatic hydrocarbons (PAR), and CYP1A2 
metabolizes aromatic amines (Parke et al., 1991). Scup CYP1A expressed in Chinese 
hamster V-79 cells has catalytic properties of both mammalian CYP1A1 and CYP1A2, 
consistent with the hypothesis that teleost CYP1As represent a type ancestral to both of the 
mammalian genes (Morrison et al., 1995; Stegeman et al., 1996). The scup CYP1A amino 
acid sequence is 57-59% similar to mammalian CYP1A1 representatives and 52-55% 
similar to CYP1A2 representatives. Scup CYP1A has an 78-82% amino acid sequence 
similarity to CYP1As from rainbow trout, toadfish (Ospanus tau), plaice (Plueronectes 
platessa), and tomcod (Microgadus tomcod) (Morrison et al., 1995; Morrison et al., 1998). 
Biochemical evidence also supports the conclusion that scup P450E, rainbow trout 
P450LM4 and cod P450c are orthologous proteins and that these teleost proteins are 
closely related to mammalian CYP1A1 (see (Stegeman and K.loepper-Sams, 1987; 
Stegeman, 1989)). The scup, trout and cod proteins are all induced by polynuclear 
aromatic hydrocarbons, PCBs and B-naphthoflavone and are inhibited by a-
naphthoflavone. When reconstituted with epoxide hydrolase all produce high percentages 
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of benzo-ring dihydrodiols. All of the proteins are primary catalysts for ethoxyresorufin 
and aryl hydrocarbon hydroxylase (AHH) activity and have similar spectral properties (a 
maximum at 447 nm when reduced and CO-ligated). Antibodies raised against the purified 
form of each protein cross-reacts with each of the other proteins, and scup CYP1A shares 
21 of 25 amino acids in theN-terminal sequence with the trout protein. Finally, scup and 
rat CYP1As are immunologically related. Although, only 1 of 9 antibodies raised against 
scup CYP1A recognize rat CYP1A1, and 2 of 10 antibodies raised against rat CYP1A1 
recognize scup CYP1A (Klotz et al., 1986). 
Recently, two unique CYP1A genes were found to be expressed in MC treated 
rainbow trout (Bemdtson and Chen, 1994). This gene is the result of a duplication after 
the divergence of fish from other vertebrates. 
POLYCHLORINATED BIPHENYLS 
3 2 
Ortho Meta 
Para 
5 6 
Figure 2. Generalized structure of polychlorinated biphenyls. 
Polychlorinated biphenyls (PCB) are compounds composed of two phenyl rings 
connected by a single carbon-carbon bond with various patterns of chlorine substitution. 
Chlorines can be substituted in the 2-6 and 2'-6' positions, resulting in 209 possible 
congeners (Figure 2, Table II). 
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TABLE IT 
Chlorination patterns and IUP AC numbers for select PCBs 
Structure 
3-Methylcholanthrene-Type 
3,3' ,4,4'-tetrachlorobiphenyl 
3,4,4',5-tetrachlorobiphenyl 
3,3' ,4,4' ,5-pentachlorobiphenyl 
3,3',4,4',5,5'-hexachlorobiphenyl 
Phenobarbital-Type 
2,2'-dichlorobiphenyl 
2,2',4,4'-tetrachlorobiphenyl 
2,2' ,5 ,5'-tetrachlorobiphenyl 
2,2',4,5,5'-pentachlorobiphenyl 
2,2' ,3,3 ',4,4-hexachlorobipheny 1 
2,2',3,4,4',5-hexachlorobiphenyl 
2,2' ,4,4' ,5 ,5'-hexachlorobiphenyl 
2,2',4,4',6,6-hexachlorobiphenyl 
2,3,3' ,4,4' ,5-hexachlorobiphenyl 
2,3,3' ,4' ,5,6-hexachlorobiphenyl 
2,2',3,4',5,5',6-heptachlorobiphenyl 
Mixed-Type 
2,3,3',4,4'-pentachlorobiphenyl 
2,3' ,4,4' ,5-pentachlorobiphenyl 
2,3,3',4,4',5-hexachlorobiphenyl 
IUPAC No. 
77 
81 
126 
169 
4 
47 
52 
101 
128 
138 
153 
155 
156 
163 
187 
105 
118 
156 
Several properties lend PCBs to many uses; they are inflammable, chemically stable 
and miscible with organic compounds. PCBs were used as organic diluents, plasticizers, 
pesticide extenders, adhesives, dust reducing agents, cutting oils, flame retardants, heat 
transfer fluids, dielectric fluids for transformers and capacitors, hydraulic lubricants, 
sealants, and in carbonless copy paper (Safe, 1994). Of the 1.5 million metric tons of 
PCBs that were produced, 65% is land-locked, 31% has been released into the 
environment and 4% has been degraded or incinerated (Tanabe, 1985). Reports of PCB 
residues in the environment began in the 1960's (Jensen, 1966; Risebrough et al., 1968). 
PCB residues have been found in every component of the global ecosystem, including the 
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atmosphere, rivers, lakes, soil, marine sediment, open ocean, and fish, wildlife and human 
adipose tissue, blood and milk (Safe et al., 1985; Tanabe, 1985). Of the environmental 
load, 97% can be found in coastal sediments and open ocean (Tanabe, 1985). 
PCBs regulate CYPs on multiple levels. Individual chlorobiphenyl (CB) congeners 
can be grouped structurally by their induction of different CYP isoforms. CB congeners 
with no ortho substitutions induce CYP1A1, CYP1A2 and CYP2A1 and are called Me-
type inducers (Parkinson et al., 1980; Parkinson et al., 1980). The most potent inducers 
have chlorine substitutions at both para positions and at least two meta positions (i.e. CBs 
77, 81, 126, 169) (Poland and Glover, 1977; Kafafi et al., 1993). Structurally diverse CB 
congeners induce CYP2B 1/2B2, but all effective PB-type inducers have two or more ortho 
substitutions (Parkinson et al., 1980; Parkinson et al., 1980). The two most potent 
CYP2Bl/2B2 inducers are CBs 163 and 187 (Connor et al., 1995). CB congeners with a 
mono-ortho substitution induce all five CYP forms and are called mixed-type inducers 
(Parkinson et al., 1980; Parkinson et al., 1980). Mixed-type CB congeners are less potent 
at inducing CYPs than the type-specific congeners (see (Safe, 1994)). 
The structure activity relationships seen in fish differ somewhat from those seen in 
mammals. A number of studies in a range of fish species have demonstrated that CB 77 
(Franklin et al., 1980; Melancon and Lech, 1983; Gooch et al., 1989; Monosson and 
Stegeman, 1991; Tyle et al., 1991; Lindstrom-Seppa et al., 1994; Newsted et al., 1995; 
Otto and Moon, 1995; Huuskonen et al., 1996; Sleiderlink and Boon, 1996; White et al., 
1997a), CB 126 (Engwall et al., 1994; Newsted et al., 1995; Huuskonen et al., 1996; 
Palace et al., 1996) and CB 169 (James and Little, 1981; Miranda et al., 1990; Newsted et 
al., 1995) induce CYP1A in fish. Several studies have found that no P450 induction 
occurs in fish following treatment with PB-type congeners (i.e. CBs 52, 128, 138, 153) 
(Forlin and Lidman, 1978; James and Little, 1981; Gooch et al., 1989). However, two 
studies have suggested that AHH activity is increased following treatment with PB-type 
congeners (i.e. CBs 101 and 153) (Gruger et al., 1976; Da Costa and Curtis, 1995), and 
one study showed an increase in total P450 and p-nitroanisole 0-demethylation following 
CB 153 treatment (Forlin and Lidman, 1978). There is contradictory evidence as to 
whether mixed-type congeners are effective CYP inducers in fish. CB 105 was ineffective 
at inducing CYP1A in scup, rainbow trout and cod (Gooch et al., 1989; Bernhoft et al., 
1994; Newsted et al., 1995). CB 118 did not induce CYP1A in scup but did induce 
CYP1A in rainbow trout (Gooch et al., 1989; Skaare et al., 1991). CB 156 significantly 
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induced CYP1A in flounder (Platichthys flesus L.) (Beyer et al., 1997). The reasons for 
the relative insensitivity of fish to PB- and mixed-type congeners is unknown. 
Following induction, CBs can inhibit CYP catalytic activities. CB 77 is a 
competitive inhibitor of ethoxyresorufin 0-deethylation (EROD), a CYP1A catalytic 
activity, in scup liver microsomes. The mono-ortho CB 156 has a limited capacity to 
inhibit EROD in scup liver microsomes as well (Gooch et al., 1989). In rat liver 
microsomes, CB 77 is a mixed-type inhibitor of EROD (DeMatteis et al., 1989), and CB 
169 is a noncompetitive inhibitor of estradiol 2-hydroxylase activity, a CYP1A2 catalytic 
activity (Voorman and Aust, 1987). Furthermore, treatment with high doses of non-ortho 
CB congeners results in a decrease in CYP1A catalytic activity in vivo (Melancon and 
Lech, 1983; Voorman and Aust, 1988; Miranda et al., 1990; Monosson and Stegeman, 
1991; Lindstrom-Seppa et al., 1994) or in cultured cells (Sawyer and Safe, 1982; Rodman 
et al., 1989; Hahn et al., 1993; Kennedy et al., 1993; Lorenzen et al., 1997). In rat liver 
microsomes, CBs 4, 52 and 155 all inhibit 0-demethylation of p-nitroanisole, a CYP2B 
catalytic activity, with inhibitory capacity decreasing with increasing chlorination (Hesse 
and Wolff, 1977). 
CB 77 and other planar CB congeners that are AhR agonists also stimulate 
inactivation of CYP1A. While CYP1A mRNA remains elevated in rainbow trout exposed 
to high doses of CB 77 or 126 and in scup exposed to high doses of CB 77, CYP1A 
activity and protein both decrease at high doses (Gooch et al., 1989; Newsted et al., 1995; 
White et al., 1997a). Similar results have been described in studies of cultured chick 
embryo hepatocytes and porcine aorta endothelial cells exposed to high doses of CB 77 
(Lambrecht et al., 1988; Sinclair et al., 1989; Stegeman et al., 1995; Lorenzen et al., 
1997). In scup, the CB 77-dependent decrease in CYP1A was shown to be post-
transcriptional and hypothesized to result from oxidative modification of the protein (White 
et al., 1997a). 
The environmental significance of a CB congener can be determined by assessing 
its potential for toxicity, its frequency of occurrence in the environment and its relative 
abundance in animal tissues (McFarland and Clark, 1989). Exposure to PCBs can result in 
hepatocellular carcinoma, immunotoxicity, wasting syndrome and reproductive, endocrine 
and developmental toxicity (see (Safe, 1994)). The most toxicologically active congeners 
are those having chlorine substitutions at both para positions and at least two meta positions 
but no chlorine substitutions at the ortho positions (Safe et al., 1985). By comparing the 
TCDD equivalency factors (TEF) of CB congeners, the coplanar congeners are most potent 
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in eliciting toxic effects in fish (Janz and Metcalfe, 1991; Walker and Peterson, 1991; 
Newsted et al., 1995) and mammals (Safe, 1990; Tillitt et al., 1991). While these coplanar 
CB congeners occur at extremely low concentrations in environmental samples, their 
potential toxicity ranks them as the congeners of highest environmental concern (McFarland 
and Clark, 1989). Mixed-type inducers are considered the next most toxic group of 
congeners, and they are relatively abundant. PB-type inducers are most abundant in 
environmental samples but are considered to have limited toxic potential. 
REACTIVE OXYGEN SPECIES 
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Figure 3. Oxygen chemistry. 
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Reactive oxygen species (ROS) are free radical species containing an unpaired 
electron in an outer orbital resulting in an unstable electron configuration. Technically, 
molecular oxygen is a hi-radical, as it has two unpaired electrons in the outer orbitals in the 
ground state. Molecular oxygen oxidizes by accepting two electrons; however the electrons 
must have parallel spins. This spin restriction is advantageous to aerobic organisms 
because it slows oxygen reactions but is disadvantageous because it allows one electron 
transfers. Reduction of molecular oxygen results in the formation of the superoxide radical 
(Or•), which is a good reductant but a poor oxidant. Protonation of Or• to the 
perhydroxyl radical (H02•) increases the oxidizing potential. Addition of a second electron 
to oxygen results in the formation hydrogen peroxide (H202), which is also a product of 
OT• dismutation. Addition of a third electron to oxygen forms the hydroxyl radical (OH•), 
the most reactive oxygen species. OH• are formed by the interaction of H202 with either 
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reduced iron (Fenton reaction, Fe2+ + H202 --------> Fe3+ + OH• + OH-) or with 02-• 
(Haber Weiss reaction, OT• + H202 --------> 02 + OH• + QH-). 
Both singlet oxygen and H202 are considered to be ROS, but are not radicals. 
Singlet oxygen, a powerful oxidizer, is produced by an electron rearrangement, with 
electrons in non-parallel spin or in the same orbital. While H202 is not reactive enough to 
oxidize in an aqueous environment, it is biologically important because it forms OH•, 
diffuses readily and crosses biological membranes. 
TABLE Ill 
Oxygen species and their reactivity (From: Yu, 1994) 
Species Chemical 
Symbol 
Molecular Oxygen 3o2 
Singlet Oxygen 1o2 
Superoxide 02-· 
Hydroxyl OH• 
Perhydroxyl H02• 
Alkoxyl RO• 
Peroxyl ROO• 
Hydrogen peroxide H202 
Half Life 
at 3T C (Sec) 
>102 
1 • 10-6 
1 • 10-6 
1 • 10-9 
1. 10-6 
1. 10-2 
Properties 
Powerful oxidizing agent 
Good reductant, poor oxidant. 
Extremely reactive, very low diffusion distance. 
Stronger oxidant, more lipid soluble than 02-•. 
Intermediate in its reactivity with lipid between 
ROO•andHO• 
Low oxidizing ability relative to HO• but 
greater diffusibility. 
Oxidant, but reactions with organic substrates 
very slow, very diffusable. 
Both exogenous and endogenous sources of ROS are present in cells. Exogenous 
sources include radiation, ozone and hyperoxia (see (Freeman and Crapo, 1982)). A major 
endogenous source of ROS is 02-• produced during leakage of electrons by mitochondria 
(see (Freeman and Crapo, 1982)). Other endogenous sources include lipid breakdown 
(Girotti, 1985), production of 02-• during inflammatory response (Baboir, 1978), 
oxidative metabolism by oxidases such as monoamine oxidase (Cohen, 1985), NADPH 
oxidase (Shatwell and Segal, 1996) and xanthine oxidase (McCord and Fridovich, 1968), 
peroxisomes (see (Mannaerts and Veldhoven, 1993)) and CYP. Interruption of the CYP 
catalytic cycle after passage of the first electron results in OT• release and after passage of 
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the second electron results in H202 release (Parkinson, 1996). OT• also can be produced 
by cytochrome P450 reductase (Aust et al., 1972; Morehouse et al., 1984). 
ROS can initiate radical damage to lipids, proteins and DNA (Kappus, 1987). 
Oxidative damage to lipids results in a loss of membrane fluidity, a reduction in membrane 
potential and an increase in ion permeability (Bagchi et al., 1989; Simonian and Coyle, 
1996). Oxidation of amino acids, particularly those that are unsaturated and sulfur-
containing (i.e. tryptophan, tyrosine, phenylalanine, histidine, methionine and cysteine), 
can lead to gross structural modification of proteins (Kyle et al., 1989), can result in 
crosslinking and aggregate formation (Davies, 1987; Davies et al., 1987) and can mark 
proteins for proteolysis (Davies et al., 1987). ROS oxidize nucleotides and cause single-
and double- strand breaks (Floyd et al., 1988; Simonian and Coyle, 1996). 
ROS regulate both gene transcription and post-translational activation of certain 
proteins involved in signal transduction. The tumor suppresser p53 inhibits growth and 
suppresses transformation by blocking the cell cycle and preventing gene amplification 
(Baker et al., 1990; Lane, 1992). Binding of p53 to DNA is controlled post-translationally 
by the redox status of cysteine residues at the zinc and DNA binding regions (Rainwater et 
al., 1995). Activator protein 1 (AP-1) is a complex of oncogene proteins from the Fos and 
Jun families which are intermediary transcriptional regulators in signal transduction 
processes leading to proliferation and transformation (Angel and Karin, 1991). Both 
H202 and the antioxidant pyrrolidine dithiocarbamate induce c-fos and c-jun expression 
(Meyer et al., 1994). However, H202 only moderately activates AP-1 DNA binding while 
antioxidants strongly activate binding (Meyer et al., 1994). Nuclear factor-KB (NF-KB) is 
a complex of homo- or heterodimers (e.g. p50 and p65) of members of the Rel family of 
transcriptional activator proteins. NF-KB resides in the cytoplasm complexed with an 
inhibitor IKB, and degradation of IKB is required to allow translocation and DNA binding 
(see (Piette et al., 1997)). Degradation of IKB has been suggested to involve ROS, as 
antioxidants block NF-KB activation, and potent NF-KB activators such as tumor necrosis 
factor-a, interlukin-1, phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide and 
okadaic acid all elevate ROS levels (Schreck et al., 1991; Schreck et al., 1992). Redox 
regulation also has been suggested for the c-myb protooncogene (Guehmann et al., 1992), 
Ets transcription factor (Wasylyk and Wasylyk, 1993), SP-1 transcription factor (Knoepfel 
et al., 1994), glucocorticoid receptor (Esposito et al., 1995), early growth response-1 
transcription factor (Huang and Adamson, 1993), thyroid transcription factors (Civitareale 
et al., 1994; Arnone et al., 1995), upstream stimulatory transcription factor (Pognonec et 
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al., 1992), aryl hydrocarbon receptor (Ireland et al., 1995), and estrogen receptor (Hayashi 
et al., 1997). Oxidants also may stimulate signal transduction by altering ca2+.flux and 
protein phosphorylation (see (Suzuki et al., 1997)). 
An antioxidant defense system has evolved to lower the steady state cellular 
concentrations of ROS and to repair damage caused by ROS. Primary antioxidant defenses 
include: 1) ROS scavenging compounds, both lipid- and water-soluble and 2) antioxidant 
enzyme systems (Table IV) (see (Freeman and Crapo, 1982; Yu, 1994)). Secondary 
defenses include lipolytic enzymes, phospholipases, proteolytic enzymes, proteases, 
peptidases, DNA repair enzymes, endonucleases, exonucleases and ligase (Davies, 1986). 
TABLE IV 
Antioxidant defenses (From: Yu, 1994) 
Category 
Enzyme Systems 
Cu/Zn SOD 
MnSOD 
CuSOD 
Catalase 
GSH Redox Cycle 
GSH Peroxidase 
Primary Tissue Site 
Cytosol 
Mitochondria 
Plasma 
Peroxisomes 
GSH reductase 
Lipid-Soluble Compounds 
Cytosol 
Cytosol 
Vitamin E 
13-Carotene 
Bilirubin 
Lipid membranes 
Lipid Membranes 
Bloodstream 
Water-soluble Compounds 
Vitamin C Wide distribution 
Uric Acid Wide distribution 
Glucose Wide distribution 
Cysteine Wide distribution 
GSH Wide distribution 
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Actions 
Dism\}tation of 02-. to H202. 
Dismutation of 02-. to H202. 
Dismutation of 02-. to H202. 
Dismutation of H202, reduces methyl and ethyl 
hydroperoxides. 
Reduction of H202 and other hydroperoxides. 
Reduction of low molecular weight disulfides. 
Converts 02··, OH• and lipid ROO• to less reactive 
forms, breaks lipid peroxidation chain reactions. 
Scavenges 02··, reacts with ROO•. 
Chain-breaking anti-oxidant. Reacts with ROO•. 
Scavenges 02-. and OH•. 
Scavenges 02··, OH•, oxoheme oxidants and 
ROO•. 
Scavenges OH•. 
Reduces organic compounds. 
Reacts directly with 02··, OH• and organic free 
radicals. 
ARACHIDONIC ACID 
Arachidonic acid (AA) is both a structural component of membranes and a 
functional participant in signaling cascades. Following release from membranes by 
phospholipase A2, AA is metabolized through three major pathways: cyclooxygenase, 
lipoxygenase or cytochrome P450 (Needleman et al., 1986). CYP can metabolize AA to 
three types of products (Figure 4). Allylic oxidation forms mid-chain conjugated dienols, 
or mid-chain hydroxyeicosatetraenoic acids (5-, 8-, 9-, 11-, 12-, or 15-HETE). w-
Terminal hydroxylation forms C16- through C2o-alcohols of AA (16-, 17-, 18-, 19, or 20-
HETE). Olefin epoxidation forms epoxyeicosatrienoic acids (5,6-, 8,9-, 11,12- and 
14,15-EET). Mammalian CYP in families 1-4 metabolize AA (Figure 4). 
Epoxygenation 
CYP2Bs, CYP2Js, CYP2Cs 
Human CYP1 A2 
Chicken CYP1 A5 
OOH 
Oi.za-i 
w-Terminal Hydroxylation 
CYP2E1 
CYP4s 
Rat/Rabbit CYP1 A 1 
Rat CYP1A2 
Allyljc Oxidation 
Figure 4. CYP-mediated arachidonic acid metabolism and the specific CYP isoforms 
which favor those reactions (Oliw et al., 1982; Capdevila et al., 1990; Laethem et al., 
1993; Rifkind et al., 1994; Capdevila et al., 1995; Rifkind et al., 1995; Zeldin et al., 1995; 
Wu et al., 1996; Wu et al., 1997; Zhang et al., 1997). 
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CYP-mediated AA metabolites can promote potent biological activities including 
inhibition of platelet aggregation, neutrophil aggregation and cyclooxygenase activity 
(Proctor et al., 1989), alteration of endothelial cell permeability, vascular tone, and cellular 
ion flux (Schwartzman et al., 1987; Ohnishi et al., 1992; Harder et al., 1995; Campbell et 
al., 1996), and stimulation of angiogenesis and peptide hormone release (Falck et al., 
1983; Harder et al., 1995). BETs, particularly 5,6- and 14,15-EET, stimulate a wide range 
of effects from vasoconstriction, to vasodilation, to alteration of Ca2+ homeostasis, to 
inhibition of Na+fK.+ -ATPases, to stimulation of peptide hormone release (see (Fitzpatrick 
and Murphy, 1989)). Other physiologically relevant CYP-mediated AA metabolites include 
12(R)-HETE which inhibits Na+fK.+-ATPases in the cornea (Schwartzman et al., 1987) 
and 19- and 20-HETE which modulate renal Na+fK.+-ATPases (Escalante et al., 1990). 
Investigations of AA metabolism in fish have focused on prostaglandin and RETE 
formation. A variety of fish tissues have been shown to metabolize AA to prostaglandins 
and hydroxy metabolites, including gills (Strivastava and Mustafa, 1984; Van Praag et al., 
1987; Beckman and Mustafa, 1992), heart (Herman et al., 1979; Strivastava and Mustafa, 
1984; Brown and Bucknall, 1986), red blood cells (Cagen et al., 1983), skin (Anderson et 
al., 1981), kidney, liver and stomach (Bandyopadhyay et al., 1982; Henderson et al., 
1985). Studies in gills have demonstrated that both .lipoxygenases and cyclooxygenases 
contribute to AA metabolism (Van Praag et al., 1987; Beckman and Mustafa, 1992). In 
fish, prostaglandins may participate in the regulation of cardiovascular function (Brown 
and Bucknall, 1986), hormone release (Chang et al., 1993; Hsu and Goetz, 1993; Wade 
and Van Der Kraak, 1993), ovulation (Goetz et al., 1982), nervous system function 
(Mustafa and Strivastava, 1989), fluid and electrolyte balance in gills and kidney (Wales 
and Gaunt, 1985; Brown and Bucknall, 1986; Beckman and Mustafa, 1992) and immune 
response (Rowley et al., 1995). It is likely then that CYP-mediated AA metabolism plays 
an important role in the production of biologically active metabolites. However, CYP-
mediated AA metabolism has been examined only in killifish, scup, and skate (Raja 
erinacea) (Zacharewski et al., 1996; Oleksiak et al., 1998a; Oleksiak et al., 1998b). 
ENDOTHELIUM 
Endothelial cells are those cells which line all of the blood and lymphatic vessels of 
the body. In the large arteries and veins, the endothelium forms only a one-cell layer thick 
lining. Endothelial cells themselves form the smallest of the blood vessels, the capillaries. 
Endothelial cells can be classified on the basis of their continuity. Continuous 
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endothelium, found in the brain, retina, muscle, lung and adipose tissue, forms continuous 
tight junctions with no breaks in the vessel wall. Discontinuous endothelium, found in the 
liver, spleen and bone marrow, has gaps between cells. Fenestrated endothelium, found in 
the endocrine glands, renal glomeruli and tubules and the intestinal villi, is characterized by 
specialized intracellular pores that are important to transport and filtration (Gerritsen, 
1987). Also, while large and small vessels share many common features, there is evidence 
for differences in their nutritional requirements, in their responses to growth and migration 
stimuli and in their metabolism of signaling compounds (Zetter, 1981; Gerritsen, 1987). 
The functions of endothelial cells are many and diverse. First, they provide a 
physical lining of the heart and blood vessels which maintains the fluidity of the blood. 
Second, they maintain and control blood vessel tone. Mammalian endothelial cells produce 
several vasoactive substances including the vasodilators, nitric oxide, endothelium derived 
hyperpolarizing factor, and prostacyclin and the vasoconstrictor endothelin (Thiemermann, 
1991; Hecker et al., 1994). They also metabolize other vasoactive compounds including 
angiotensin and bradykinin (Hornig and Drexler, 1997). Some of these substance, such as 
nitric oxide, actively maintain tone in the normal circulation, while others such as 
prostacyclin, are more important in damage response (Vane et al., 1990). Shear stress is 
an important signal that controls production of these vasoactive compounds (Ando and 
Kamiya, 1993). Third, the ability of endothelial cells to relax or contract allows them to 
control microvascular permeability (Crone, 1986; Miller and Sims, 1986). Fourth, they 
regulate platelet clumping and clotting (Vander et al., 1990), and lymphocyte traffic 
(Pearson, 1991). Last, these cells are responsible not only for repair of damaged blood 
vessels but also angiogenesis (Alberts et al., 1989). Endothelial cells provide a diversity of 
functions and may be referred to more appropriately as an "organ." 
Considering the amount of endothelium in the body, endothelial CYP1A could 
contribute significantly to total bodily CYP1A induction (Stegeman et al., 1989). 
Endothelial cells can constitute between 0.5 and 1.5% of body weight depending on the 
species. In comparison, the liver can constitute between 1 and 1.5% of body weight. Liver 
is considered the major site of induction of CYP1A; however, endothelial CYP1A has been 
shown to be strongly inducible in mammalian and fish endothelial cells (Dees et al., 1982; 
Miller et al., 1989; Stegeman et al., 1989; Smolowitz et al., 1991; Farin et al., 1994; 
Thirman et al., 1994; Stegeman et al., 1995). Considering the numerous and important 
functions of endothelial cells and the potential for CYP1A induction, the effect of CYP1A 
induction on endothelial cells is an important area of investigation. 
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OBJECTIVES OF THESIS RESEARCH 
While the toxicity of planar halogenated aromatic hydrocarbons (pHAH) has been 
recognized for many years, the mechanisms of their toxicity are uncertain. The toxicity of 
these compounds has been linked to AhR mediated processes; however the processes 
directly involved in pHAH toxicity are unknown. Considering the ubiquitous presence of 
these compounds in the environment, investigation of their mechanisms of toxicity is of 
utmost importance. I have examined two potential CYP1A-dependent mechanisms of AhR 
agonist toxicity in the marine teleost Stenotomus chrysops, alteration of AA metabolism 
(Chapter 2) and production of ROS (Chapters 3-6). The oxidative inactivation of scup, rat 
and human CYP1As stimulated by CB 77 in vitro and its relationship to ROS production is 
demonstrated (Chapter 3). The relationship of substrate structure to the oxidative 
inactivation of CYP1A was investigated by comparing the effects of ortho and non-ortho 
substituted PCBs in vitro (Chapter 4). Further, the ability of CB 126 to mediate 
inactivation of CYP1A and oxidative stress was investigated in vivo (Chapter 5). The 
reactive oxygen sensitive transcription factor, NF-KB, was characterized in scup, and its 
activation by BP and CB 126 was exainined (Chapter 6). Last, I have described CYP1A 
induction in endothelial cells in the American eel (Anguilla rostrata)(Chapter 7). 
Endothelium is a site which may be particularly susceptible to alterations in AA metabolism 
and ROS production 
The majority of this research was conducted in two teleost species, Stenotomus 
chrysops (scup) (Figure 5), and Anguilla rostrata (American eel)(Figure 6). Scup are 
marine teleosts that migrate along the Eastern coast of the United States (Morse, 1978). 
This is a well characterized species that is extremely sensitive to both CYPlA induction and 
inactivation. The American eel is a catadromous fish, that spawns in the Sargasso Sea and 
spends the majority of its life in estuaries and rivers (Fahay, 1978). Eels may be 
particularly useful for the study of in vivo induction of endothelial CYPlA because they 
have a rete rnirabile, a counter-current vascular structure, composed entirely of capillaries, 
which increases the partial pressure of oxygen to aid its secretion into the swim bladder 
(Krogh, 1959). 
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Figure 5. Stenotomus chrysops. Actual adult size: 12-22 em. 
From: ( www. wh. whoi.edulphotos!lineart/) 
Figure 6. Anguilla rostrata. Actual adult size: 61-107 em. 
From: (www.wh.whoi.edu/photosllineart/) 
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CHAPTER 2 
Arachidonic Acid Metabolism in the Marine Fish Stenotomus chrysops 
(scup) and the Effects of Cytochrome P4501A Induction 
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Cytochrome P450-mediated arachidonic acid (AA) 
metabolism was investigated in the marine fish scup, 
Stenotomus chrysops. Liver microsomes incubated 
with AA and NADPH produced epoxyeicosatrienoic 
acids (EETs) and their hydration products (dihy-
droxyeicosatrienoic acids, DHETs), midchain conju-
gated dienols (midchain HETEs), and C16- through C20-
a!coho!s of AA (c..~terminal HETEs), all identified by 
HPLC and GC/MS. Gravid females had 4-fold lower AA 
metabolism rates than males but identical metabolite 
profiles. The 5,6-EET (inferred from stable metabo-
lites) was most abundant (47% of total EETs) followed 
by 14,15-, 11,12-, and 8,9-EET (27, 13, and 13%, respec-
tively). The 12-HETE represented 25% of total HETEs 
followed in abundance by 16-, 15-, 11-, 19-, 20-, 8-, and 
9-HETE. Antibodies against scup CYP1A and a scup 
CYP2B-like protein inhibited liver microsomal AA me-
tabolism by 30 and 46%, respectively. GC/MS analysis 
revealed EETs and DHETs as endogenous constituents 
in scup liver; the predominant EETs were 8,9- and 
14,15-EET, followed by a lesser amount of 11,12-EET. 
Chiral analysis showed a preference for the S,R-enan-
tiomers of endogenous 8,9-, 11,12-, and 14,15-EET (op-
tical purities 80, 64, and 64%, respectively). Treatment 
of scup with the CYP1A inducer benzo(a)pyrene (BP) 
increased liver microsomal formation of EETs and 
HETEs by 2. 7-fold in spring and 1. 7-fold in summer. BP 
treatment did not affect microsomal EET regioselec-
tivity, but shifted hydroxylation in favor of 19-HETE 
and induced 17-HETE formation. 2,3,7,8-Tetrachlorod-
ibenzo-p-dioxin (TCDD) treatment in summer did not 
induce liver microsomal AA metabolism ra~es, yet BP 
and TCDD both increased endogenous EET content of 
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liver (5- and 3-fold, respectively), with a shift to 14,15-
EET. BP treatment increased the selectivity for the 
S,R-enantiomers of endogenous 8,9-, 11,12-, and 14,15-
EET (optical purities 91, 84, and 83%, respectively). 
Kidney, gill, and heart microsomes all metabolized AA, 
at rates 10- to 30-fold less than liver microsomes. Sim· 
ilar amounts of endogenous 8,9- and 14,15-EET and 
less 11,12-EET were detected in heart and kidney, and 
there was a strong enantioselectivity for 8(R),9(S)-EET 
in heart (optical purity 78%) but not in kidney. BP 
treatment did not alter the total EET content in these 
organs but did shift the regiochemical profile in heart 
to favor 14,15-EET. Thus, scup liver and extrahepatic 
organs metabolize AA via multiple cytochrome P450 
(CYP) forms to eicosanoids in vitro and in vivo. BP or 
TCDD induced endogenous AA metabolism in liver, 
altering EET regioselectivity and, with BP, stereose-
lectivity. While AhR agonists alter metabolism of AA in 
early diverging vertebrates expressing both CYP1A 
and AhR, the magnitude of effects may depend upon 
the type of inducer. Q 1998 Academic Press 
Key Words: arachidonic acid; cytochrome P450 1A; 
Stenotomus chrysops. 
Metabolism of free arachidonic acid (AA2 ) released 
from cell membranes by phospholipase A2 is catalyzed 
by cyclooxygenases, lipoxygenases, and cytochrome 
2 Abbreviations used: AA, arachidonic acid; AhR, aryl hydrocarbon 
receptor; BNF, /3-naphthoflavone; BP, benzo(a)pyrene; CYP, P450, cy-
tochrome P450; DHET, dihydroxyeicosatrienoic acid; EET, epoxyeico-
satrienoic acid; EROD, ethoxyresorufin 0-deethylase; ETCP, 1,2-epoxy· 
3,3,3-trichloropropane; HETE, hydroxyeicosatetraenoic acid; NBT-B· 
CIP, nitroblue tetrazolium/5-bromo-4-chloro-3-indoyl-phosphate; PeCB, 
3,3' ,4,4' ,5-pcntachlorobiphenyl; PFB, pcntafluorobenzyl; TCDD, 2,3,7,8-
tetrachlorodibenzo..p-<lioxin; TMS, trimethylsilyl. 
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P450 (P450 or CYP) monooxygenases (1). P450s can 
metabolize AA to three types of products (2). Allylic 
oxidation forms midchain conjugated dienols or mid-
chain hydroxyeicosatetraenoic acids (5-, 8-, 9-, 11-, 12-, 
or 15-HETE). w-Terminal hydroxylation forms C16-
through C20-alcohols of AA (16-, 17-, 18-, 19-, or 20-
HETE). Olefin epoxidation forms epoxyeicosatrienoic 
acids (5,6-, 8,9-, 11,12-, and 14,15-EET), which are 
metabolized to dihydroxyeicosatrienoic acids (DHET) 
by epoxide hydrolases. In mammals, these AA metab-
olites have potent biological activities including inhibi-
tion of platelet aggregation, neutrophil aggregation, 
and cyclooxyg!'!nase activity (3); alteration of endothe-
lial cell permeability, vascular tone, and cellular ion 
fluxes (4-6); and stimulation of angiogenesis (7) and 
peptide hormone release (8). 
P450s in gene families 1-4 have been shown to metab-
olize AA, and the product profile depends on the CYP 
isoform. CYP2B, CYP2J2, and CYP2C proteins are pri-
marily epoxygenases (9, 12), CYP2E1 and CYP4A are 
primarily w-terminal hydroxylases (13, 14), while 
CYP2J3 and CYP2J4 catalyze both activities (15, 16). 
CYPlA proteins show varied patterns of AA metabolism. 
Purified rabbit or rat CYP1A1 and rat CYP1A2 form 
primarily 16- through 20-HETE and form lesser amounts 
of midchain HETEs and EETs (10, 17). In contrast, re-
combinant human CYP1A2 and chicken CYP1A5 are 
primarily epoxygenases (9, 18). The regio- and stereo-
chemical selectivity ofEET formation also varies with the 
CYPlA protein catalyzing the reaction. Thus, the major 
epoxide formed by rat CYP1A1 is 14,15-EET (10), that 
formed by rat and human CYP1A2 is 11,12-EET (9, 10), 
and that formed by chicken CYP1A5 is 8,9-EET (18). Rat 
CYP1A1 favors production of8(8),9(R)-, ll(S),12(R)-, and 
14(R),15(S)-EET enantiomers (10). Rat CYP1A2 and 
chicken CYP1A5 .favor 8(S),9(R)-, ll(R),12(S)-, and 
14(R),15(S)-EET (10, 18). 
Consistent with observations that CYP1As can me-
tabolize AA, treatment of mammals or birds with aryl 
hydrocarbon receptor (AhR) agonists (CYP1A induc-
ers) alters microsomal AA metabolism. However, the 
response to treatment differs among species. In chick 
embryos, 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin (TCDD) 
or {3-naphthofl.avone (BNF) induced liver microsomal 
metabolism of AA to 8,9- and 11,12-EET by 6- to 10-fold 
(19). In rabbits, 3-methylcholanthrene and BNF induce 
19- and 20-HETE formation by renal and hepatic mi-
crosomes by 2-fold (20). Similarly, in guinea pigs BNF 
induced a 3-fold increase in formation of 19- and 20-
HETEs by lung microsomes (21), and 3,3' ,4,4' ,5-penta-
chlorobiphenyl (PeCB) induced hepatic microsomal20-
HETE formation by 2-fold (22). In rats, BNF and PeCB 
decreased liver microsomal EET formation but in-
creased 16- through 19-HETE formation (10, 22, 23). 
The inconsistent effects of CYP1A induction on AA 
metabolism in vitro by different tissues and species 
make it difficult to determine the significance of AhR 
agonist effects on AA metabolism. Moreover, although 
it has been suggested that such effects in vivo could 
modulate or contribute to the toxicity ofTCDD (19), we 
are unaware of studies that have examined effects on 
endogenous EET formation. 
In this study we consider whether multiple P450s 
catalyze AA metabolism, and the identity of metabolic 
products, in fish, the earliest diverging vertebrate 
group. We also address the hypothesis that AhR ago-
nists affect AA metabolism in fish. Fish possess AhRs, 
and testing this hypothesis is important in determin-
ing whether effects on AA metabolism are involved in 
AhR agonist toxicity generally. Preliminary studies in-
dicated that BNF treatment of the marine teleost fish 
scup (Stenotomus chrysops) and the elasmobranch 
skate (Raja erinacea) induced microsomal AA metabo-
lism in those species (24). Here we examine the in vitro 
metabolism of AA by hepatic and extrahepatic micro-
somes of male and female scup, both untreated and 
treated with CYPlA inducers. Regiospecific and ste-
reospecific metabolism of endogenous AA is described, 
providing the first demonstration that in vivo metabo-
lism of AA is altered by benzo(a)pyrene (BP) and 
TCDD. The results indicate that endogenous AA me-
tabolism can be altered to a greater extent than sug-
gested by microsomal rates measured in vitro. 
MATERIALS AND METHODS 
Materials. 1,2-Epoxy-3,3,3-trichloropropane was kindly provided 
by Dr. Bruce Hammock (U.C. Davis). Benzo(a)pyrene, triph-
enylphosphine, a-bromo-2,3,4,5,6-pentafluorotoluene, N,N-diisopro-
pylethylamine, and N,N-dimethylformamide were purchased from 
Aldrich (Milwaukee, WI). Purified rabbit IgG was purchased from 
Cappel (Durham, NC). 8-, 9-, 12-, and 15-HETEs were purchased 
from Cayman Chemical Co. (Ann Arbor, MI). [1-14C]Arachidonic acid 
was purchased from DuPont-New England Nuclear (Boston, MA). 
7-Ethoxyresorufin was purchased from Molecular Probes (Eugene, 
OR). 2,3,7,8-Tetrachlorodibenzo(p)dioxin was purchased from Ultra 
Scientific (North Kingstown, RI). All other chemicals and reagents 
were purchased from Sigma (St. Louis, MO). 
Animals. S. chrysops (scup) were purchased from the Marine 
Biological Laboratory (Woods Hole, MA). The fish were originally 
wild-caught and had been depurated for 6 months prior to use. Fish 
were held in flow-through seawater tanks at 14•c and maintained on 
a diet of Purina Trout Chow. The studies were performed in accor-
dance with principles and procedures outlined in the NIH Guide for 
the Care and Use of Laboratory Animals. 
Treatment offish. Experimental animals ranged in size from 104 
to 452 g. Experiments took place in March and May (spring) and July 
(summer). Fish were injected intraperitoneally with com oil (1 ml/ 
kg) or with solutions ofBP (10 mg/k.g) orTCDD (1 fLg/k.g) in corn oil. 
These doses were selected based on previous work that has demon-
strated the greater potency ofTCDD for CYPlA induction [see (25)]. 
Each fish was kept in a separate tank postinjection. Three days 
following injection, the fish were killed by severing the spinal cord. 
Body and gonad weights were recorded and used to calculate the 
percent of total body weight represented by the gonads. Livers, 
hearts, kidneys, and gills were harvested. Portions of organs for 
endogenous metabolite assays were frozen immediately and stored 
in liquid N2 . 
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Microsome preparation and assays. Microsomes were prepared 
from freshly collected tissue by differential centrifugation (26). Mi-
crosomes were prepared from individual livers. Equivalent portions 
of kidney, heart, and gill tissue from each of the fish used in the 
spring induction study were pooled before microsomes were pre-
pared. Microsomes were resuspended in 0.15 M KCl following the 
initial sedimentation and resedimented. Pellets were resuspended in 
buffer (50 mM Tris-Cl, pH 7.4, 1 mM dithiothreitol, 1 mM EDTA, 
20% glycerol) and frozen in liquid N2 until use. Protein content was 
determined using the bicinchoninic acid method, with bovine serum 
albumin as a standard (27). Ethoxyresorufin 0-deethylase (EROD) 
activity was determined fluorometrically as previously described 
(28). Dithionite-difference spectra of CO-treated microsomes were 
obtained as previously described (29). 
Western blotting. Immunoblotting procedures used here were mod-
ified from those previously described (30). Briefly, microsomal proteins 
(10-80 ,..g/lane) were resolved on 12% SDS-PAGE gels and transferred 
to either nitrocellulose or nylon membrane. The primary antibodies 
were mouse monoclonal antibody 1-12-3 (31) against scup CYPlA (32) 
and rabbit polyclonal antibody 7-94 against scup P450B (a CYP2B-like 
protein) (33). PAb 7-94 does not cross-react with purified CYPlA (33) 
but does cross-react weakly with CYP2N and CYP2P from the fish 
Fundulus heteroclitus. 3 The secondary antibody to MAb 1-12-3 was goat 
anti-mouse alkaline phosphatase and to PAb 7-94 was goat anti-rabbit 
alkaline phosphatase (Schleicher and Schuell, Keene, NH). Immunore-
active proteins were visualized with nitroblue tetrazolium and 5-bromo-
4-chloro-3-indoyl-phosphate (NBT-BCIP) or enhanced chemilumines-
cence (Tropix, Bedford, MAl. CYPlA- and CYP2B-like proteins detected 
were quantified by video image analysis by comparison to scup stan-
dards of known concentration. 
Analysis of microsomal metabolites and antibody inhibition studies. 
Duplicate reaction mixtures containing 0.5 IU/ml isocitrate dehydro-
genase, 2.0 mg/ml microsomal protein, and [1-14C]AA (55-57 p.Ci/ 
p.mol; 50-70 p.M, final concentration) were shaken constantly at 
30°C. After a 5-min temperature equilibration, NADPH (1 mM, final 
concentration) was added to initiate the reaction. At various time 
points, the reactions were stopped by the addition of ethyl ether, and 
the organic soluble products were extracted three times. Samples 
were dried under a N2 stream, separated by reverse-phase HPLC, 
and quantified by on-line liquid scintillation using a Radiomatic 
Flo-One ,(3-detector (Radiomatic Instruments, Tampa, FL) as previ-
ously described (2). Determination of the regiochemistry of epoxida-
tion required greater reverse-phase separation and was performed 
as previously described (34). Formation of each regioisomer was 
calculated as the sum of the EET and the DHET and, in the case of 
the 5,6-olefin, the S-lactone as well. For antibody inhibition experi-
ments, microsomes from freshly caught fish obtained in fall were 
used. These fish had appreciable levels ofCYP1A and higher levels of 
CYP2B-like protein than did the fish used in the treatment experi-
ments. Normal rabbit IgG, the polyclonal antibody 118 against scup 
CYPlA (30), or the polyclonal antibody 7-94 against scup P450B (33) 
were added to the reaction mixtures at a protein/total P450 ratio of 
4, 8, or 16 mg total IgG/nmol ofP450. After 15 min at 30°C, [1-14C]AA 
was added, and the reaction was initiated with NADPH. Metabolites 
were extracted, resolved, and quantified as before (2). To determine 
EET chirality, 1 mM 1,2-epoxy-3,3,3-trichloropropane (ETCP), an 
epoxide hydrolase inhibitor, was included in the incubation, and the 
samples were resolved into individual regioisomers and enantiomers 
by HPLC as described (35, 36). To resolve the hydroxylation prod-
ucts, fractions corresponding to minutes 15-23 on reverse-phase 
HPLC were collected batchwise, dried under N2 , and separated by 
normal-phase HPLC as described (23, 37). A UV detector (Waters 
Model 990) monitored the HETE standards at 234 nm (12-, 15-, 11-, 
9-, and 5-HETEs) and 210 nm (16-, 17-, 19-, and 20-HETEs). The 
3 M. F. Oleksiak and J. J. Stegeman, unpublished observations. 
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microsomal 11-'•CJHETEs were monitored by a Radiomatic Flo-One 
,B-detector. 
Quantification of endogenous EETs and DHETs in scup tissues. 
Methods used to quantify endogenous EETs and DHETs in scup tissues 
were similar to those used with rat and human tissues (12, 36). Briefly, 
frozen tissues were homogenized in 15 ml phosphate-buffered saline 
containing the peroxide-reducing agent triphenylphosphine (5-10 mg). 
The homogenates were extracted twice, under acidic conditions, with 2 
volume of chloroform/methanol (2:1) and once with an equal volume of 
chloroform. The combined organic phases were neutralized and evapo-
rated in tubes containing mixtures of[1-"Cl8,9-,11,12-, and 14,15-EET 
(55-57 p.Ci/p.mol, 80 ng each) or [1-"CJ8,9-, 11,12-, and 14,15-DHET 
(55-57 ,._Ci/p.mol, 20 ng each) internal standards. Saponification to 
recover phospholipid-bound EETs and DHETs was followed by Si02 
column purification. The eluent, containing a mixture of radiolabeled 
internal standards and total endogenous EETs and DHETs, was re-
solved into individual regioisomers and enantiomers by HPLC as de-
scribed (35, 36). Individual EET pentafiuorobenzyl (PFB) esters were 
dissolved in dodecane and analyzed by GCIMS on a VG TRI0-1 quad-
rupole mass spectrometer (Fisons!VG, Altrincham, United Kingdom) 
operating under negative-ion chemical ionization conditions (source 
temperature, 100°C; ionization potential, 70 eV; filament current, 500 
p.A) at unit mass resolution and using methane as a bath gas. Quanti-
fications were made by selected ion monitoring of m./z 319 Qoss of PFB 
from endogenous EET-PFB) and m./z 321 (loss of PFB from [1-,.C]-
EET -PFB internal standard). Aliquots of individual DHET -PFB-tri-
methylsilyl (TMS) ether derivatives were dissolved in dodecane and 
analyzed by GC/MS as described (12). Quantifications were made by 
selected ion monitoring ofm./z 481 (loss ofPFB from endogenous DHET-
-PFB-TMS) and m./z 483 (loss of PFB from [1-14C]DHET-PFB-TMS 
internal standard). EET-PFB/11-14C]EET-PFB and DHET-PFB-
TMS/(1-,.C]DHET-PFB-TMS ratios were calculated from the inte-
grated values of the corresponding ion current intensities. 
Other methods. (1-14C!EET internal standards were synthesized 
from [1-14C]AA (55-57 p.Ci/p.moi) by nonselective epoxidation as 
previously described (38). DHET and [1-14C]DHET internal stan-
dards were prepared by chemical hydration of EETs and [1-14C]-
EETs (39). The w-terminal HETEs were synthesized as previously 
described (23, 40). All synthetic EETs, DHETs, and HETEs were 
purified by reverse-phase HPLC (2). Methylations were performed 
using an ethereal solution of diazomethane (41). PFB esters were 
formed by reaction with pentafiuorobenzyl bromide as described (36). 
TMS ethers were prepared using 25% (v!v) bis(trimethylsilyl)triflu-
oroacetamide in anhydrous pyridine (42). 
Statistics. Statistics were calculated using SuperAnova (Abacus 
Concepts, Inc., Berkeley, CA) for Macintosh. Student's t test and 
single-factor ANOVAs in combination with the Tukey-Kramer mul-
tiple comparisons test were used to determine significance. All data 
are reported as means :!: SE. 
RESULTS 
Characterization of Scup Liver Microsomes 
Prior to use in AA metabolism studies, liver micro-
somes from variously treated fish were characterized. 
Levels of total spectral P450, immunoreactive CYPlA 
protein, and CYPlA catalytic activity (EROD) in liver 
microsomes of control male and female fish are shown 
in Table I. In spring, control female fish had less total 
P450, CYPlA, and EROD activity than did males; 
these values increased in summer (Table 1). The con-
tent of the major protein recognized by anti-P450B 
(putative CYP2B) also was less in females than in 
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TABLE I 
Characterization of P450 in Liver Microsomes 
Total spectral P450 CYPlA EROD activity 
(pmol!minlmg) Treatment n Sex (nmol!mg) (pmol!mg) 
Spring 
Control 3 Male· 0.410 :!: 0.180 1:!: 1 175:!: 112 
90:!: 18 4 Female 0.122 :!: 0.034 nd 
Summer 
Control 4 Male 0.404 :!: 0.065 12:!: 3 736:!: 157 
168:!: 44 
8973:!: 163* 
7364:!: 919* 
8090:!: 960* 
4668,5995* 
3 Female 0.212 :!: 0.028 5:!: 0 
BP 5 Male 0.902 :!: 0.031 * 321:!: 13* 
3 Female 0.596 :!: 0.123* 222:!: 46* 
TCDD 5 Male 0. 725 :!: 0.100* 237:!: 40* 
2 Female 0.321, 0.428" 130, 133 
Note. Scup liver microsomes were characterized for their total P450 content, CYPlA content, and CYPlA catalytic activity (EROD) as 
described under Materials and Methods. Values are means :t SE. Spring and summer indicate the season in which experiments took place 
and fish were killed. Low levels of CYP1A detected in control fish are consistent with the fact that these fish had depurated for only 6 months. 
Longer times result in a further decrease of signal. Microsomes from these fish were used to determine rates of AA metabolism and the 
distribution of products. nd, not detectable. 
• Individual values. 
*Significantly different from control (P < 0.05, Tukey-Kramer). 
males in spring (P < 0.05, 417 :± 81 vs density units/mg 
microsomal protein 876 :± 95 density units/mg micro-
somal protein), but not in summer. Gonad-body 
weight ratios were significantly different in spring and 
summer (P < 0.002, spring: 3.8 :± 0.5, n = 7; summer: 
2.3 :± 0.2, n = 22). The trend of the relationship be-
tween gonad size, P450 levels, and CYP1A activity in 
females is consistent with previous observations that 
gonadal status affects P450s and their activity in scup 
liver (43). 
Treatment of male scup with either BP (10 mglkg) or 
TCDD (1 JLg/kg) resulted in significant increases in 
total P450 (1.8- to 2.2-fold), corresponding to the in-
crease in CYP1A content (20- to 27-fold) (Fig. 1 and 
Table I). EROD activity increased 11- to 12-fold follow-
ing treatment with either BP or TCDD (Table I). BP or 
TCDD induced total P450 content, CYP1A immunore-
Lane 
1234567 
___ .._ ........ 
FIG.l. Immunodetection ofCYP1Ain scup livermicrosomes. Liver 
microsomal fractions prepared from scup treated with com oil (80 
~!lane), BP (10 l-40ane), or TCDD (10 /Lg/lane) were electropho-
resed, transferred to nitrocellulose, and immunoblotted" with MAb 
1-12-3 against scup CYP1A. Lanes 1-3, corn oil; lanes 4 and 5, 
BP-treated; lanes 6 and 7, TCDD-treated. Visualization by NBT-
BCIP. 
active protein, and EROD activity also in female scup 
(Table D. The amounts ofCYP2B-like protein were not 
increased and if anything were decreased by treatment 
(control, 1110 :± 161; BP, 725 :± 170; TCDD, 669 :± 135 
density units/mg protein). 
Liver Microsomal AA Metabolism 
Hepatic microsomes prepared from control male 
and female fish incubated with [1-14C]AA, NADPH, 
and an NADPH-regenerating system formed EETs, 
DHETs, midchain HETEs, and w-terminal HETEs 
(Fig. 2). Identity of the metabolites was verified by 
coelution with authentic standards on reverse-phase 
and normal-phase HPLC and by GC/MS analysis (2, 
37). Epoxygenase metabolites (EETs and DHETs) 
were the major products, accounting for 44 :± 2% of 
total metabolites formed by both male or female liver 
microsomes, regardless of season. Lesser amounts of 
midchain HETEs, w-terminal HETEs, and polar me-
tabolites were produced (26 :± 2, 13 :± 1, and 11 :± 2% 
of total metabolites, respectively). Metabolite forma-
tion was NADPH-dependent and increased linearly 
with time and protein concentration (data not 
shown). The reaction rate was temperature depen-
dent, with the maximum reaction rate occurring at 
3o•c (data not shown), as with other scup liver P450 
reactions (26). 
Microsomal epoxidation of AA was highly regioselec-
tive, with a strong preference for epoxidation at the 
5,6-olefin (47 ::!: 2% of total EETs, n = 3 summer 
males). Epoxidation at the 14,15-, 11,12-, and 8,9-ole-
fins occurred less often (27 ::!: 1, 13 ::!: 1, and 13 :± 1%, 
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FIG. 2. Reverse-phase HPLC chromatograms of the organic soluble arachidonic acid metabolites generated by scup liver microsomes. (A) 
Untreated female scup. (B) BP-treated female scup. (C) Untreated male scup. (D) BP-treated male scup. Scup liver microsomes (2 mg/ml 
protein) were incubated with [l-14C)AA (50-70 p.M), NADPH, and an NADPH-regenerating system at ao•c for 1 h. Products were extracted, 
dried under a N2 stream, separated by reverse-phase HPLC, and quantified by on-line liquid scintillation as under Methods (2). Products 
were identified based on coelution with authentic standards. A similar amount of radioactivity was injected onto the column in each case. 
Data are from the spring experiment. Ordinate, radioactivity in cpm; abscissa, time in minutes. 
respectively; n = 3). We were unable to determine the 
stereochemistry of the epoxides as they were hydrated 
to DHETs by microsomal epoxide hydrolase (17). Ad-
dition of ETCP did not completely block the activity; 
DHETs still represented 24-49% of epoxygenase me-
tabolites in reactions containing ETCP. Hydroxylation 
of AA also occurred in a regioselective manner (Table 
II). 12-HETE was produced in the greatest amount 
(23% of total HETEs) followed by lesser amounts of 19-, 
15-, 20-, 11-, 8-, 9-, and 17-HETE. 
Hepatic microsomal AA metabolism differed by 4.2-
fold (P < 0.05) between sexes in fish sampled in spring 
(Figs. 2 and 3). In summer, the rates increased in 
females, and they were not significantly different from 
rates in males (135 ::!:: 18 pmol!min/mg vs 180 ::!:: 18 
pmol!min/mg, respectively). 
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To investigate the contribution of individual P450s 
to scup liver microsomal metabolism of AA, we per-
formed inhibition studies using PAb 118 against scup 
CYPlA and PAb 7-94 against scup P450B (Table III). 
Metabolism was inhibited progressively by increasing 
amounts of either antibody (Table III). Addition of the 
anti-CYP1A and anti-P450B antibodies together re-
sulted in approximately additive inhibition, up to 70% 
of microsomal AA metabolism (Table III). Epoxygenase 
and hydroxylase reactions were inhibited similarly. 
The results above suggest that CYP1A contributes in 
part to AA metabolism in scup liver. To investigate 
further a role for teleost CYP1A, we examined the 
effects of CYP1A induction on microsomal metabolism 
of AA. In male and female scup, BP treatment signifi-
cantly increased the total rate of formation of AA me-
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TABLE ll 
Regioselectivity of HETE Formation by Liver Microsomes 
from Untreated and BP-Treated Scup 
HETE 
8-
9-
11-
12-
15-
16-
17-
19-
20-
Distribution (%) of HETE formation 
in microsomes from 
Control scup BP-treated scup 
6::!:2 1::!:1 
4::!:2 2:!:2 
11::!: 4 16 ::!: 1 
23::!: 4 19::!: 3 
12::!: 4 12::!: 7 
19::!: 3 21::!: 2 
1::!: 1 5::!:3 
13::!: 4 21::!: 6 
12::!: 4 4::!:2 
Note. Scup liver microsomes (2 mg/ml protein) were incubated with 
[1-14C]AA (50-70 p.M), NADPH, and a NADPH-regenerating system 
at 3o•c for 1 h. Fractions corresponding to minutes 15-23 on reverse-
phase HPLC were collected batchwise, dried under N2 , and resolved 
into individual regioisomers by normal-phase HPLC (23, 37). Mini-
mal amounts of 5-HETE were detected. Data are from fish in sum-
mer experiments. Values are means ::!: SE (n = 3-5). Rate of total 
HETE formation was 35 ::t 14 pmollmin/mg (N = 8) by control scup 
liver microsomes and 63 ::!: 10 pmol/min/mg (N = 8) by liver micro-
somes from BP-treated scup. 
tabolites, by 2.7-fold in spring and 1.7-fold in summer 
(Fig. 4). Comparable increases occurred in EETs, 
HETEs, and unidentified polar metabolites (Fig. 2). 
Treatment did not alter significantly the regioselectiv-
ity for AA-epoxide formation by liver microsomes (data 
not shown). BP-treated animals in summer showed a 
2-fold induction in the formation of 19-HETE and a 
5-fold induction of 17-HETE (a minor metabolite) (Ta-
ble II). In contrast to BP, TCDD treatment in summer 
did not significantly induce microsomal metabolism of 
AA (Fig. 4), despite significant increases in total P450, 
CYP1A protein, and activity (Table I). 
Endogenous EET and DHET Content of Scup Liver 
EETs and DHETs were detected as endogenous con-
stituents of scup liver. Control fish livers contained 61 :!: 
5 ng EET/g tissue (Table IV) and 14 :!: 3 ng DHET/g 
tissue. The predominant EETs recovered from untreated 
fish liver were 8,9- and 14,15-EET, followed by a lesser 
amount of 11,12-EET (Table IV). The labile 5,6-EET 
could not be quantified. BP treatment resulted in a five-
fold increase in total liver EETs with a disproportionate 
increase in the amount of 14,15-EET recovered, from 31 
to 64% of the total (Table IV). TCDD treatment resulted 
in a threefold increase in total liver EETs, with a lesser 
shift in favor of the 14,15-EET (Table IV). In liver from 
untreated fish the S,R-enantiomers of 8,9-, 11,12-, and 
14,15-EET were predominant (optical purity 80, 64, and 
64%, respectively) (Table IV). Importantly, treatment 
with BP significantly increased the selectivity for the 
S,R- enantiomer of the three endogenous EETs measured 
in scup liver (Table IV). 
Metabolism of AA in Extrahepatic Scup Tissues 
AA metabolism by heart, kidney, and gill was exam-
ined using microsomal preparations of tissues from 
control and BP-treated fish. Microsomes from these 
tissues when incubated with [1-14C]AA, NADPH, and 
an NADPH-regenerating system formed EETs, 
DHETs, midchain HETEs, and w-terminal HETEs. 
HPLC analysis of EETs and DHETs indicated epoxi-
dation at the 5,6-, 8,9-, 11,12-, and 14,15-olefins by 
heart, gill, and kidney microsomes. Individual HETEs 
could not be identified because the radioactivity was 
too low for further normal-phase separation. The over-
all rates were 10- to 30-fold less than those observed 
with liver microsomes (activity in heart ranged from 
9.9 to 10.6 pmollminlmg; in gill, 2.8 to 3.9 pmollmin/ 
mg; and in kidney, 4.7 to 7.2 pmollminlmg). Extrahe-
patic microsomal AA metabolism rates were not in-
duced by BP (data not shown). To confirm that AA 
metabolism occurs in vivo in scup extrahepatic organs 
and to examine the effects of BP, endogenous EETs 
were measured in heart and kidney. In the summer 
experiment, heart and kidney from untreated fish con-
tained moderate amounts of 8,9-, 11,12-, and 14,15-
EET (Table V). 8,9-EET was the most prominent re-
gioisomer in heart (42% of total EETs), and 14,15-EET 
was the most prominent regioisomer in kidney ( 43% of 
total EETs). BP treatment did not significantly alter 
the concentration of total EETs present in heart or 
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FIG. 3. Seasonal and sex differences in scup liver microsomal me-
tabolism of arachidonic acid. Scup liver microsomes (2 mg/ml pro· 
tein) were incubated with [1-14C]AA (50-70 p.M), NADPH, and an 
NADPH-regenerating system at 3o•c for 1 h. Products were pro-
cessed, identified, and quantified as described in the legend to Fig. 2. 
Spring includes March and May. Data are means ::!: SE. *Significant-
ly different from spring (P < 0.01, Student's t test). Ordinate, AA 
metabolism in pmol product formed/min/mg microsomal protein; ab· 
scissa, gender and seasonal group. 
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TABLE Ill 
Antibody Inhibition of Scup Liver Microsomal Metabolism of Arachidonic Acid 
% Inhibition 
Anti-CYP1A Anti-P450B Anti-CYP1A + anti-P450B 
4 mglnmol 8 mg/nmol 
Metabolites P450 P450 
Total 21,6 44,21 
EET/DHET 24,0 49, 17 
HETE 16,5 37,20 
4 mg/nmol 
P450 
44,8 
49,3 
37, 7 
8 mglnmol 
P450 
48,44 
50,43 
44,34 
4 mg each/nmol 
P450 
34 
30 
32 
8 mg each/nmol 
P450 
70 
67 
65 
Note. Normal rabbit IgG, the polyclonal antibody 118 against scup CYP1A, or the polyclonal antibody 7-94 against scup P450B was added 
to microsomal reaction mixtures at protein/total P450 ratios of 4, 8, or 16 mg total IgG/nmol of P450. After 15 min at 30°C, [1-14C]AA (50-70 
!-<Ml was added, and the reaction was initiated with NADPH. Metabolites were extracted, resolved, and quantified as before (2).% Inhibition 
was calculated by comparing the metabolism by microsomes in incubations with specific antibodies to that by microsomes incubated under 
identical conditions with the same concentration of normal rabbit IgG. Data represent metabolism in a single individual. One individual had 
a greater amount ofCYPlA than the other, but both had similar amounts ofP450B. Microsomes from a third individual were incubated with 
2.5, 5, and 10 mg anti-CYP1A/nmol P450; increasing inhibition of AA metabolism also was seen. 
kidney (Table V). However, the relative concentration 
of 14,15-EET tended to increase in heart ofBP-treated 
fish (Table V). 
The stereochemical composition of endogenous EETs 
in scup heart and kidney was determined from a pooled 
sample of three organs from control animals (Table V). 
In kidney, the 8(S),9(R)- and ll(S),12(R)-EETs were 
recovered in excess (79 and 69%, respectively). In 
heart, the ll(S),12(R)- and 14(S),15(R)-EETs were re-
covered in excess (65 and 77%, respectively). In con-
trast to those EETs and to the liver and kidney, the 
8,9-EET showed a strong preference for the 8(R),9(S)-
enantiomers (78% optical purity). The stereochemistry 
of EETs formed in extrahepatic organs of BP-treated 
fish was not determined. 
DISCUSSION 
Metabolism of AA by cytochromes P450 results in 
products that are physiologically active, affecting a 
variety of functions including peptide hormone release 
(8), platelet aggregation (3), fluid electrolyte transport 
(44), and vascular tone [as reviewed in (5)]. Alteration 
in the expression of specific CYP isoforms may affect 
these biological processes. A general understanding of 
the importance of P450-derived eicosanoids in control-
ling physiological processes may be aided by examining 
AA metabolism in early vertebrate species and identi-
fying the CYP isoforms involved: Here we determined 
that P450s including CYP1A- and 2B-like proteins in 
hepatic microsomes of the marine fish scup (S. chry-
sops) catalyze regioselective metabolism of AA to EETs 
and HETEs. Recovery of endogenous AA epoxides from 
scup liver, heart, and kidney establishes that fish 
P450s metabolize AA in vivo. BP treatment induced 
rates of liver microsomal AA metabolism, but that ef-
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feet varied with season. Endogenous AA epoxide con-
tent, particularly in liver, was significantly elevated by 
BP even when microsomal rates were only slightly 
induced. The effects of TCDD on endogenous metabo-
lism were qualitatively similar to those of BP. 
Hepatic Metabolism of AA 
Untreated scup liver microsomes metabolized AA 
predominantly to EETs and also to HETEs. Similarly, 
rat, rabbit, and human liver microsomes all favor ep-
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FIG. 4. Effect ofBP and TCDD treatment on scup liver microsomal 
metabolism of arachidonic acid. Scup liver microsomes (2 mglml 
protein) were incubated with [l-14C]AA (50-70 !-<Ml. NADPH, and 
an NADPH-regenerating system at 30°C for 1 h. Products were 
processed, identified, and quantified as described in the legend to 
Fig. 2. In the March experiment, each dose group consisted of two 
females and one male. In the July experiment, each dose group 
contained seven to eight fish of mixed sex. Data are means ::!: SE. 
#Significantly different from control (P < 0.1, Student's t test). *Sig-
nificantly different from control (P < 0.05, Tukey-Kramer). Ordi-
nate, AA metabolism in pmol product formed/minlmg microsomal 
protein; Abscissa, treatment group. 
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oxidation of AA (9, 10, 17, 45). In contrast, chick em-
bryo liver microsomes favor w-terminal hydroxylation 
of AA (18). Scup liver microsomes had lower rates of 
AA metabolism (0.1-0.2 nmoVmin/mg microsomal pro-
tein) than did rat, chicken, or human liver microsomes 
(0.5, 1.3, and 0.6 nmol/min/mg, respectively) (9, 10, 18, 
45). However, the rate obtained with scup was similar 
to that measured in liver microsomes of another fish, 
F. heteroclitus (0.2 nmoVmin/mg).4 Similarly, the con-
centration of endogenous EETs in scup liver was six- to 
eightfold less than that seen in human or rat liver but 
was comparable to that in F. heteroclitus liver (41).5 
Both the regio- and stereochemistry of scup liver en-
dogenous EETs differ from that found in F. heterocli-
tus, rat, and human liver (36, 41, 45).5 
Species differences in the amount of endogenous eico-
sanoids recovered may reflect differences in the amount 
of AA present endogenously in cell membranes. Marine 
fish contain less AA and greater amounts of n-3 fatty 
acids (e.g., eicosapentaenoic acid) than do mammals or 
freshwater fish (46), presumably due to differences in diet 
and in ability to elongate fatty acids (47). However, dif-
ferences in the identity and abundance of specific metab-
olites will depend more on the P450 isoforins involved. 
The results here and those of Oleksiak et al. 4 •5 establish 
that multiple teleost P450s metabolize AA. Antibody in-
hibition indicated that CYPlA and a CYP2B-like protein 
contribute to AA metabolism in scup liver microsomes 
and may account for 70% of total AA metabolism. Mem-
bers of two new subfamilies in the CYP2 gene family, 
CYP2N and CYP2P, recently identified in the fish F. 
heteroclitus, also catalyze AA epoxygenase and hydroxy-
lase reactions.4•5 Homologues ofCYP2N and CYP2P have 
been identified in scup liver3 and likely contribute to AA 
metabolism in this species. CYP4 genes occur in fish (48), 
but homologues of CYP2C, prominent AA epoxygenases 
and hydroxylases in mammalian liver (45), have not been 
identified in fish. Having established that there are mul-
tiple CYP involved in AA metabolism in fish provides a 
foundation for determining the regulation of metabolite 
formation by P450 pathways in these early vertebrates 
and their relationship to P450-mediated AA metabolism 
in mammalian systems. 
Sex and Seasonal Differences in Hepatic AA Metabolism 
Microsomal AA metabolism in scup showed season-
ally dependent sex differences that could result from 
hormonal regulation of P450 gene expression. In con-
trol fish in spring (i.e., during gonadal development), 
females had lower AA metabolism rates than males. In 
• M. F. Oleksiak, S. Wu, C. Parker, J. J. Stegeman, and D. C. 
Zeldin, in preparation. 
5 M. F. Oleksiak, S. Wu, C. Parker, D. C. Zeldin, and J. J. Stege· 
man, in preparation. 
TABLE IV 
Endogenous EET Content in Scup Liver Following 
Treatment with CYPlA Inducers 
Enantioselectivity 
EET Distribution ofEET 
concentration ofEET 
Regioisomer (ng/g) (%) (%R,S) (%S,R) 
Control 
14,15- 19:!: 1 31 36:!: 6 64:!: 6 
11,12- 13:!: 1 21 36:!: 2 64:!: 2 
8,9- 29:!: 5 48 20:!: 3 80:!: 3 
Total 61:!: 5 100 
BP 
14,15- 208:!: 62* 64 17:!: 5 83:!: 5 
11,12- 39:!: 7* 12 16:!: 2 84:!: 2 
8,9- 77:!: 13* 24 9:!:0 91:!: 0 
Total 324:!:81* 100 
TCDD 
14,15- 93:!: 8*** 51 ND ND 
11,12- 32:!: 3** 18 ND ND 
8,9- 59:!: 7*** 31 ND ND 
Total 184:!: 17*** 100 
Note. Endogenous scup liver 14,15-, 11,12-, and 8,9-EET were 
extracted, purified, and quantified as described under Materials and 
Methods. Data are from male fish in the summer experiment. Fe-
males and the spring experiment with BP gave similar results. 
Concentration values are means :!: SE (n = 3-4). ND, not deter-
mined. 
*Significantly different from control (P < 0.01, Tukey-Kramer). 
**Significantly different from control (P < 0.05, Tukey-Krarner). 
*** Significantly different from control (P < 0.03, Student's t test; 
P < 0.1, Tukey-Kramer). 
summer (i.e., post-spawning), there was no significant 
sex difference in the rates of AA metabolism. CYPlA 
and CYP2B- and CYP3A-like proteins are suppressed 
by estradiol treatment or during natural maturation of 
female fish (43, 49). The lesser amounts ofCYPlA and 
putative CYP2B in female scup in spring indicate that 
at least two CYPs may contribute to the sex differences 
in AA metabolism in scup liver. However, expression of 
hepatic CYP2P and CYP2N, homologues of which occur 
in scup, does not differ between sexes of F. heterocli-
tus. 4•5 In rats, CYP2A, CYP2C, and CYP4A genes show 
sex differences in expression (50, 51); there might be 
sex differences in AA metabolism in rats. The physio-
logical significance of sex-linked differences in hepatic 
AA metabolism in any species is not known. 
Extrahepatic Metabolism of AA 
P450-mediated AA metabolism also was demon-
strated in scup heart, gill, and kidney, organs in which 
AA metabolites might be expected to be of physiological 
importance. Similar to human and rat kidney cortex 
(36, 52), the 14,15- and 8,9-EETs predominate in scup 
kidney. Interestingly, concentrations of endogenous 
EETs were as high in scup kidney as they were in liver, 
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TABLE V 
Endogenous EET Content of Scup Heart and Kidney 
Organ 
Heart 
Kidney 
EET regioisomer 
14,15-
11,12-
8,9-
Total 
14,15-
11,12-
8,9-
Total 
Control 
EETcontent 
(ng/g) (%) 
11:!: 2 35 
7:!: 1 23 
13 :!: 3 42 
34:!: 6 
35:!: 9 43 
17:!: 2 21 
29:!: 2 36 
80:!: 20 
BP-trcated 
Enantioselectivity of EETs EET content 
(%R,S) (o/oS, R) (ng/g) (%) 
23 77 15:!: 2 52 
35 65 6:!: 1 22 
78 22 8:!: 2 26 
29:!: 6 
ND ND 41:!: 5 46 
31 69 17:!: 1 19 
21 79 32:!: 2 35 
92:!: 11 
Note. Endogenous scup heart and kidney 14,15-, 11,12-, and 8,9-EETwere extracted, purified, and quantified as described under Materials 
and Methods. Data are from fish in summer experiments. Concentration values for EETs are means :!: SE from three pools of two to three 
individuals. ND, not detennined because the 14C/12C ratio was too low for quantification. 
suggesting that P450-derived EETs may be important 
to kidney function in fish. In mammalian kidney, EETs 
and HETEs modulate Na+/K+-ATPase, alter Ca2 + 
flux, affect proximal tubule sodium transport, and have 
vasoactive effects [see (44)]. 
The regioisomeric distribution of EETs in scup heart 
was similar to that in liver and kidney; however, the 
enantiomeric selectivity was different. In contrast to 
scup liver and to human and rat heart (12, 15), the 
8(R),9(S)-EET predominated in scup heart. Oleksiak et 
al. 5 determined that CYP2N2 cloned from F. heterocli-
tus heart forms 8(R),9(S)-EET; thus, a CYP2N2 homo-
logue might contribute to the enantioselectivity seen in 
scup heart. EETs have been shown to modulate mam-
malian cardiac physiology (15, 53), and their presence 
in scup heart may indicate a physiological role for 
these AA metabolites in fish heart as well. 
CYP lA and AA Metabolism 
Following BP treatment of scup, total hepatic micro-
somal AA metabolism increased 2-fold, with compara-
ble increases occurring in hydroxylase and epoxygen-
ase reactions. The regiochemistry of EETs was unaf-
fected by treatment, but hydroxylation shifted in favor 
of 17- and 19-HETE. This is similar to results with 
some, but not all, other species treated with AhR ago-
nists. In rats, BNF and PeCB decrease total hepatic AA 
metabolism, mainly resulting from a suppression of 
EET formation, while formation of 16- through 19-
HETE increases (22, 23). In guinea pig and rabbit, AhR 
agonists increase total hepatic AA metabolism 2-fold, 
with increases mainly in HETE formation (20, 22). In 
chick embryo liver, AhR agonists increase total AA 
metabolism and formation of EETs 6- to 10-fold (19). 
A major question concerns whether effects on AA 
metabolism contribute to AhR agonist toxicity (19) and 
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whether this involves induction of CYPlA. Several re-
sults support a hypothesis that AhR agonists affect AA 
metabolism in scup, possibly through CYP1A induc-
tion. (i) Specific antibodies to CYP1A inhibited AA 
metabolism in scup liver microsomes. (ii) Treatment of 
scup with the CYP1A inducer BP produced an expected 
strong induction of CYP1A in liver and increased liver 
microsomal AA metabolism, in both epoxygenase and 
hydroxylase reactions. (iii) Treatment with BP or 
TCDD increased endogenous hepatic EET content. (iv) 
Both the regia- and stereochemical profiles of liver 
EETs were altered following BP treatment, favoring 
the 14,15-EET and the S,R-enantiomers of all three 
EETs. (v) TCDD also caused a shift favoring the 14,15-
EET in liver. (vi) The regiochemical EET profile in 
heart shifted in favor of 14,15-EET following treatment 
with BP. On the other hand, BP treatment did not alter 
the total endogenous EET content in scup kidney or 
heart and did not alter the regiochemical profile of AA 
metabolites in the kidney; CYPlA is strongly induced 
in those organs by BP (unpublished observations). 
Also, treatment of scup with TCDD did not alter rates 
ofliver microsomal AA metabolism. While the antibody 
inhibition results and inducer effects on endogenous 
EETs suggest that CYPlA catalyzes AA metabolism in · 
scup, the TCDD and extrahepatic data are not fully 
consistent with this conclusion. 
TCDD effects on scup liver AA metabolism were 
qualitatively similar to those of BP, but were less 
strong, even though both compounds elicited similar 
induction of hepatic CYP1A. A difference in AA metab-
olism could occur if BP and TCDD induced different 
P450s in scup liver. In chick embryo there are two 
CYP1As which have different efficiencies for AA me-
tabolism (18). Phylogenetic analysis of CYPlA genes 
(32) suggests that many fish, including scup, have a 
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single CYP1A gene. [Multiple CYP1A genes in trout 
represent a very recent divergence (32), distinct from 
the divergence in birds and mammals.] Scup CYPlA 
expressed in Chinese hamster V -79 cells has catalytic 
properties of both mammalian CYP1A1 and CYP1A2, 
consistent with the hypothesis that teleost CYP1As 
represent a type ancestral to both of the mammalian 
genes (54); however, we cannot rule out that scup have 
an inducible CYP not yet identified. Also, BP, but not 
TCDD, might induce CYP1A through binding to gly-
cine N-methyltransferase (55) present in scup (56). 
Whether different induction processes affect CYPlA 
expression in fish is unknown. 
To our knowledge, these are the first observations of 
effects of TCDD or BP on endogenous AA metabolism. 
While CYPlA may be involved, alteration of AA metab-
olism in vivo by BP or TCDD might occur through pro-
cesses additional to CYPlA induction, perhaps involving 
effects on membrane structure. TCDD causes a loss of 
membrane fluidity, possibly by stimulation of lipid per-
oxidation (57), and a decrease in 20:5 and 22:5 polyun-
saturated fatty acids (58). BP causes a transition in mem-
branes from the gel to liquid crystal state (59), although 
the effect of this transition on AA availability is not 
known. That effects ofBP and TCDD cannot be ascribed 
solely to their action as AhR agonists is indicated, for 
example, by effects ofBP but not TCDD on expression of 
epidermal growth factor receptors, transforming growth 
factor />-1 and c-myc in human placental choriocarcinoma 
cells (60), and evidence for an AhR-independent induc-
tion of fos andjun genes by TCDD (61). 
Effects of BP treatment on extrahepatic AA metabolism 
also are not entirely consistent with CYPlA being a catalyst 
of AA metabolism in scup. CYPlA is strongly induced in the 
heart and kidney by AhR agonists (62) and is the dominant 
P450 in heart of induced scup (63). However, induction of 
CYPlA did hot affect cardiac microsomal AA metabolism, 
although there was a modest increase in endogenous 14,15-
EET of BP-treated fish. CYP2N2 is highly expressed in 
heart of some fish,5 and a CYP2N homologue might be a 
dominant AA metabolizing enzyme in scup heart. It will be 
important to determine whether CYPlA contributes to AA 
metabolism in heart in vivo, given that CYPlA-derived AA 
metabolites have been shown to possess potent cardioactive 
(15, 53) and vasoactive effects (64). Neither the total endog-
enous EET content nor the regiochenlical profile ofEETs in 
· scup kidney was altered by treatment with BP. In contrast, 
CYPlA inducers have been shown to alter renal nlicrosomal 
AA metabolism in the rabbit (20). Proteins in the CYP2C 
~ubfanlily may donlinate AA metabolism in mammalian 
kidney (65). CYP2C homologues have not been identified in 
fish, but certainly some isoforms other than CYPlA are 
contributing to AA metabolism in teleost kidney. 
In summary, the results here demonstrate that the 
marine fish scup metabolizes AA in a regio- and ste-
reospecific fashion in vivo and in vitro, producing eico-
sanoids in organs including liver, heart, and kidney. 
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Physiological roles for cyclooxygenase- and lipooxygen-
ase-derived AA metabolites have been demonstrated in 
fish (66, 67). Our results and those of Oleksiak et a/.4•5 
demonstrate that P450s are members of the AA meta-
bolic cascade in teleosts; P450-derived AA metabolites 
may play physiological roles in fish, as they do in mam-
mals. Given the greater content ofn-3 fatty acids in some 
fish, it will be important to determine whether they also 
are metabolized to biologically active metabolites by 
teleost P450s. Treatment with AhR ag01lists produced 
variable though generally weak effects on microsomal 
metabolism of AA, but they had stronger effects on the 
extent of metabolism of endogenous AA and affected the 
regio- and stereospecificity of that metabolism. The alter-
ations in AA metabolism following BP or TCDD treat-
ment leave open the possibility that such changes may be 
involved in toxicity of AhR agonists in early vertebrates, 
although whether such metabolism might act in a pro-
tective way cannot be ruled out. 
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CHAPTER 3 
Oxidative Inactivation of Cytochrome P450 lA Stimulated by 3,3',4,4'-
Tetrachlorobiphenyl: Production of Reactive Oxygen by Vertebrate 
CYPlAs 
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ABSTRACT 
Microsomal cytochrome P450 1A (CYP1A) in a vertebrate model (teleost fish scup 
(Stenotomus chrysops)) recently was shown to be inactivated by the planar aryl 
hydrocarbon receptor agonist 3,3',4,4'-tetrachlorobiphenyl (TCB) (Biochem. Phannacol. 
53, 1029-1040 (1997)). Here, the mechanism of CYP1A inactivation and its relationship 
to substrate-dependent generation of reactive oxygen species (ROS) were examined in liver 
microsomes .from scup and rat. Initially we confirmed that inactivation of scup CYP1A 
activity (7-ethoxyresorufin 0-deethylation (EROD)) by TCB was time- and NADPH-
dependent. This loss ofEROD activity, equated with CYP1A inactivation, was irreversible 
and dependent upon molecular oxygen. Microsomal NADPH oxidation rates increased 
upon addition of TCB, and CYP1A inactivation was lessened by addition of cytochrome c. 
Loss of EROD activity was accompanied by a loss of spectral P450, by a variable loss of 
heme and by a variable appearance of P420. Rates of TCB metabolism were <0.5 
pmolJmin/mg, indicating that inactivation did not proceed via a TCB metabolite. Addition 
of non-heme iron chelators (diethylenetriaminepenta-acetic acid and deferoxamine), anti-
oxidant enzymes (catalase and superoxide dismutase ), and ROS scavenging compounds 
(ascorbate, ma."lrJtol a11d tocopherol) had no influence on the inactivation. Added H202 
enhanced the inactivation, but only the enhanced loss of activity could be eliminated by 
addition of catalase. TCB-dependent CYP1A inactivation was accelerated by azide but not 
by hydroxylamine or aminotriazole. TCB stimulated the formation of ROS when added to 
microsomes with induced levels of CYP1A but not microsomes from untreated animals. 
Moreover, as native CYP1A was lost due to TCB-dependent inactivation, there was a 
concurrent reduction in ROS formation. TCB-stimulated inactivation of CYP1A also was 
identified in rat liver microsomes. Liver microsomes from Aroclor-treated rats also showed 
an increased ROS production when incubated with TCB. TCB stimulated ROS formation 
by baculovirus expressed human CYP1A1 but not CYP1A2. The results indicate that slow 
metabolism of TCB uncouples electron transfer to and monooxygenation by CYP1A, 
resulting in inactivation due to the formation and attack of ROS within the CYP1A1 active 
site. ROS formed by CYP1A bound with planar halogenated aromatic hydrocarbons may 
contribute to the toxic effects of these compounds. Species differences in the metabolism 
of and the inactivation by TCB also suggest differences in the topology of the substrate 
access channels or the active sites of homologous CYP1As. 
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INTRODUCTION 
Mechanisms by which planar halogenated aromatic hydrocarbons (pHAH) 
(2,3,7,8-tetrachlorodibenzo-p-dioxin - TCDD, non-ortho polychlorinated biphenyls -
PCBs) exert toxicity are not understood fully. PHAH, polycyclic aromatic hydrocarbons, 
and natural products are agonists of the aryl hydrocarbon receptor (AhR), a basic-helix-
loop-helix/PAS protein that is a ligand activated transcription factor (Hankinson, 1995). 
AhR activation leads to altered expression of drug metabolizing enzymes (cytochrome P450 
1A, glutathione S-transferase, UDP glucuronosyl transferase) and genes involved in cell 
growth control (e.g. transforming growth factors-a and -B, B-Jun, Jun-D) (Hankinson, 
1995). Mice rendered AhR deficient by locus-specific homologous recombination are 
resistant to TCDD toxicity, indicating that toxicity of pHAH is dependent upon the AhR 
(Fernandez-Salguero et al., 1996). The occurrence of oxidative damage in animals or cells 
exposed to pHAH (Stohs et al., 1990; Buchmann et al., 1991; Toborek et al., 1995; Park 
et al., 1996) suggests that toxicity of some AhR agonists might involve reactive oxygen 
species (ROS). 
Uncoupling of electron transfer and oxygen reduction from monooxygenation by 
cytochromes P450 (CYP) can result in t.l:le release of ROS (OT• and H202). Gillette et al. 
(1957) first demonstrated microsomal NADPH-dependent generation of H202 by rabbit 
liver microsomes. 02-•, H202 and/or OH• also are formed by human or rat liver 
microsomes in the presence ofNADPH (Rashba-Step and Cederbaum, 1994; Reinke et al., 
1994). NADPH-stimulated formation of ROS by liver microsomes can be decreased by the 
inhibitor SKF525A (Bondy and Naderi, 1994), implying CYP involvement. CYP forms 
including CYP2E1, CYP2B4 and CYP3A have been shown to release ROS, usually upon 
substrate binding, which accelerates electron transfer to CYP heme (Kuthan and Ullrich, 
1982; Ekstrom et al., 1986; Ahmed et al., 1995). However, for most CYP, the degree to 
which uncoupling occurs and the conditions that might favor uncoupling are not known. 
This study considers uncoupling of and ROS formation by CYP1As. 
Suggestions that CYP1A can produce ROS initially came from studies of 
microsomal oxidation of uroporphyrinogen and bilirubin. That oxidation was suggested to 
occur as a result of ROS formed during uncoupling of the CYP1A catalytic cycle by non-
ortho PCBs (Sinclair et al., 1986; DeMatteis et al., 1991). Oxidative damage correlated 
with CYP1A induction following treatment of cells with pHAH (Toborek et al., 1995; Park 
et al., 1996) further suggests uncoupling of CYP1A. To our knowledge, there has been no 
direct demonstration that pHAHs stimulate ROS production by CYP1A. 
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One effect of ROS generated by CYP1A may be inactivation of the enzyme. 
3,3',4,4'-Tetrachlorobiphenyl (TCB) and other planar PCBs not only induce CYP1A but 
also can elicit sharp declines in CYP1A activity and content following exposure to high 
doses (Gooch et al., 1989; Sinclair et al., 1989; Hahn et al., 1993; Stegeman et al., 1995). 
In the fish model, scup (Stenotomus chrysops), the TCB-dependent decrease in CYP1A 
was shown to be post-transcriptional, and studies in microsomes showed that TCB can 
inactivate as well as inhibit scup CYP1A (White et al., 1997a). TCB is a ligand for scup 
CYP1A but is metabolized slowly (Gooch et al., 1989; White et al., 1997b). Therefore, it 
was speculated that inactivation may be due to uncoupling of CYP1A and formation of 
ROS (White et al., 1997a). A number of enzymes (CYP2B, Cu,Zn-superoxide dismutase 
(SOD), Fe-SOD, lactoperoxidase, myeloperoxidase, xanthine oxidase) that use or produce 
H202 and that contain· a metal ion undergo oxidative auto-inactivation (Loosemore et al., 
1980; Matheson and Travis, 1985; Beyer and Fridovich, 1987; Jenzer et al., 1987; 
Karuzina and Archakov, 1994). 
In this paper we examine the nature of non-ortho PCB-stimulated inactivation of 
CYP1A and its relationship to ROS formation in uncoupled catalytic cycles of CYP1A. We 
examine this process using TCB as a model pH.AH in liver !!licrosomes from the marine 
fish scup, a system in which the phenomenon of CYP1A inactivation was identified and 
where it is quite strong. The results indicate that inactivation of CYP1A is a result of 
uncoupling and provide the first direct demonstration that CYP1A in the native state bound 
with a pHAH is a source of ROS. Similar studies were conducted using rat liver 
microsomes and expressed human CYP1As. In the mammals, as in scup, the formation of 
ROS was linked to binding of TCB to CYP1A, apparently CYP1Al. However, 
inactivation of mammalian CYP1As was less strong than in scup, suggesting differences in 
the active sites of the CYP1A homologues in these species. 
MATERIALS AND METHODS 
Chemicals: Benzo[a]pyrene was purchased from Aldrich (Milwaukee, WI). 2',7'-
Dichloro-dihydrofluorescein diacetate, dihydroethidium, 7 -ethoxyresorufin and 7-
methoxyresorufin were purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
tetrachlorobiphenyl and 3,3',4,4'-tetrachlorobiphenyl-Ring-UL-14c (52.1 mCi/mmol) 
were purchased from Pathfinder (St. Louis, MO). Analysis of the 14c-3,3',4,4'-TCB by 
GC/ECD and GC/MS revealed no hydrophobic contaminants (>99% pure); small amounts 
of polar contaminants were removed by dissolving the TCB in hexane and extracting twice 
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with NaOH. Hydroxylamine was purchased from Fisher (Pittsburgh, PA). Catalase was 
purchased from Sigma, contained less than 0.1% thymol and was determined to have the 
manufacturer specified activity. All other reagents were purchased from Sigma (St. Louis, 
MO). 
Animals: Scup (Stenotomus chrysops ) were caught by angling in Vineyard 
Sound, MAin 1992, 1994 and 1996. Fish were held in flow-through seawater tanks at 
14 oc and maintained on a diet of Purina Trout Chow. Experimental animals ranged in size 
from 1~5 to 358g. -Control fish received no treatment. To induce CYP1A, fish were 
injected intra-peritoneally with a solution of benzo[a]pyrene (BP) (10 mglkg) in corn oil. 
BP was used because it is a potent inducer, is rapidly metabolized, and does not cause 
uncoupling of scup CYP1A (unpublished results). Three days following injection the fish 
were killed by severing the spinal cord. The livers were harvested, and microsomes were 
made immediately. Eleven microsomal pools were prepared with livers from 3 to 6 fish per 
pool. 
Microsome preparation: Hepatic microsomal fractions were prepared by differential 
centrifugation (Stegeman et al., 1979). Following the initial sedimentation, microsomes 
were washed by resuspending in 0.15 M KCl and sedimenting again. Microsomes also 
were prepared from post-mitochondrial supernatants from livers of untreated rats and rats 
treated with Aroclor 1254 (Molecular Toxicology, Inc., Annapolis, :MD). Pellets were 
resuspended in buffer (50 mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20% 
glycerol) and frozen in liquid N2 until use. Microsomes from baculovi_rus-infected insect 
cells expressing human NADPH cytochrome P450 reductase together with either human 
CYP1A1 or CYP1A2 were purchased from Gentest Corp. (Boston, MA). Protein content 
was determined by the bicinchoninic acid method (Smith et al., 1985), using bovine serum 
albumin (BSA) as a standard. 
Western blotting for CYP IA quantification: Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal 
proteins (10 J.lg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically 
transferred to 0.1 J.lm nitrocellulose membrane. The primary antibodies were the mouse 
monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E (CYP1A; 
(Morrison et al., 1995)) and the polyclonal antibody Rye, raised against mouse CYP1A2 
(Stegeman et al., 1995). MAb 1-12-3 is highly specific for CYP1A in fish and CYP1A1 in 
mammals. The secondary antibodies were alkaline phosphatase linked goat anti-mouse 
IgG and goat anti-rabbit IgG (Biorad, Hercules, CA). The immunoreactive bands were 
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visualized using nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate and 
quantified by video image analysis (NIH Image 1.60b5) by comparison to scup standards 
of known concentration. Where appropriate, the CYP1A1 values for rat are relative, 
reported as scup CYP1A equivalents. 
Enzyme assays: Microsomal ethoxyresorufin 0-deethylation (EROD) and 
methoxyresorufin 0-demethylation (MROD) were determined fluorometrically (Hahn et al., 
1993), using a Cytofluor 2300 (Millipore) multiwell plate reader. NADPH-dependent 
cytochrome c reductase activity was measured at room temperature from the increase in 
absorbance at 550 nm using a Shimadzu 210 difference spectrophotometer (Stegeman et 
al., 1982). NADPH oxidation was determined at room temperature from the decrease in 
absorbance at 340 nm (Imai, 1979). TCB metabolism was assessed using the methods of 
White et al. (1997b). Radioactivity was determined by liquid scintillation counting on a 
Beckman LS5000TD counter. 
In vitro studies of CYP JA inhibition and inactivation: The procedure followed that 
of White et al. (1997a). Microsomes were incubated at 0.1 mg/ml in buffer (50 mM TRIS, 
0.1 mM EDT A, pH 7 .6) at a final volume of 1 ml in glass test tubes at 30°C. The 
following chemicals were added in various combinations at the final concentrations 
indicated: acetone (0.5 %), ascorbate (1 mM), 3-amino-1,2,4-triazole (0.1 mM), azide 
(0.01-1 mM), catalase (800 units/ml), cytochrome c (10 J.1M), deferoxamine (1 mM), 
DTPA (1 mM), Fe-EDTA (1 mM), H202 (1 mM), hydroxylamine (0.1 mM), mannitol (1 
mM), NADPH (1.8 mM), SOD (400 units/ml), TCB (0.017-17 J.1M) and tocopherol (1 
mM). Aliquots were removed from the reaction mixtures at times zero, 10, 20 and 30 
minutes and then were assayed as above for the rate of EROD or MROD over 5 minutes 
(White et al., 1997a). Inhibition was calculated by comparing EROD activity at 10 minutes 
in control reaction mixtures to that in reaction mixtures containing TCB alone. Inactivation 
was calculated by comparing EROD activity at 30 minutes in reaction mixtures containing 
TCB alone to that in reaction mixtures containing TCB+NADPH. Curve fitting was 
performed using Sigma Plot for Macintosh (SSPS Inc., Chicago, IL). For inhibition, the 
IC50 was determined directly from the plot of TCB concentration and activity loss. The 
method of (Cha, 1975) was used to convert the IC50 to a Ki, considering TCB as a tight 
binding inhibitor. To remove TCB from reaction mixtures, microsomes were sedimented, 
resuspended (50 mM TRIS, pH 7.4, 0.15 M KCl, 0.1 mM BSA), incubated 6 minutes at 
37°C, sedimented and resuspended. 
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Some incubations were performed under anaerobic conditions. Hungate techniques 
were used to prepare reaction mixtures as these techniques completely purge the 
experimental system of oxygen (Hungate, 1969). Reaction mixtures were prepared in 
stoppered serum bottles. Oxygen was purged from the bottles by bubbling argon gas 
through the bottles for 30 minutes while they were on ice. The argon had been rendered 
free of oxygen by passage through a hot, reduced copper column. An NADPH solution 
was purged in the same manner. NADPH was added to the appropriate reaction mixtures 
using a syringe repeatedly purged of oxygen by filling it with the argon gas and evacuating 
it. Aliquots of reaction mixtures also were withdrawn using an argon purged syringe. 
Otherwise, sampling and analysis procedures were as described above. 
Spectral P450 and heme assays: To determine if there was a loss of P450 or heme, 
microsomes (0.4 mg protein/ml) were incubated in buffer (50 mM TRIS, 0.1 mM EDTA, 
pH 7.6) at 30°C. The following chemicals were added in various combinations at the final 
concentrations indicated: acetone (0.5 %), TCB (17 j.tM), and NADPH (0.7 mM). 
Following a 30 minute incubation, total P450 concentration was determined by bubbling 
reaction mixtures with CO and obtaining the dithionite-difference spectra (Bonkovsky et 
al., 1984). Heme was determined in reaction mixtures using the pyridine hemochrome 
assay (Omura and Sato, 1964). 
Peroxide and superoxide formation: The production of H202 was determined by 
measuring the formation of formaldehyde from the oxidation of methanol by the catalase I 
complex (Rashba-Step and Cederbaum, 1994). The SOD-sensitive rate of adrenochrome 
formation was measured by the absorption change at 485 nm (Misra and Fridovich, 1972). 
H202 and 02-• formation also were determined simultaneously using two 
fluorescent dyes. The oxidation of 2',7'-dichlorodihydrofluorescein diacetate (DCDFDA) 
and dihydroethidium (HE) to fluorescent products was used to measure H202 and 02-• 
production, respectively. The method is a modification of those by Bondy and Naderi 
(1994) and Robinson et al. (1994). In a 48-well plate, 0.1 mg of microsomal protein was 
diluted to 160 j.tl with Hank's buffered salt solution (HBSS)(120 mM NaCl, 2.5 mM, 
KCL, 1.2 mM NaH2P04, 0.1 mM MgCl2, 5.0 mM NaHC03, 6.0 mM glucose, 1.0 rnM 
CaCl2 and 10 mM HEPES) containing 5 j.tM DCDFDA and 7.5 j.tM HE (final 
concentrations). Following a 15 minute pre-incubation at 3o·c, either acetone (5 j.tl) or 
TCB (1.7 nmol in acetone) was added. In some cases 200 units of SOD then were added. 
Reactions were initiated with NADPH (1.4 mM) and fluorescence was monitored over 10 
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minutes with 485 nm excitation and 530 nm and 625 nm emission filters for DCDFDA and 
HE, respectively. 2',7'-Dichlorofluorescein and ethidium bromide were used as standards. 
The capacity for formation of ROS during in vitro inactivation of CYP1A was 
determined as follows. Reaction mixtures were prepared as for the inactivation assay. 
Aliquots were removed from the reaction mixtures at 10, 20 and 30 minutes. OT• 
production was assessed as described above except that 50 Ill aliquots were combined with 
100 Ill HBSS and HE (15 !lM). NADPH (1.4 mM) was added to those aliquots taken 
from reaction mixtures that did not contain NADPH. Ethidium production rates were 
monitored fluorometrically over 5 minutes as described above. 
Statistics: Statistics were calculated using SuperAnova for Macintosh (Abacus 
Concepts, Inc., Berkeley, CA). Two-factor ANOVAs (microsomal pool and treatment) 
were used to analyze the spectral P450, inactivation and ROS time course experiments. 
One factor ANOV As were used to analyze the cytochrome c experiments and ROS 
determinations. The Tukey-Kramer and Dunnett's multiple-comparisons tests were used to 
determine differences between incubation conditions. 
RESULTS 
Inactivation of scup liver CYP JA: Initially we sought to confirm that 
TCB+NADPH could inactivate microsomal CYP1A, using methods employed previously 
(White et al., 1997a). Incubating liver microsomes from BP-treated scup with acetone or 
with NADPH over 30 minutes did not alter their capacity to catalyze EROD (Figure 1). 
Incubating liver microsomes with TCB alone resulted in an immediate 50% inhibition of 
EROD, but the activity did not decline further over time (Figure 1). That inhibition of 
EROD was TCB concentration-dependent, and the Ki was 0.16 !lM (Figure 2). In 
contrast, when hepatic microsomes were incubated with both TCB and NADPH there were 
both an immediate inhibition and a progressive loss of activity (Figure 1). Liver 
microsomes incubated with TCB and NADPH for 30 minutes had 63 ± 6% less capacity to 
catalyze EROD activity than did microsomes incubated with TCB alone. As with 
inhibition, the progressive loss of EROD activity also was TCB concentration-dependent 
(Figure 2). This inactivation of EROD did not occur when microsomes were incubated 
with TCB and NADH instead of NADPH (data not shown). 
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Figure 1. TCB-stimulated inactivation of scup liver CYP1A (EROD activity). Microsomes 
(0.1 mg proteinlml with 380 ± 150 pmol CYP1Nmg) were incubated in buffer (50 mM 
TRIS, 0.1 mM EDTA, pH 7.6) at a final volume of 1 ml in glass test tubes at 30°C. The 
following chemicals were added in various combinations at the final concentrations 
indicated: acetone (5 %), NADPH (1.8 mM), and TCB in acetone (1.7 J.tM). Aliquots 
were removed from the reaction mixtures at times zero, 10, 20 and 30 minutes and then 
were assayed fluorometrically for the rate of EROD over 5 minutes. Complete inactivation 
of EROD occurred within 1 hour. Data are means ± SD from 11 pools of microsomes. 
*Statistically different from all other incubation conditions analyzed at 30 minutes (p<0.01, 
Tukey-Kramer). 
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Figure 2. TCB concentration dependent inactivation of scup liver CYP1A. Incubation 
conditions and assay technique were as described in Figure 1, except that a range of TCB 
concentrations was used (0.017-17 JlM). Inhibition was calculated by comparing EROD 
activity at 10 minutes in control reaction mixtures to that in reaction mixtures containing 
TCB alone. Inactivation was calculated by comparing EROD activity at 30 minutes in 
reaction mixtures containing TCB alone to that in reaction mixtures containing 
TCB+NADPH. Results from 3 pools of microsomes were used to determine the curve fit. 
The ICso was determined by a non-linear regression analysis of the activity loss vs. TCB 
concentration plot. The method of (Cha, 1975) was used to convert the ICso to a Ki (0.16 
JlM). TCB was considered a tight binding inhibitor because increasing concentrations of 7-
ethoxyresorufin did not effectively displace the TCB (data not shown). 
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The capacity to catalyze EROD was not restored by removal of TCB from 
microsomes incubated with TCB+NADPH. Microsomes incubated for one hour with 
TCB+NADPH had only 7 ± 0% of the EROD capacity retained in microsomes incubated 
with acetone±NADPH; following repeated washing and resedimenting microsomes to 
remove TCB, EROD rates were unchanged. However, at least 50% of EROD activity 
could be restored by a similar removal of TCB from microsomes that had been incubated 
with TCB alone (37 ± 4% vs. 68 ± 4% of control activity before and after TCB removal, 
respectively). 
In addition to the loss of EROD, scup liver microsomes incubated with 
TCB+NADPH showed a loss of spectral P450. Incubation of microsomes for 30 minutes 
with TCB+NADPH resulted in the loss of approximately 50% of the spectral P450 signal 
(Table I). There was no loss of spectral P450 when microsomes were incubated with TCB 
alone (Table I). A slight, but not significant, loss of spectral P450 occurred when 
microsomes were incubated with NADPH alone. The TCB-stimulated loss of P450 was 
accompanied by a variable loss of heme and a variable appearance of cytochrome P420 
(Table I). Thus, while the amount of P450 decreased consistently in the experiments, the 
proportion which was modified to P420 varied. 
The above results suggest that TCB could cause the loss of CYP1A activity either 
by mechanism-based inactivation, i.e. inactivation by a metabolite of TCB, or by 
stimulation of oxidative inactivation. TCB is a substrate for scup CYP1A, but it is 
metabolized very slowly (White et al., 1997b). Scup hepatic microsomes used in these 
inactivation studies metabolized TCB at a rate of 0.34 ± 0.08 pmol/min/mg. However, 
P450 content declined at 12 ± 6 pmollmin/mg, calculated from the difference spectra, and 
CYP1A content declined at 8 ± 3 pmol /min/mg, calculated from the loss of EROD 
(assuming that loss of EROD is equated with loss of CYP1A). Even though rat liver 
microsomes have been shown to activate TCB to a form which can bind to CYP1A1 
(Shimada and Sawabe, 1983), the rate of TCB metabolism and hence possible covalent 
binding of TCB cannot account for the loss of P450. 
In light of the extremely slow metabolism of TCB, we examined the possibility that 
catalytic uncoupling may be occurring. Microsomal oxidation of NADPH in the presence 
of acetone (carrier) was 13 ± 5 nmollmin/mg and increased in the presence of TCB, to 33 ± 
9 nmol/min/mg (Table V). When microsomes were incubated under anaerobic conditions, 
TCB-dependent inactivation of EROD did not occur. Thus, microsomes incubated 
anaerobically with TCB alone for 45 minutes had a capacity for EROD activity of 2544 
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TABLE I 
Loss of scup liver P450 stimulated by TCB and NADPH 
P450 P420 Heme 
Additions to nmollmg %Loss nmol/mg nmollmg %Loss 
reaction (Range) (Range) (Range) 
mixtures 
Acetone 0.89 ± 0.33 ND 1.44 ± 0.52 
NADJ'H 0.73 "± 0.35 22 ± 9 0.04 ± 0.07 1.26 ± 0.49 16 ± 12 
(17- 47) (0.00- 0.19) (0- 37) 
TCB 0.91 ± 0.46 ND 1.34 ± 0.46 
TCB+NADPH 0.48 ± 0.22* 49 ± 7 0.07 ± 0.10 1.05 ± 0.40 28 ± 16 
~32- 632 ~0.00 - 0.292 ~1 - 482 
To determine if there was a loss of P450 or heme, microsomes (0.4 mg protein/ml) were 
incubated in buffer (50 mM TRIS, 0.1 mM EDTA, pH 7.6) at 30°C. The following 
chemicals were added in various combinations at the final concentrations indicated: acetone 
(0.5 %), TCB (17 JlM), and NADPH (0.7 mM). Following a 30 minute incubation, total 
P450 concentration was determined by bubbling reaction mixtures with CO and obtaining 
the dithionite-difference spectrum. Heme was determined in reaction mixtures using the 
pyridine hemochrome assay. P450 determinations were made on 9 pools of microsomes 
and initial concentrations ranged from 0.53- 1.40 nmol/mg. Heme determinations were 
made on 6 .pools of microsomes, and initial concentrations ranged from 0.60 - 2.04 
nmol/mg. Heme and P450 determinations were not made in the same experiments. Data 
are means± SD. 
* -Significantly different from all other incubation conditions (p<0.01, Tukey-Kramer). 
ND- Not detectable. 
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pmol/min/mg, and aliquots of the same pool of microsomes incubated anaerobically with 
TCB plus NADPH had an EROD activity of 2829 pmol/min/mg. Enhanced electron 
transfer, oxygen dependence and exceedingly slow rates of substrate turnover are 
consistent with uncoupling of electron transport from substrate oxidation. 
If inactivation is occurring because of uncoupling, then interruption of the electron 
flow to CYP1A should reduce the magnitude of inactivation. Cytochrome c inhibits CYP 
by competing for electrons from CYP reductase (Estabrook et al., 1996). Addition of 10 
J..lM cytochrome c to microsomal incubations with TCB+NADPH lessened the rate of 
inactivation (Figure 3). The rate of loss of EROD was 3.5 ± 0.6 pmol/min/mg in the 
presence of cytochrome cas compared to 7.7 pmol/min/mg in its absence. 
A series of antioxidants, prooxidants and enzymes were tested for their influence on 
TCB-dependent EROD inactivation. Initially, several catalase inhibitors were tested. Azide 
(0.1 mM) caused a 2-fold increase in the rate of inactivation in the presence of 
TCB+NADPH by 10 minutes, and inactivation in the presence of TCB+NADPH was 
enhanced significantly by azide by 20 minutes (Figure 4A). There was no significant loss 
of EROD activity from microsomes incubated with NADPH and 0.1 mM azide and without 
TCB. (There was a loss of activity at a higher concentration of azide (1 mM) +NADPH; 
Figure 4). Two other catalase inhibitors, aminotriazole (ATA) and hydroxylamine (HA), at 
0.1 mM, did not alter the rate of inactivation (Table II). Therefore, the enhanced 
inactivation due to azide does not appear to result from inhibition of catalase but rather 
occurs through some other mechanism. 
As with addition of azide, addition of H202 increased the rate of inactivation by 
TCB+NADPH (Figure 4B). At 10 minutes, .there was a 3-fold greater loss of EROD 
activity from microsomes when H202 was added with the TCB+NADPH, compared to the 
loss occurring without added H202. Little loss of activity occurred with H202 alone, or 
with H202+NADPH. As expected, when catalase was added together with H202, it 
eliminated the increase in inactivation due to the exogenous H202 (Table III). However, 
adding catalase did not affect the inactivation caused by TCB+NADPH (Table ill). 
Attempts to scavenge ROS or to alter the iron concentration external to the active 
site had no effect on inactivation. Addition of SOD did not decrease the inactivation due to 
TCB+NADPH (Table IV). Similarly, neither the hydrophilic reactive oxygen scavenging 
compounds, ascorbate and mannitol, nor the lipophilic reactive oxygen scavenging 
compound, tocopherol, altered the inactivation stimulated by TCB (Table IV). Likewise, 
manipulation of the iron content in the reaction mixture did not influence inactivation (Table 
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Figure 3. Effect of cytochrome c on TCB-stimulated scup liver CYP1A inactivation. 
Incubation conditions and assay technique were as described in Figure 1, except for the 
addition of cytochrome c (10 J.LM). Percent control EROD activity was calculated by 
comparing reaction mixtures containing TCB+NADPH to control reaction mixtures, 
reaction mixtures containing TCB+cytochrome c to those containing cytochrome c and 
reaction mixtures containing TCB+cytochrome c+NADPH to those containing 
TCB+cytochrome c. Data are the means ± SD from 5 pools of microsomes. *Statistically 
different from all other incubation conditions analyzed at 30 minutes (p<0.01, Tukey-
Kramer). 
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Figure 4. Effects of azide (A) and H202 (B) on TCB-stimulated scup liver CYP1A 
inactivation. Incubation conditions and assay technique were as described in Figure 1, 
except for the addition of azide (0.1 mM) or H202 (100 mM). Addition of 1 mM 
azide+NADPH resulted in a loss of activity over time; the EROD activity was 3158 ± 1046 
pmollmin/mg at 10 minutes and 1599 ± 606 pmol/min/mg at 30 minutes. Addition of 0.1 
mM azide or 100 mM H202 to acetone or TCB reaction mixtures did not alter EROD 
activity. Data are the means± SD from 5 pools of microsomes. *Statistically different 
from all other incubation conditions analyzed at 20 minutes (p<0.01, Tukey-Kramer). 
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TABLE IT 
Effect of catalase inhibitors on TCB-stimulated CYP1A inactivation 
Additions to reaction mixtures EROD Activity (pmollmin/mg) % Loss of activitya 
in aliquots taken at: 
10 minutes 30 minutes 30 minutes 
Aminotriazole (ATA)b 
TCB 1705 ± 831 1626 ± 659* 
TCB+NADPH 1456 ± 616 785 ± 207 52 
0.1 mM ATA+NADPH 3932 ± 1330 3498 ± 841 * 
0.1 mM ATA+TCB 1653 ± 686 1614 ± 547* 
0.1 mM ATA+TCB+NADPH 1001 + 546 709 + 298 56 
Hydroxylamine (HA)c 
TCB 3283 ± 257 3118 ± 164* 
TCB+NADPH 2482 ± 483 1072 ± 157 66 
0.1 mM HA+NADPH 7642 ± 481 6595 ± 1107* 
0.1 mM HA+TCB 3283 ± 428 3203 ± 379* 
0.1 mM HA+TCB+NADPH 2766 ± 274 947 ± 85 70 
Microsomes (0.1 mg protein/ml) were incubated in buffer (50 mM TRIS, 0.1 mM EDTA, 
pH 7 .6) at 30°C. The following chemicals were added in various combinations at the final 
concentrations indicated: acetone (0.5 %), ATA (0.1 mM), HA (0.1 mM), NADPH (1.8 
mM), TCB (1.7 j..tM). Aliquots were removed from the reaction mixtures at times 10 and 
30 minutes and then were assayed fluorometrically for EROD over 5 minutes. ATA (1 
mM) in the presence of NADPH reduced EROD activity; the EROD activity was 2910 ± 
937 pmol!min/mg at 10 min and 1753 ± 896 pmollmin/mg at 30 minutes. 
a - % loss of activity was calculated by comparing EROD activity in reaction mixtures 
containing TCB+NADPH to that in reaction mixtures containing TCB. 
b - For all of the reaction mixtures described below, data are the means ± SD from 5 pools 
of microsomes. 
c - For all of the reaction mixtures described below, data are the means ± SD from 3 
determinations with one pool of microsomes. 
*-Significantly different from TCB+NADPH (p<0.05, Dunnett's). 
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TABLE ill 
Effect of H202 on TCB-stimulated CYPlA inactivation 
Additions to reaction mixtures 
TCB 
TCB +NADPH 
TCB + NADPH + Catalase 
H202 + TCB + NADPH 
EROD Activity (pmollmin/mg) 
in aliguots taken at: 
10 minutes 30 minutes 
2579 ± 501 2387 ± 475* 
2045 ± 525 879 ± 290 
2072 ± 549 908 ± 204 
795 ± 400 230 ± 136* 
% Loss of activitya 
30 minutes 
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62 
90 
H202 + TCB + NADPH +Catalase 1887 ± 593 813 ± 195 66 
Incubation conditions and assay technique were as described in Figure 2, except for the 
additions of catalase (800 units) and H202 (1 mM). Data are the means± SD from 3 pools 
of microsomes. 
a- % loss of activity was calculated by comparing the EROD activity in reaction mixtures 
containing TCB+NADPH to that in reaction mixtures containing TCB. 
* -Significantly different from TCB+NADPH (p<0.05, Dunnett's). 
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TABLE IV 
Effects of antioxidants and iron concentration on TCB-stimulated inactivation of CYPlA 
Additions to reaction mixtures Property EROD Activitya Retained After 
Incubation with: 
TCB TCB+NADPHb 
None 2428 ± 512 912 ± 293 
Superoxide Dismutase ( 400 u) Metabolizes superoxide 2563 927 
Ascorbate ( 1 mM) ROS scavenger 2736 ll01 
Mannitol (1 mM) ROS scavenger 2627 854 
Tocopherol (1 mM) ROS scavenger 2509 ± 482 1045 ± 132 
Iron (1 mM) 2347 789 
DTPA (1 mM) Iron chelator 3352 919 
Deferoxamine (1 mM) Iron chelator 2143 554 
Incubation conditions and assay technique were as described in Figure 2, except for the 
additions listed. Data are either the average of two determinations or the means ± SD of at 
least 3 determinations. 
a- EROD activity (pmol/min/mg) was measured following a 30 minute incubation. 
b - Activity with TCB and NADPH reflects inactivation. 
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IV). If iron external to the enzyme was catalyzing OH• formation, and if such externally 
produced radicals were involved in inactivation, then chelation of external iron may reduce 
inactivation. However, addition of the iron chelators, deferoxamine or 
diethylenetriaminepenta-acetic acid (DTPA), did not reduce inactivation. Additions of 
chelated iron also had no effect on inactivation. 
Stimulation of the fonnation of reactive oxygen species by TCB: The above results 
are indicative of oxidative inactivation and suggest that ROS are formed in the active center 
of scup CYP1A. This should be accompanied by enhanced release of ROS from 
microsomes. The production of H202 and 02-• by liver microsomes was measured by 
several methods, but primarily by using the fluorescent probes 2',7'-
dichlorodihydrofluorescein (DCDFDA) and dihydroethidium (HE). DCDFDA is oxidized 
to 2',7'-dichlorofluorescein (DCF) by H202, and HE is oxidized by 02-• directly to 
ethidium. The stoichiometry of both reactions is 1:1 (Robinson et al., 1994). 
Liver microsomes from both control and BP-treated scup oxidized DCDFDA and 
HE at very low rates in the presence of the probes alone. These rates were increased by 
addition of NADPH (Figure 5). Adding either acetone+NADPH or TCB+NADPH to 
control liver microsomes did not alter DCDFDA and HE oxidation rates, compared to rates 
obtained with NADPH alone. Addition of acetone+NADPH to liver microsomes from BP-
treated scup also did not alter significantly the DCDFDA and HE oxidation compared to that 
with NADPH. However, when TCB + NADPH were added to liver microsomes from 
BP-treated scup, there was a significant increase in DCDFDA and HE oxidation over that 
seen with NADPH alone (Figure 5). That the HE oxidation stimulated by TCB+NADPH 
was due to OT• was confirmed by addition of SOD to reaction mixtures; SOD abolished 
fluorescence produced above the levels occurring with NADPH only. 
The Nash and adrenochrome reactions supported conclusions that both H202 and 
OT• were being produced by BP-treated scup liver microsomes in the presence of 
TCB+NADPH. H202 formation quantified using the Nash reaction was 1 ± 1 nmol 
formaldehyde formed/min/mg. 02-• formation determined using the adrenochrome 
reaction was 19 ± 5 pmol adrenaline oxidized/min/mg. 
To evaluate further the possible involvement of CYPlA in production of ROS, 
microsomes pre-incubated under various conditions were examined for the capacity to 
oxidize HE (Figure 6). When microsomes were pre-incubated with acetone or 
acetone+NADPH for periods of 0-30 minutes, and then combined with NADPH and HE, 
those microsomes oxidized HE at a very low rate. When microsomes pre-incubated with 
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Figure 5. ROS production in liver microsomes from control and BP-treated scup. (A) 
H202 production as assessed by the oxidation ofDCDFDA to DCF. (B) OT• production 
as assessed by the oxidation of HE to ethidium. In a 48-well plate, approximately 0.1 mg 
of microsomal protein was diluted with HBSS containing 5 ~M DCDFDA and 7.5 ~M HE 
(final concentrations). Some reaction mixtures contained 200 units SOD. Following a 15 
minute incubation at 30°C, 1. 7 nmol TCB in acetone or 5 ~1 acetone was added. Reactions 
were initiated with NADPH (1.7 mM). The rates of DCF and ethidium production were 
monitored fluorometrically over 5 minutes. Calculations were made using DCF and 
ethidium bromide as standards. Data are the means + SD from at least 3 pools of 
microsomes. *Statistically different from acetone+NADPH (p<0.05, Dunnett's). 
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Figure 6. Effect of TCB and NADPH on the capacity of scup liver CYP1A to produce 
ROS. Microsomes were pre-incubated as described in Figure 1, except that reaction 
mixtures contained 0.4 mg of microsomal protein and 17 nmol TCB. Aliquots (50 J.tl) 
were removed from each reaction mixture at 10, 20 and 30 minutes, and each was 
combined with 100 J.tl HBSS, HE (15 J.tM), and NADPH (1.4 mM) in a well of a 48-well 
plate. The rates of ethidium production were determined as in Figure 6. Data are the 
means ± SD from 3 pools of microsomes. *Statistically different from all other incubation 
conditions analyzed at 30 minutes (p<O.Ol, Tukey-Kramer). 
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TCB alone were combined with HE and NADPH, they oxidized HE at a high rate, 
regardless of the duration of the pre-incubation. Aliquots of microsomes pre-incubated 
with TCB+NADPH initially had a high capacity for HE oxidation. However, those 
microsomes pre-incubated with TCB+NADPH showed a time-dependent loss of the 
capacity to produce ROS that paralleled the loss of CYPlA (EROD) activity; by 30 
minutes, the capacity to produce ROS decreased to levels seen with microsomes pre-
incubated with acetone or NADPH. 
TCB-stimulated CYP inactivation in rat liver microsomes: When microsomes from 
Aroclor-treated rats were incubated with TCB+NADPH there was inactivation of CYPlA 
(EROD activity) (Table V). However, with rat liver microsomes, the loss ofEROD activity 
due to inactivation was less than was seen with scup; at 30 minutes there was only a 15% 
inactivation of rat CYPlA, compared to the 63% inactivation in scup liver microsomes. 
Immunoblot analysis with antibodies to scup CYPlA and to mouse CYP1A2 showed that 
both CYPlAl and CYP1A2 were present in rat liver microsomes (data not shown). 
However, methoxyresorufin 0-demethylation (MROD), a preferred activity of CYP1A2 in 
rat liver microsomes, was not inactivated by TCB+NADPH, while scup liver microsomes 
experienced a 77 ± 8% ioss of MROD activity due to inactivation (Table V). A.s with scup 
liver microsomes, the TCB+NADPH dependent loss of EROD activity from rat liver 
microsomes was enhanced by the addition of azide (Table V). 
The rate of TCB metabolism by rat liver microsomes was 50 pmol/min/mg. 
Although this rate is two orders of magnitude greater than the rate with scup liver 
microsomes (Table V), it still may be slow enough to be promote uncoupling. The rat liver 
microsomal NADPH oxidation rate in the presence of TCB was similar to that seen with 
scup liver microsomes and was greater than the rate of TCB turnover (Table V). 
Formation of reactive oxygen species by rat liver microsomes: Patterns of ROS 
production similar to those with scup liver microsomes were seen also with rat liver 
microsomes. Liver microsomes alone from control or from Aroclor-treated rats oxidized 
DCDFDA and HE at low rates, and those rates increased in the presence of NADPH 
(Figure 7). With control rat liver microsomes, addition of acetone+NADPH or 
TCB+NADPH did not alter DCDFDA and HE oxidation rates, compared to that caused by 
NADPH alone. However, when liver microsomes from Aroclor-treated rats were 
incubated with TCB+NADPH, there was a significant increase in the rate of both DCDFDA 
and HE oxidation compared to that obtained with NADPH alone, or to the rate seen with 
control microsomes incubated under any condition (Figure 7). SOD only partly abolished 
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TABLEV 
Comparison of scup and rat liver microsomal enzyme activities and CYPlA inactivation 
Assay 
Spectral P450 
(nmol/mg) 
CYP1Aa 
(nmoUmg) 
NADPH Oxidationb 
(nmoUmin/mg) 
Cytochrome c Reductase Activity 
(nmoUmin/mg) 
TCB Metabolism 
(pmoUmin/mg) 
EROD Activity 
(nmoUmin/mg) 
MROD Activity 
(nmoUmin/mg) 
% EROD InactivationC 
% MROD lnactivationC 
% EROD Inactivation with Azidec 
Scup Liver 
Microsomes 
n=7 
0.75 ± 0.23 
0.38 ± 0.15 
20 ± 4 
125 ± 39 
0.3 ± 0.1 
4.8 ± 0.9 
2.2 ± 0.8 
63 ± 6 
77 ± 8 
95 ± 1 
Rat Liver 
Micro somes 
n=3 
2.38 ± 0.60 
0.26 ± 0.28 
5 ± 1 
263 ±55 
38.5 ± 7.8 
2.5 ± 0.3 
0.1 ± 0.0 
15 ± 3 
0±0 
29 ± 2 
a- The immunoreactive bands were visualized using NBT/BCIP and quantified by video 
image analysis by comparison to scup standards of known concentration. Where 
appropriate, the CYPlAl values for rat are relative, reported as scup CYPlA equivalents. 
b - Calculated by subtracting the rate of NADPH oxidation with the carrier present from the 
rate of oxidation with TCB present. 
c - Assayed at 30 minutes. 
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Figure 7. ROS production in liver microsomes from control and Aroclor treated rats. (A) 
H202 production as assessed by the oxidation ofDCDFDA to DCF. (B) OT• production 
as assessed by the oxidation of HE ~o ethidium. Incubations were as described in Figure 6 
using liver microsomes from untreated rats and rats treated with 62.5 to 500 mglkg Aroclor 
1254. Data are the means + SD from 3 pools of microsomes except that values from 
control rats were determined from 1 pool of microsomes. *Statistically different from 
acetone+NADPH (p<0.05, Dunnett's). 
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Figure 8. ROS production in microsomes from insect cells expressing human CYPlAl 
and CYP1A2. (A) H202 production as assessed by the oxidation of DCDFDA to DCF. 
(B) OT• production as assessed by the oxidation of HE to ethidium. Incubations were as 
described in Figure 6. The P450 concentration and cytochrome c reductase activity were 
the same in both the CYPlAl and CYP1A2 microsomes, as indicated by the 
manufacturer's analyses. Data are the means + SD from three replicates. *Statistically 
different from acetone+NADPH (p<0.05, Dunnett's). 
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HE oxidation, suggesting that radicals additional to Or• were contributing to the oxidation 
by rat liver microsomes (data not shown). Comparing microsomes from rats treated with a 
range of doses of Aroclor 1254 (62.5 - 500 mg/kg) showed that ROS production 
stimulated by TCB+NADPH was correlated with the CYPlAl catalytic activity (EROD) of 
those microsomes (r2=0.968, p<O.OOl). 
ROS production by human CYP lAs. Microsomes from baculovirus-infected insect 
cells expressing NADPH-CYP reductase and either human CYPlAl or CYP1A2 were 
examined for their ability to produce ROS. The rates of DCDFDA and HE oxidation by 
microsomes containing either expressed CYPlAl or CYP1A2, but with no additions, were 
low (data not shown). In the presence of NADPH alone, CYP1A2 microsomes oxidized 
DCDFDA and HE at substantial rates, 5-fold greater than the rates obtained with CYPlAl 
microsomes under the same conditions (Figure 8). Addition of TCB+NADPH stimulated 
DCDFDA and HE oxidation by the CYPlAl microsomes by 2-fold, but decreased probe 
oxidation by the CYP1A2 microsomes (Figure 8). Rates of NADPH-CYP reductase 
activity were similar in microsomes containing CYPlAl and CYP1A2, indicating that the 
differences in ROS production reflected differences in activity of the CYPlAs. 
DISCUSSION 
3,3',4,4'-Tetrachlorobiphenyl is a competitive inhibitor of CYPlA (Gooch et al., 
1989) and recently was found to inactivate CYPlA (White et al., 1997a). Suppression of 
hepatic CYPlA content by high doses of TCB was attributed to that inactivation (White et 
al., 1997a). We employed hepatic microsomes from a species (scup) that is highly 
susceptible to CYPlA inactivation as a model to investigate the mechanism. We 
determined that inactivation occurs through uncoupling, resulting in formation and attack of 
ROS within the CYPlA active site. TCB also stimulates release of ROS by liver 
microsomes of scup and rats induced for CYPlA. In rat, ROS release and EROD 
inactivation appeared to involve CYPlAl, not CYP1A2. The balance between inactivation 
and ROS release appears to differ between species, suggesting differences in CYPlA active 
site structure. TCB also stimulated ROS production by expressed human CYPlAl but not 
CYP1A2. This is the first demonstration of a pHAH AhR agonist directly stimulating the 
release of ROS from CYPlAl. 
CYP JA Inactivation: Several observations suggest that inactivation of scup CYPlA 
by TCB involves uncoupling. TCB binds tightly in the scup CYPlA active site, indicated 
by a low Km for TCB metabolism (0.7 J..t.M (White et al., 1997b)) and low Ki for 
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competitive inhibition of CYP1A (< 0.3 J.!M) (Gooch et al., 1989; M. E. Hahn, 
unpublished results). Yet, the rate of metabolism is exceedingly slow (<1 pmol TCB 
metabolized/min/nmol CYP1A). TCB stimulated microsomal NADPH oxidation, and the 
TCB-stimulated inactivation of CYP1A was both NADPH and oxygen dependent. We 
speculate that steric hindrance due to lateral chlorines lodges TCB in the substrate access 
channel, rendering it inaccessible to attack by the peroxy-ferryl complex of CYP and 
favoring release of reduced oxygen from the heme iron. Exogenous antioxidant enzymes, 
oxygen scavenging compounds, iron and iron chelators had no effect on CYP1A 
inactivation by TCB, indicating that the chemistry involved is initiated and constrained 
within the active site. 
The identity of the chemical species causing CYP1A inactivation is unclear. Both 
H202 and OT• were released by microsomes incubated with TCB+NADPH. SOD 
abolished HE oxidation, indicating that there was release of OT• following addition of one 
electron, as shown for other CYP (Kuthan et al., 1978). H202 could result either from 
dismutation of 02-· or from direct formation after addition of a second electron. Notably, 
the reactivity of H202 or OT• is limited (Davies, 1987), with half-lives three orders of 
magnitude longer than that of OH• (Yu, 1994). 
It is possible that OH• is responsible for CYP1A inactivation. In the Fenton reaction, 
H202 reacts with Fe2+ to form OH•. With unmetabolized TCB lodged in the active site, 
heme iron may undergo cycles of oxidation and reduction to Fe2+. We suggest that penta-
coordinate ferrous heme resulting from that reduction acts as a Fenton catalyst in the 
conversion of H202 to OH• in the active site. The ability of heme iron to act as a Fenton 
catalyst has been questioned (Gutteridge, 1986). However, observations that Cu,Zn-SOD 
and Fe-SOD but not Mn-SOD are oxidatively inactivated suggests that Fenton chemistry 
might occur in an enzyme active site; manganese cannot act as a Fenton catalyst (Beyer and 
Fridovich, 1987). The auto-inactivation of lactoperoxidase was proposed to involve heme 
iron in the ferrous state acting as a Fenton catalyst (Jenzer et al., 1987). It has been 
suggested (Hodgson and Fridovich, 1975; Matheson and Travis, 1985) that "free" OH• 
(formed external to the active site) is not responsible for inactivation of SOD and 
myeloperoxidase, but rather that either a caged OH• or a metal coordinated OH• (in the active 
site) causes inactivation of these enzymes. In like fashion, oxidative inactivation of CYP1A 
could occur via production and attack of OH• entirely within the active site. 
Low concentrations of azide or H202 enhanced the TCB-dependent inactivation of 
CYP1A. Other catalase inhibitors, ATA or HA, did not affect the inactivation, indicating that 
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the azide effect did not result from catalase inhibition. This implies that both azide and H202 
can enter the active site even with TCB bound in the access channel, while slightly larger 
molecules (AT A or HA) can not. The release of OT• suggests latitude for passage of small 
molecules. As with H202, azide can interact with reduced iron to form highly reactive azidyl 
radical (Ortiz de Montellano et al., 1988); microsomes incubated with azide and NADPH can 
produce azidyl radicals (Reinke et al., 1994). Azide is thought to inactivate horseradish 
peroxidase via formation and addition of an azidyl radical to the heme (Ortiz de Montellano et 
al., 1988). CYP1A heme iron transiently reduced in the presence of TCB could catalyze 
conversion of both azide and H202 to radical species. The results with azide and H202 
support the possibility that heme iron may be acting as a Fenton catalyst. 
Microsomes incubated with TCB+NADPH consistently lost spectral P450 content, 
corresponding to the loss of CYP1A activity (EROD). However, the fate of that P450 
appeared to vary. Cytochrome P420 was formed in some instances, indicating modification 
of the environment of an intact heme (Stern et al., 1973). However, the amount of P420 
formed was always less than the amount of P450 lost. In most incubations heme was lost, 
but the extent of that loss also was highly variable. Lack of correspondence between P450 
loss, heme loss and P420 formation implies that there may be muitipie sites of attack during 
inactivation of CYP1A. Oxidative auto-inactivation in other enzymes can involve amino acid 
modification (Blech and Borders, 1983) and/or heme modification (Matheson and Travis, 
1985; Beyer and Fridovich, 1987). 
As far as we are aware, this is the first study to show that substrate-mediated 
inactivation of CYP1A can result from attack of ROS formed in situ. This differs from the 
inactivation of rat CYP1A1 by the alkylating agent 2-bromo-4'-nitroacetophenone (Parkinson 
et al., 1986). Alkylation destabilizes the oxy-cytochrome complex so that it decomposes 
before mono-oxygenation of a substrate can occur. Decomposition of the oxy-cytochrome 
complex results in ROS release, but unlike TCB-stimulated inactivation of CYP1A, 
alkylation does not result in oxidative modification of the protein or in a loss of spectrally-
detectable P450. 
Previously, inactivation of CYP2B was proposed to result from the production of 
H202 (Guengerich and Strickland, 1977; Karuzina and Archakov, 1994), but that 
inactivation, and hence the mechanism, differs from the inactivation of scup CYP1A. First, 
CYP2B inactivation occurred with excess NADPH alone and decreased when substrate was 
added (Guengerich and Strickland, 1977; Loosemore et al., 1980; Karuzina and Archakov, 
1994). Inactivation of CYP1A required the presence of both NADPH and TCB. Second, 
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CYP2B inactivation was attributed to H202 released from the enzyme. With CYP1A, 
oxygen is released as Or• and possibly as H202. Third, inactivation of CYP2B was 
exacerbated by catalase inhibitors, both azide and HA, and was relieved by catalase and the 
radical scavengers ionol and mannitol (Guengerich and Strickland, 1977; Karuzina and 
Archakov, 1994). Similar attempts to modify ROS concentrations external to the active site 
had no influence on CYP1A inactivation. Fourth, inactivation of CYP2B was primarily due 
to effects on heme; spectral P450 content declined in parallel with heme, there was no P420 
formation, and heme was covalently bound to the protein (Guengerich, 1978; Karuzina and 
Archakov, 1994). In contrast, heme loss and P420 formation both occurred, and were 
variable, during CYP1A inactivation by TCB. 
CYP lAs and Reactive Oxygen Production: The evidence here indicates that CYP1A 
is a source of ROS when microsomes are incubated with the AhR agonist TCB. Control 
scup liver microsomes formed ROS when incubated with NADPH, similar to results with 
control rat and human liver microsomes (Rashba-Step and Cederbaum, 1994; Reinke et al., 
1994). The stimulation of ROS formation by TCB occurred only with liver microsomes 
from animals induced for CYP1A. Induced rat liver microsomes also formed ROS; these 
microsomes metabolized TCB at 100 times the rate seen in scup liver microsomes, yet that 
rate was only 50 pmol/min/mg, slow enough to suggest that TCB could uncouple rat 
CYP1A. As activity of scup CYP1A declined due to inactivation, ROS production declined 
in parallel, further supporting the role of CYP1A in the production of ROS. 
A single CYP1A form has been identified in scup, and while it has properties of both 
CYP1A1 and CYP1A2, scup CYP1A is more like CYP1A1 (Morrison et al., 1995; 
Stegeman et al., 1996). Given the role of mammalian CYP1A1 in TCB metabolism (Ishida 
et al., 1991), we hypothesized that CYP1A1 might form ROS when bound with TCB. TCB 
stimulated ROS production only by rat liver microsomes having high levels of CYP1A. Both 
CYP1A1 and CYP1A2 were detectable by Western blot in the rat microsomes. However, 
rates of EROD (a preferred CYP1A1 activity) in native microsomes were correlated closely 
with the degree to which TCB stimulated ROS production by those microsomes. Moreover, 
EROD in rat liver microsomes was inactivated while MROD, a preferred CYP1A2 activity 
(Tsyrlov et al., 1993), was not inactivated by incubation with TCB+NADPH. The results 
with baculovirus-expressed human CYP1Al and CYP1A2 also support the hypothesis that 
TCB-bound CYP1A1 is a source of ROS. TCB stimulated an increase in ROS production by 
expressed human CYP1A1, while it decreased ROS production by expressed human 
80 
CYP1A2. Notably, when incubated with NADPH alone, CYP1A2 released much more ROS 
than did CYP1Al. 
Others have suggested that rat CYP1A1 can form ROS when bound with pHAH. 
The pHAH-stimulated oxidation of bilirubin was proposed to result from its reaction with 
ROS produced during uncoupling of CYP1A1, although ROS were not directly measured 
(DeMatteis et al., 1991 ). Our findings that pHAH stimulate release of ROS by CYP1A1 may 
also help to explain observations of oxidative damage associated with induction of CYP1Al. 
Porcine endothelial cells treated with TCB showed increased CYP1A1, ROS production and 
lipid peroxidation (Toborek et al., 1995). In Hepa1c1c7 cells, TCDD treatment resulted in 
increased CYP1A1 activity and oxidative DNA damage (Park et al., 1996). Thus, CYP1A1 
induced by pHAH may be a source of ROS, thereby contributing to oxidative damage in 
vivo. 
In conclusion, the results here demonstrate that rat, human and scup CYP1As 
produce ROSin the presence of a slowly metabolized pHAH, apparently due to uncoupling. 
One result of ROS production is the inactivation of CYP1A via attack of ROS within the 
active site. We suggest that the attacking species is OH•, formed via Fenton chemistry 
between H202 and the heme iron. The oxidation of CYPlA couid target it for degradation 
(Davies, 1987), which could explain the decrease in CYP1A content seen in animals and cells 
in culture exposed to higher concentrations of pHAH (Sinclair et al., 1989; Stegeman et al., 
1995; White et al., 1997a). Such an in vivo effect has not been described for oxidative 
inactivation of other CYP. The difference in susceptibility of scup and rat CYP1A to 
inactivation suggests that the active sites are conformationally different. Such differences 
may favor metabolism of TCB by rat CYP1A1 and retention of ROS by scup CYP1A. 
Modeling studies are underway to determine if TCB "fits" differently into CYP1A active sites 
from various species. ROS from CYP1A may modify proteins, lipids and nucleotides (Yu, 
1994) as well as alter gene expression (Sen and Packer, 1996). The pHAH-stimulated 
formation and release of ROS from CYP1A may be a mechanism contributing to the toxicity 
of planar halogenated AhR agonists. 
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CHAPTER 4 
Structure-Activity Relationships in the Stimulation of Reactive Oxygen 
Production and Cytochrome P450 lA Inactivation by Halogenated Aromatic 
Hydrocarbons 
83 
ABSTRACT 
The relationship of chemical structure to the substrate-dependent inactivation of 
cytochrome P4501A (CYP1A) was investigated in the marine teleost scup (Stenotomus 
chrysops). Previously, we demonstrated that the binding of 3,3'4,4'-tetrachlorobiphenyl 
(IUP AC# 77) to scup CYP1A elicited oxidative inactivation of the enzyme and also resulted 
in release of reactive oxygen species (ROS) (Chapter 3). Here, benzo[a]pyrene (BP), two 
ortho substituted chlorobiphenyls (CB), 2,2',5,5'-tetrachlorobiphenyl (IUPAC# 52) and 
2,3,3',4,4'-pentachlorobiphenyl (IUPAC# 105) and two non-ortho substituted CBs, 
3,3',4,4',5' pentachlorobiphenyl (IUP AC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl 
(IUPAC# 169) were examined for the ability to stimulate ROS generation and to inactivate 
CYP1A in scup liver microsomes containing high levels of CYP1A. Both CB 126 and 169 
stimulated release of ROS from liver microsomes in the presence of NADPH, while BP 
and the ortho-substituted CBs, 52 and 105, did not. Microsomal NADPH oxidation rates 
increased upon addition ofBP, or CBs 105, 126 and 169. Microsomal ethoxyresorufin 0-
deethylation (EROD) was inhibited by BP and CBs 105, 126 or 169. Ki values for CBs 
126 and 169 were similar (0.16 and 0.20 JlM, respectively); however, that for CB 105 was 
greater (0.60 JlM). In addition to inhibition, there was a progressive loss of EROD in the 
presence of NADPH and CBs 105, 126 or 169, attributed to inactivation of CYP1A. 
Following a 30 minute incubation, the Kminactivation values were similar for CBs 77, 126 
and 169, and that for CB 105 was greater (0.05, 0.14, 0.08, and 0.37 JlM, respectively). 
Similarly, the rate of inactivation stimulated by CB 105+NADPH was 70% less than the 
rates seen with CBs 77, 126 or 169. CB 52 neither inhibited nor inactivated EROD. 
Inactivation of CYP1A stimulated by CBs 126 and 169 was accompanied by loss of 
spectral P450, enhanced by the addition of azide or H202 and decreased by addition of 
cytochrome c. Thus, CB 126 and 169 appear to oxidatively inactivate CYP1A, as has been 
shown for CB 77. The inactivation of CYP1A and the release of ROS were stimulated 
only by planar CBs that are aryl hydrocarbon receptor (AhR) agonists and possibly CYP1A 
substrates. The release of ROS resulting from planar CB binding to CYP1A represents a 
possible mechanism by which these AhR agonists exert their toxicity. 
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INTRODUCTION 
Polychlorinated biphenyls are ubiquitous in the global environment, and exposure 
can result in hepatocellular carcinoma, immunotoxicity, wasting syndrome and 
reproductive, endocrine and developmental toxicity (as reviewed in (Safe, 1994)). 
Congeners that lack substitution at ortho sites (e.g. 3,3',4,4'-tetrachlorobiphenyl, IUPAC# 
77) can achieve a planar conformation similar to that of 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) (Safe et al., 1985). By comparing the TCDD equivalency factors (TEF) of 
chlorobiphenyl (CB) congeners, the coplanar congeners, including CB 77, 3,3',4,4',5,-
pentachlorobiphenyl (IUPAC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl (IUPAC# 
169), are most potent in eliciting toxic effects in fish (Janz and Metcalfe, 1991; Walker and 
Peterson, 1991; Newsted et al., 1995) and mammals (Safe, 1990; Tillitt et al., 1991). 
Even though other congeners are found more frequently or at greater concentrations in 
environmental samples, the coplanar CB congeners 77, 126 and 169 are most likely to 
contribute to adverse biological effects attributable to pHAH in environmental samples 
(McFarland and Clark, 1989). 
Despite intensive study confirming the aryl hydrocarbon receptor-dependence of 
pHAH toxicity (Poland and Glover, 1980; Fernandez-Salguero et al., 1996), the 
mechanism(s) of toxicity remains unclear. Bioactivation has not been found to be a 
significant avenue to toxicity of pHAH. Metabolism of pHAH is slow, and the metabolites 
are not considered reactive (Yoshimura et al., 1987; Koga et al., 1990; Safe, 1992). 
Potential mechanisms of pHAH-mediated toxicity may include altered regulation of genes 
involved in growth and differentiation (Choi et al., 1991; Gaida et al., 1992; Hoffer et al., 
1996; Wang et al., 1997), altered arachidonic acid metabolism (Rifkind et al., 1990; 
Schlezinger et al., 1998) and altered ca2+ homeostasis (McConkey et al., 1988). In 
addition, stimulation of oxygen activation may contribute significantly to pHAH toxicity, 
considering that reactive oxygen species (ROS) can attack any member of the cellular 
machinery, including proteins (Davies, 1987; Stadtman and Berlett, 1991), lipids (Girotti, 
1985) and nucleotides (Breen and Murphy, 1995). 
A growing number of studies support the conclusion that TCDD and CB congeners 
induce oxidative stress and that this is dependent upon the aryl hydrocarbon receptor (AhR) 
(Faux et al., 1992; Alsharif et al., 1994; Park et al., 1996). Although the mechanism of 
ROS generation by AhR agonists also is not clear, evidence supports the hypothesis that 
induction of cytochrome P4501A (CYPlA) might be involved in ROS generation. CYP1A 
induction has been correlated with oxidative damage following pHAH exposure (Toborek 
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et al., 1995; Park et al., 1996). Hepatic microsomal and mitochondrial fractions but not 
cytosolic fractions from TCDD-treated rats can stimulate oxidative DNA damage 0N ahba et 
al., 1989). CB 77 stimulates the production of ROS by teleost and mammalian CYP1As 
(Chapter 3), and this supports the earlier suggestion that bilirubin oxidation is catalyzed by 
ROS produced during uncoupling of rat CYP1A1 by CB 77 (DeMatteis et al., 1991). 
Under the same conditions, CB 126 stimulates bilirubin oxidation as well (DeMatteis et al., 
1991). Considering also that CB 126 is even more refractory to metabolism than CB 77 
(Yoshimura et al., 1987; Koga et al., 1990), ROS production via uncoupling of CYP1A 
may be a common effect of pHAH. 
Determining the structure-activity relationships for uncoupling should indicate 
whether CYP1A-generated ROS might be involved in AhR agonist toxicity. Our approach 
to determine uncoupling was to examine oxidative inactivation of CYP1A. We have 
demonstrated that CYP1A is oxidatively inactivated when CB 77 is present in the active site 
in the marine fish model scup (Stenotomus chrysops) and have hypothesized that 
inactivation occurs by the attack of OH•, leading to denaturation of the protein (Chapter 3). 
Evidence from earlier studies suggests that like uncoupling, oxidative inactivation of 
CYP1A by planar CB congeners including CBs 126 and 169 may be a general 
phenomenon (Rodman et al., 1989; Newsted et al., 1995; Lorenzen et al., 1997). 
In this paper we examined the hypothesis that, like CB 77, planar CB congeners in 
general stimulate the production of ROS through uncoupling of the CYP1A catalytic cycle 
and oxidative inactivation of the enzyme. We used scup CYP1A as our model because it 
has been shown to be extremely sensitive to inactivation by CB 77 in vitro and to 
suppression in·vivo (White et al., 1997a; Chapter 3). We investigated the effects of a 
rapidly metabolized substrate, benzo[a]pyrene (BP), and both ortho and non-ortho 
substituted CB congeners on scup liver CYP1A. ROS release and inactivation of CYP1A 
appear to be dependent upon chemical structure; only substrates of CYP1A that are slowly 
metabolized stimulated inactivation. While the physiological consequences of a loss of 
CYP1A are unknown, release of ROS may represent a mechanism of pHAH toxicity. 
MATERIALS AND METHODS 
Chemicals: Benzo[a]pyrene was purchased from Aldrich (Milwaukee, WI). 2',7'-
Dichlorodihydrofluorescein diacetate, 7 -ethoxyresorufin, and dihydroethidium were 
purchased from Molecular Probes (Eugene, OR). 2,2',5,5'-Tetrachlorobiphenyl (IUPAC# 
52) was purchased from Pathfinder (St. Louis, MO). 3,3',4,4'-Tetrachlorobiphenyl 
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(IUPAC#. 77), 2,3,3',4,4'-pentachlorobiphenyl (IUPAC# 105), 3,3',4,4',5-
pentachlorobiphenyl (IUPAC# 126) and 3,3',4,4',5,5'-hexachlorobiphenyl (IUPAC# 169) 
were purchased from Ultra Scientific (North Kingstown, Rl). All other reagents were 
purchased from Sigma (St. Louis, MO). 
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard 
Sound, MAin August of 1996. Fish were held in flow-through seawater tanks at 14°C 
and maintained on a diet of Purina Trout Chow. Experimental animals ranged in size from 
182 to 305g. Control fish received no treatment. To induce CYP1A, fish were injected 
intra-peritoneally with a solution of benzo[a]pyrene (10 mg/kg) in com oil. Three days 
following injection the fish were killed by severing the spinal cord. The livers were 
harvested, and microsomes were made immediately. Four microsome pools were prepared 
with livers from 3 fish per pool. 
Microsome preparation: Microsomes were prepared from livers by differential 
centrifugation (Stegeman et al., 1979). Following the initial sedimentation, microsomes 
were washed by resuspending in 0.15 M KCl and sedimenting again. Pellets were 
resuspended in buffer (50 mM TRIS, pH 7 .4, 1 mM dithiothrietol, 1 mM EDTA, .20% 
glycerol) and frozen in liquid N2 until use. Protein content was determined using the 
bicinchoninic acid method (Smith et al., 1985), with bovine serum albumin standards. 
Western blotting for CYP IA quantification: Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal 
proteins (10 J.tg/lane) were resolved on 8-16% SDS-PAGE gels and electrophoretically 
transferred to 0.05 J.tm nitrocellulose membrane. The primary antibody was the mouse 
monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E (CYP1A; 
(Morrison et al., 1995)). The secondary antibody was alkaline phosphatase linked goat 
anti-mouse IgG (Biorad, Hercules, CA). The immunoreactive bands were visualized using 
nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate and quantified by video 
image analysis (NIH Image 1.60b5) by comparison to scup standards of known 
concentration. 
In vitro studies of CYP IA inactivation: The procedure was as described in Chapter 
3 except for the following additions: BP (1.5 J,tM), CB 52 (1.7 J,tM), CB 105 (0.015-31 
J,tM), CB 126 (0.015-15 J,tM), and CB 169 (0.014-14 J,tM). EROD loss resulting from 
inhibition was calculated by comparing EROD at 10 minutes in control and CB reaction 
mixtures. EROD loss resulting from inactivation was calculated by comparing EROD at 30 
minutes in CB and CB+NADPH reaction mixtures. Curve fitting was performed using 
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Sigma Plot for Macintosh (SSPS Inc., Chicago, IL). For inhibition, the IC50 values were 
determined directly from the plot of CB concentration and activity loss. The methods of 
(Cha, 1975) and (Cheng and Prusoff, 1973) were used to convert the IC50 to a Ki with 
0.22 J.!M as the Km for 7-ethoxyresorufin metabolism (M. E. Hahn, unpublished results). 
NADPH oxidation: NADPH oxidation was determined by monitoring the decrease 
in absorbance at 340 nm in reaction mixtures prepared as in the inactivation assay using 0.4 
mg protein/ml and 15 J.!M CB (Imai, 1979). 
Spectral P450 assay: Loss of spectral P450 was determined as described in 
Chapter 3 except for the following additions: CB 126 or 169 (13-15 J.!M) 
Peroxide and superoxide formation: H202 and OT• formation were determined as 
described in Chapter 3 except for the following additions: BP and CBs 52, 105, 126, or 
169 (1.5 nmol in acetone). 
Statistics Statistics were calculated using Microsoft Excel (Microsoft, Inc., 
Redmond, WA) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA). 
A two-tailed Student's t-test was used to analyze EROD and total P450 inactivation data 
(CB vs. CB+NADPH). A one-factor ANOV A was used to analyze the inactivation 
experiments including additions and the ROS experiments. The Tukey-Kramer muitipie-
comparisons test was used in analyses of inactivation experiments. The Dunnett's test was 
used for the ROS experiments with the acetone+NADPH reaction mixture as the control. 
RESULTS 
ROS production stimulated by CYP JA substrates: BP and the CB congeners were 
tested for the ability to stimulate ROS production in scup liver microsomes. Production of 
ROS during incubation of liver microsomes from untreated scup with NADPH was 
unaffected by the addition of any CB congener (data not shown). As with CB 77, 
incubation of liver microsomes from BP-treated scup with NADPH and the non-ortho CBs 
126 and 169 significantly increased DCDFDA and HE oxidation (Figure 1). DCDFDA is 
oxidized to DCF by H202, and HE is oxidized to ethidium by 02-.. BP and the ortho CBs 
52 and 105, did not alter ROS production significantly from that obtained with 
acetone+NADPH. 
Inactivation of scup liver CYP JA: CB- and NADPH- dependent inactivation of 
CYP1A was studied in liver microsomes from BP-treated scup using the in vitro assay 
employed previously (White et al., 1997a). In control reaction mixtures containing 
acetone±NADPH, EROD remained constant over 30 minutes (data not shown). When 
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microsomes were incubated with CB alone, EROD was decreased 20 ± 10% with CB 105, 
70 ± 6% with CB 126 and 62 ± 10% with CB 169 as compared to control reaction 
mixtures (Figure 2), but this decrease remained constant through time (data not shown). At 
30 minutes, reaction mixtures containing CB 105+NADPH showed a 32 ± 7% loss of 
EROD, containing CB 126+NADPH showed a 70 ± 7% loss of EROD and containing CB 
169+NADPH showed a 67 ± 11% loss of EROD compared to those reaction mixtures 
containing CB alone (Figure 2). Confirming earlier results, reaction mixtures containing 
CB 77 showed a 50 ± 6% decrease in EROD due to inhibition and 62 ± 6% decrease in 
EROD due to inactivation when NADPH was added (Figure 2). The capacity to catalyze 
EROD was not altered by incubation of microsomes with either CB 52 alone or CB 
52+NADPH (Figure 2). When microsomes were incubated with BP alone, EROD 
decreased 93 ± 6%. due to inhibition. However, in contrast to results with the CB 
congeners, EROD in reaction mixtures containing BP+NADPH increased 7-fold above that 
in reaction mixtures with BP alone, by 30 minutes (Figure 2). 
To determine if loss of P450 protein co-occurred with loss of CYP1A catalytic 
activity, spectral P450 content was assessed in the reaction mixtures. Similar to EROD, no 
significant loss of total P450 occurred with either CB 126, CB 169 or NADPH alone 
(Figure 3a). Incubation of hepatic microsomes for 30 minutes with CB 126 or 169 
+NADPH resulted in 52 ± 8% and 4 7 ± 9% losses of P450, respectively (Figure 3b ). The 
loss of P450 was accompanied by a variable appearance of cytochrome P420, with 
amounts of P420 formed ranging from 0.14-0.20 nmol/mg for CB 126, and 0.11-0.19 
nmollmg for CB 169. In comparison, incubation of microsomes for 30 minutes with CB 
77 and NADPH resulted in a 38 ± 9% loss of P450 and formation of 0.15-0.26 nmol 
P420/mg (Figure 3b). 
Both inhibition and inactivation were CB concentration dependent (Figure 4). 
Variation of the 7 -ethoxyresorufin concentration had little affect on the inhibition of EROD 
by the non-ortho CB congeners (data not shown), therefore the Cha calculation for the 
conversion of the IC50 to a Ki may provide the closest approximation of the true Ki. CB 
126 and CB 169 had Ki values similar to that for CB 77 while that for CB 105 was 3-fold 
greater (Table I). The Kminactivation values for CBs 126 and 169 were 2 to 3-fold less 
than that for CB 105 (Table I). CBs 126 and 169 had greater efficacy in stimulating 
inactivation than did CB 105 (Table I). Using EROD and spectral P450 data 
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Figure 1. Effect of CB congeners and BP on ROS production in scup liver microsomes. 
A) OT• production as assessed by oxidation of HE to ethidium. B) H202 production as 
assessed by oxidation ofDCDFDA to DCF. In a 48-well plate, approximately 0.1 mg of 
microsomal protein (398 ± 42 pmol CYP1A/mg) was diluted to 160 J..ll with HBSS 
containing 5 J..lM DCDFDA and 7.5 J..lM HE (final concentrations). Following a 15 minute 
incubation at 30°C, 1.3-1.5 nmol BP or CBs 52, 105, 126 or 169 in acetone or 5 J..ll 
acetone was added. Reactions were initiated with NADPH (1.7 mM). The rates of DCF 
and ethidium production were monitored fluorometrically over 5 minutes. Calculations 
were made using DCF and ethidium bromide as standards. Incubation of microsomes 
without NADPH resulted in very low levels of DCF or ethidium production. Data for CB 
77 are from Chapter 3. Data are means ± SD from at least 3 pools of microsomes. 
*Statistically different from acetone+NADPH (p<0.01, Dunnett's). 
90 
6 1000 
:;::; ...-... 
(.) 0') 
::::~ E 
-g c 750 
:r......_ 
a.. E 
-E o 500 ::::~ E 
"Co. 
..s:::::-
w 250 
c-o 0') 
0 
:t:J E (.) - 40 
::J c 
"C ·-E E 
a_:::: 
0 
u... E 
() 0.. 20 o ......... 
A 
* 
* 
Acetone BP CB 52 CB 77 CB 105 CB 126 CB 169 
Treatment 
B 
Acetone BP CB 52 CB 77 CB 105 CB 126 CB 169 
Treatment 
91 
-E 6ooo 
-c 
E 
:::::: 
0 
E 4000 
c. 
>. 
+-' 
·:; 
t5 2000 
~ 
0 
0 
a: 
w 0 
II Chemical 
~ Chemicai+NADPH 
Acetone BP CB 52 CB 77 CB 105 CB 126 CB 169 
Chemical 
Figure 2. Inhibition and inactivation of scup liver CYP1A stimulated by BP and CBs 52, 
77, 105, 126 and 169. Microsomes (0.1 mg protein/ml with 398 ± 42 pmol CYP1A/mg) 
were incubated in buffer (50 mM TRIS, 0.1 mM EDTA, pH 7.6) at a final volume of 1 ml 
in glass test tubes at 30°C. The following chemicals were added in various combinations at 
the final concentrations indicated: acetone (5 J..ll), NADPH (1.8 mM), CB 52, 77, 105, 126 
or 169 (1.3-1.7 J..t.M). Aliquots were removed from reaction mixtures at times zero, 10, 20 
and 30 minutes and assayed fluorometrically for EROD over 5 minutes. Data shown here 
are from the 30 minute time point. EROD was constant in microsomes incubated with 
acetone or NADPH. Following an initial loss of EROD upon addition of CBs 77, 105, 
126 or 169, EROD remained constant. The rate of loss of EROD during incubation with 
NADPH and CBs 77, 105, 126 or 169 was constant over time for each congener. Data are 
means ± SD from 3-4 pools of microsomes. *-Significantly different from CB (p<0.005, 
Student's t-test). 
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independently, rates of inactivation were calculated (Table I). Rates of inactivation were 
determined from the decline in EROD by assuming that loss of EROD is equated with loss 
of CYP1A. Both methods rendered similar rates of inactivation. CBs 77, 126 and 169 
stimulated loss of P450 at a similar rate. In comparison, the rate of inactivation with CB 
105+NADPH was at least 70% less than that seen with the coplanar congeners. 
Previously, azide and H202 were shown to enhance CB 77 stimulated inactivation 
of CYP1A (Chapter 3). Azide caused a 2-fold increase in the rate of inactivation in the 
presence of CB 126+NADPH or CB 169+NADPH at 10 minutes (Figure 5). Incubation 
of azide with CB 126+NADPH resulted in statistically significant enhancement of 
inactivation at both 10 and 30 minutes. Similarly, H202 increased the loss activity due to 
inactivation stimulated by CBs 126 and 169 by 3-fold at 10 minutes (Figure 6). Incubation 
of H202 with CB 126+NADPH resulted in statistically significant enhancement of 
inactivation at 10 and 30 minutes and with CB 169+NADPH resulted in statistically 
significant enhancement of inactivation at 10 minutes. 
Electron transfer was found to be an essential component in the inactivation of 
CYP1A mediated by CB 77, therefore BP and the CB congeners were tested for the ability 
to stimulate NADPH oxidation. BP stimulated NADPH oxidation to the greatest extent, 
with CBs 105, 126 and 169 also causing significant increases (Table II). CB 52 did not 
significantly stimulate NADPH oxidation (Table II ). 
Cytochrome c inhibits CYP1A by competing for electrons from cytochrome P450 
reductase (Estabrook et al., 1996), thereby reducing inactivation by preventing the 
reduction of molecular oxygen bound to the heme. When cytochrome c (10 ~M) was 
added to reaction mixtures containing CBs 126 or 169 and NADPH, the rate of inactivation 
decreased (Figure 7). The rate of loss of EROD was 7 ± 4 pmollmin/mg in the presence of 
CB 126+NADPH+cytochrome c as compared to 12 pmollmin/mg the absence of 
cytochrome c. The rate of loss of EROD was 4 ± 2 pmollmin/mg in the presence of CB 
169+NADPH+cytochrome cas compared to 16 pmollmin/mg the absence of cytochrome c. 
Electron transfer appears to be an essential component in the inactivation of CYP1A by 
CBs 126 and 169. 
DISCUSSION 
Microsomal CYP1A in the fish Stenotomus chrysops has been shown to be 
extremely susceptible to oxidative inactivation when CB 77 binds and uncouples the 
catalytic cycle of the enzyme (White et al., 1997a; Chapter 3). In addition, ROS are 
93 
Figure 3. Loss of spectral P450 in the presence of CBs and NADPH. A) P450 spectra of 
scup liver microsomes following incubation with acetone, NADPH, CB 126 or CB 
126+NADPH. B) Total spectral P450 content (nmol/mg) of scup liver microsomes. To 
determine if there was a loss of P450, microsomes (0.4 mg protein/ml) were incubated in 
buffer (50 mM TRIS, 0.1 mM EDTA, pH 7 .6) at 30°C. The following chemicals were 
added in various combinations at the final concentrations indicated: acetone (0.5 % ), CB 
126 or 169 (13-15 J.!M), and NADPH (0.7 mM). Following a 30 minute incubation, total 
P450 concentration was determined by bubbling reaction mixtures with CO and obtaining 
the dithionite-difference spectra (Bonkovsky et al., 1984). Data are means± SD from 3 
pools of microsomes. *-Significantly different from CB (p<0.05, Student's t-test). ** 
Significantly different from CB (p<0.001, Student's t-test). 
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Figure 4. Concentration dependent inhibition and inactivation of CYP1A stimulated by 
CBs 105 (A), 126 (B) and 169 (C). Incubation conditions and assay technique were as 
described in Figure 2, except that a range of CB concentrations was used (0.013-30 J..LM). 
Open circles- EROD loss due to inhibition was calculated by comparing EROD at 10 
minutes in control and CB reaction mixtures. Closed squares - EROD loss due to 
inactivation was calculated by comparing EROD at 30 minutes in CB and CB+NADPH 
reaction mixtures. Results from 2-3 pools of microsomes were used in the non-linear 
regression analysis. 
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TABLE I 
In vitro inhibition and inactivation of EROD by CB congeners in scu:e liver microsomes. 
Inhibition Inactivation 
CB IC5o Kia Kib Max.% Km Max.% Ratec RateC 
().LM) ().LM) ().LM) Activity ().LM) Activity Calculated Calculated 
Lost Lost fromEROD from P450 
77 0.18d 0.02 0.16 60 0.05 55 8 ± 3e 12 ± 3 
105 6.00 0.59 80 0.37 50 3±2 ND 
126 0.18 0.02 0.16 81 0.14 74 12 ± 5 11 ± 1 
169 0.22 0.02 0.20 72 0.08 68 16 ± 5 6±1 
Inhibition and inactivation constants and maxima were calculated from data presented in 
Figure 4. The ICso, Kminactivation and maximum values were determined by a non-
linear regression analysis of the plot of CB concentration and activity loss (Figure 3). 
a- The method of (Cheng and Prusoff, 1973) was used to convert the ICso to a Ki with 
0.22 !J.M as the Km for 7-ethoxyresomfin metabolism (M. E. Ha.hn, unpublished results). 
b- For CBs 77, 126 and 169, the method of (Cha, 1975) was used to convert the ICso to a 
Ki, considering the planar CB congeners as tight binding inhibitors. 
c - Rates were calculated from the data in Figures 2 and 4 and are presented as pmol 
P450/min/mg. The rate of inactivation was determined by equating the loss of EROD 
activity in a given set of microsomes over a 30 minute time period with the specific CYP1A 
content of those microsomes. 
d- Data from Chapter 3. 
e - Mean ± SD from 3-4 pools of microsomes. 
ND - Not determined. 
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Figure 5. Effect of azide on CB-stimulated CYP1A inactivation in scup liver microsomes. 
A) CB 126. B) CB 169. Incubation conditions and assay technique were as described in 
Figure 2, except for the addition of azide (0.1 mM). The azide concentration used was 
previously determined not to cause a loss of activity without the presence of both NADPH 
and CB (Chapter 3). Data are means± SD from 4 pools of microsomes .. *Statistically 
different from CB (p<0.05, Tukey-Kramer). **Statistically different from CB and 
CB+NADPH (p<0.05, Tukey-Kramer). 
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Figure 6. Effect of H202 on CB-stimulated CYP1A inactivation in scup liver microsomes. 
A) CB 126. B) CB 169. Incubation conditions and assay technique were as described in 
Figure 2, except for the addition H202 (100 rnM). The H202 concentration used was 
previously determined not to cause a loss of activity without the presence of both NADPH 
and CB (Chapter 3). Data are means± SD from 4 pools of microsomes. *Statistically 
different from CB (p<0.05, Tukey-Kramer). **Statistically different from CB and 
CB+NADPH (p<0.05, Tukey-Kramer). 
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TABLEll 
NADPH oxidation in scup liver microsomes. 
NADPH 
NADPH+ 
Additions 
Acetone 
BP 
CB 52 
CB 105 
CB 126 
CB 169 
NADPH Oxidation 
(nmoVmin/mg) 
11 ± 3 
33 ± 7* 
14 ± 4 
24 ± 5* 
28 ± 2* 
28 ± 8* 
The rate of NADPH oxidation was determined by monitoring the decrease in absorbance at 
340 nm (Imai, 1979) in incubations prepared as in the inactivation assay using 0.4 mg 
protein/ml and acetone (0.5 %) or 15 f-lM CB in acetone. 
a - Mean ± SD from at least 3 microsome pools. 
*-Significantly different from acetone+NADPH (p<0.01, Dunnett's). 
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Figure 7. Effect of cytochrome c on CB-stimulated CYPlA inactivation in scup liver 
microsomes. Incubation conditions and assay technique were as described in Figure 2, 
except for the addition of cytochrome c (10 ~- Data shown are from the 30 minute time 
point. Data are means ± SD from 3-4 pools of microsomes. *Statistically different from 
CB (p<O.Ol, Tukey-Kramer). **Statistically different from CB and CB+NADPH 
(p<O.Ol, Tukey-K.ramer). 
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released during the interaction of CB 77 and CYP1A. Here we addressed the hypothesis 
that any pHAH that is an AhR agonist would bind to CYP1A with effects similar to CB 77. 
As occurs with CB 77, the coplanar CBs 126 and 169 stimulated ROS formation by and 
inactivation of scup CYP1A. The mono-ortho CB 105 also stimulated CYP1A inactivation 
although to a lesser extent than the non-ortho CBs and did not stimulate ROS release. The 
di-ortho CB 52 and the rapidly metabolized CYP1A substrate, BP, stimulated neither ROS 
release nor CYP1A inactivation. This study lends support to the hypothesis that catalytic 
uncoupling by slowly metabolized substrates may also create an environment in the active 
site which is favorable to the formation and attack of ROS. Moreover, release of ROS 
promoted by pHAH could be a mechanism by which some AhR agonists/CYP1A 
substrates exert toxicity. 
Inactivation ofCYPIA Stimulated by CBs: We previously hypothesized that the 
inactivation of CYP1A mediated by CB 77 occurs through an oxidative mechanism 
(Chapter 3). We speculated that steric hindrance due to the chlorines may lodge the CB in 
the substrate access channel, rendering the molecule largely inaccessible to attack by the 
peroxy-ferryl complex of P450. As a result, reduced oxygen is released from the heme 
iron. The exact identity of the ROS causing CYP1A inactivation is unknown. Some 
studies have suggested that 02-· can cause release of iron from heme (Gutteridge, 1986; 
Das et al., 1992); however, the data in our study suggested that OH• is responsible. 
Fenton chemistry requires the presence of both H202 and a reduced iron. H202 is 
produced by scup CYP1A as a result of uncoupling during CB metabolism. If the CB 
remains in the active site stimulating electron flow and oxygen binding, activation and 
release, then presumably, the heme iron continues to cycle between Fe3+ and Fe2+. We 
suggested that penta-coordinate ferrous heme in the active site is able to act as a Fenton 
catalyst in the conversion of H202 to OH•. Oxidative inactivation in other enzymes can 
involve OH• attack on an amino acid or the heme (Matheson and Travis, 1985; Beyer and 
Fridovich, 1987; Jenzer et al., 1987). 
Results from this study suggest that this oxidative inactivation can be stimulated by 
any CB that is a slowly metabolized substrate for CYP1A. 1) Stimulation of NADPH 
oxidation and inhibition of EROD by CBs 126 and 169 suggest that they interact with the 
CYP1A active site. 2) ROS production was stimulated by both CBs 126 and 169, but 
only in microsomes with induced levels of CYP1A. Thus the presence of CYP1A is 
required for the production of ROS. 3) Both CBs 126 and 169 stimulated loss of CYP1A 
catalytic activity and total P450. The rate of loss was greater with CBs 126 and 169 than 
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had been seen previously with CB 77 (Chapter 3). Both CBs 126 and 169 are more 
refractory to metabolism than CB 77 (Safe, 1994), potentially increasing uncoupling. 4) 
The inactivation stimulated by CBs 126 and 169 was dependent upon electron flow. 5) As 
has been seen with CB 77, the inactivation of CYP1A could be accelerated by the addition 
of azide and H202, both of which undergo Fenton chemistry to form highly reactive 
radicals (Ortiz de Montellano et al., 1988; Partridge et al., 1994). 6) CB 52, a di-ortho CB 
which is not a substrate for CYP1A, did not stimulate NADPH oxidation, inhibit EROD, 
inactivate CYP1A or stimulate ROS release. 7) BP, a rapidly metabolized substrate, 
stimulated NADPH oxidation and inhibited EROD but did not stimulate CYP1A 
inactivation or ROS release. These results are consistent with attack of internally produced 
activated oxygen being a generalized mechanism of inactivation stimulated by slowly 
metabolized CYP1A substrates. 
On the other hand, the mono-ortho CB 105 inactivated CYP1A but did not stimulate 
ROS release. Mono-ortho CBs, including CB 105, can assume an almost co-planar 
configuration and thus are able to interact with the AhR and induce EROD activity in 
mammals (Safe et al., 1985; McFarland and Clark, 1989). Even though CB 105 is 
ineffective at inducing CYP1A in several fish species (Gooch et al., 1989; Bemhoft et al., 
1994; Newsted et al., 1995), it apparently can interact with scup CYP1A as was indicated 
by its ability to stimulate NADPH oxidation and to inhibit EROD activity. Another mono-
ortho CB, 2,3,3',4,4',5-hexachlorobiphenyl (IUPAC.#156), also inhibits EROD activity 
in scup liver microsomes (Gooch et al., 1989). However, CB 105 inhibited and 
inactivated CYP1A to a lesser extent than the coplanar CBs. Activation of oxygen may not 
be as rapid, as suggested by the lesser rate of CYP1A inactivation in the presence of CB 
105, and thus no increase in ROS release was seen. Other studies have demonstrated that 
treatment with the mono-ortho CB 2,3,4,4'5-pentachlorobiphenyl (IUP AC #118) increases 
oxidase activity in rat liver microsomes (Buchmann et al., 1991) and in porcine pulmonary 
endothelial cells (Toborek et al., 1995). Just as CB 105 is less effective at inhibiting and 
inactivating CYP1A than the coplanar congeners, it also is a less potent AhR agonist and 
has a lower TEF than the coplanar CB congeners (Safe et al., 1985; Safe, 1994). 
CYP IA and Oxidative Stress: Exposure to pHAH can result in oxidative stress. 
Kestrels show increased lipid peroxidation following treatment with CB 126 (Hoffman et 
al., 1996), and rats respond to TCDD treatment with increased lipid peroxidation and 
oxidative DNA damage (Stohs, 1990; Stohs et al., 1990). Furthermore, pHAH-induced 
oxidative stress has been correlated with activation of the AhR (Faux et al., 1992; Alsharif 
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et al., 1994; Park et al., 1996)., as well as induction of CYP1A (Otto and Moon, 1995; 
Toborek et al., 1995; Palace et al., 1996). In vitro experiments performed here with CBs 
126 and 169 and earlier studies with CB 77 (Chapter 3) showed that coplanar CB 
congeners stimulate ROS production in liver microsomes from scup induced for CYP1A 
but not from liver microsomes from control fish. In addition, hepatic microsomal and 
mitochondrial fractions but not cytosolic fractions from TCDD-treated rats can increase the 
incidence of DNA single strand breaks (Wahba et al., 1989). Together, these results 
indicate that interaction of pHAH with CYP1A induced through the AhR could be the 
immediate source of ROS in vivo. 
Whether CB congeners can stimulate ROS release from CYP other than CYPlA is 
not known. Several psuedosubstrates, including perfluoro-n-hexane and 1,1,1-
trichloroethane, and partial uncouplers, including hexobarbital, 5-alkyl-5-ethylbarbituates, 
and benzphetamine, stimulate the release of ROS by CYP2B (Estabrook et al., 1979; 
Jeffery and Mannering, 1982; Kuthan and Ullrich, 1982; Ekstrom and Ingelman-
Sundberg, 1986; Takamo et al., 1988). CB congeners with di-ortho substitutions can 
induce the CYP2B subfamily (Safe et al., 1985), and 2,2',4,4',6,6'-hexachlorobiphenyl 
(IUP AC #155) may uncouple microsomal CYP2B as it stimulates NADPH oxidation and 
oxygen consumption but is not metabolized (Hesse and Wolff, 1977). However, studies 
of porphyrinogen and bilirubin oxidation, attributed to ROS produced during catalytic 
uncoupling, show that 2,2',4,4'-tetrachlorobiphenyl (IUPAC #47) only weakly induces 
this oxidation in vivo and in vitro (DeMatteis et al., 1988; DeMatteis et al., 1989). Whether 
non-coplanar CB congeners stimulate ROS production by CYP2B remains to be 
determined. 
Considering that bioactivation of pHAH does not contribute significantly to their 
toxicity, the uncoupling of CYP1A and resultant release of ROS may be an important 
contributor to the toxicity of pHAH. We have demonstrated that the coplanar CB 
congeners stimulate release of ROS from scup liver microsomes with induced levels of 
CYP1A. Further investigation with CBs 126 and 169 indicated that the mechanism of 
CYP1A protein and activity loss associated with incubation with these CB congeners was 
oxidative inactivation, as has been shown for CB 77 (Chapter 3). Data here, together with 
results with CB 77, show that the interaction of pHAH with scup liver CYP1A stimulates 
the production of ROSin vitro. Planar HAH stimulate oxidative stress (Faux et al., 1992; 
Alsharif et al., 1994; Smith et al., 1995; Park et al., 1996), suggesting that ROS may play 
a role in AhR agonist toxicity in vivo. CBs occur in the environment as complex mixtures; 
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thus while single congeners may exist at very low concentrations, particularly coplanar 
CBs, a combination of CBs may additively or synergistically induce CYP1A catalytic 
activity and toxicity (Bol et al., 1989; Janz and Metcalfe, 1991; Newsted et al., 1995; Zabel 
et al., 1995). Potentially, combinations of congeners could stimulate physiologically 
significant amounts of ROS during environmental exposure. We suggest that release of 
ROS may be a mechanism by which pHAHs promote toxicity. 
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CHAPTER 5 
Inactivation of Cytochrome P450 lA In Vivo by 3,3',4,4',5-
Pentachlorobiphenyl and its Potential Relationship to Oxidative Stress 
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ABSTRACT 
In vertebrates, the planar halogenated aromatic hydrocarbon (pHAH) 3,3',4,4'-
tetrachlorobiphenyl both induces and inhibits cytochrome P450 1A (CYP1A). Moreover, 
multiple pHAHs, including 3,3',4,4'-tetrachlorobiphenyl (IUPAC #77), 3,3',4,4',5-
pentachlorobiphenyl (PeCB) (IUPAC #126) and 3,3',4,4',5,5'-hexachlorobiphenyl 
(IUPAC #169), inactivate CYP1A and stimulate the production of reactive oxygen (ROS) 
in vitro. The ability of PeCB to stimulate CYP1A inactivation, ROS production and 
oxidative stress in vivo was examined in the marine teleost scup (Stenotomus chrysops). 
In liver, a low dose of PeCB (0.01 mglkg) induced total P450, CYP1A protein and 
CYP1A catalytic activities (ethoxyresorufin 0-deethylation and methoxyresorufin 0-
demethylation) over an 18 day period. A high dose of PeCB (1 mglkg) only minimally 
induced hepatic total P450 and CYP1A protein, and CYP1A catalytic activities remained at 
control levels. In contrast, CYP1A mRNA expression was induced strongly by both doses 
(15- to 35-fold). That the inactivating effect was largely specific for CYP1A was 
suggested by the minimal effects on P450A (a CYP3A-like protein), P450B (a CYP2B-like 
protein) and cytochrome b5 content. Less inactivation of CYP1A occurred in heart, gill or 
kidney. ROS production (measured by the oxidation of dihydroethidium) was stimulated 
by PeCB in liver microsomes from the low dose fish, and the rate of PeCB-stimulated ROS 
production was correlated with EROD activity (rl::0.641, p<0.0005). Oxidative stress, as 
indicated by increases in catalase, glutathione peroxidase, glutathione reductase and 
superoxide dismutase activities, was simulated transiently by the low dose. PeCB appears 
to oxidatively inactivate scup liver CYP1A both in vitro and in vivo. 
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INTRODUCTION 
Interaction of planar halogenated aromatic hydrocarbons (pHAH), as well as 
polynuclear aromatic hydrocarbons and natural products, with the aryl hydrocarbon 
receptor results in the increased expression of drug metabolizing enzymes (Hankinson, 
1995). In particular, cytochrome P450 1A (CYP1A) is induced potently by such 
compounds in mammals (Parkinson et al., 1980; Parkinson et al., 1983) and fish 
(Melancon and Lech, 1983; Gooch et al., 1989; Miranda et al., 1990; Monosson and 
Stegeman, 1991). However, pHAH may regulate CYP1A at multiple levels. 3,3',4,4-
tetrachlorobiphenyl (TCB) is a substrate of CYP1A in fish (White et al., 1997b) and 
CYP1A1 in mammals (Ishida et al., 1991) and therefore can competitively inhibit CYP1A 
catalytic activity in vitro (Gooch et al., 1989). Loss of catalytic activity following treatment 
with high doses of coplanar chlorobiphenyl (CB) congeners occurs without the loss of 
protein in vivo (Melancon and Lech, 1983; Voorman and Aust, 1988; Miranda et al., 
1990; Monosson and Stegeman, 1991; Lindstrom-Seppa et al., 1994) and in cultured cells 
(Sawyer and Safe, 1982; Rodman et al., 1989; Hahn et al., 1993; Kennedy et al., 1993; 
Lorenzen et al., 1997), suggesting that coplanar CB congeners could inhibit CYP1A in 
vivo. Last, TCB, at high doses, suppresses CYP1A protein induction in several species 
(Lambrecht et al., 1988; Sinclair et al., 1989; Newsted et al., 1995; Stegeman et al., 1995; 
White et al., 1997a). 
Suppression of CYP1A protein induction at high doses of planar CB congeners has 
been hypothesized to result from oxidative inactivation. In vivo, suppression occurs post-
transcriptionally. A low dose of TCB (0.1 mg/kg) induces hepatic CYP1A mRNA 
expression, protein and catalytic activity to nearly maximal levels in the marine fish model 
scup (Stenotomus chrysops); a high dose of TCB (5 mg/kg) strongly induces CYP1A 
mRNA expression but minimally induces CYP1A protein and activity (White et al., 
1997a). Loss of CYP1A occurs during the incubation of scup liver microsomes with 
TCB+NADPH, as well (White et al., 1997a; Chapter 3). Attack of a metabolically 
activated product cannot account for the loss of CYP1A because metabolism of TCB by 
scup proceeds exceedingly slowly (White et al., 1997a; White et al., 1997b). Enhanced 
electron transfer, oxygen dependence and exceedingly slow rates of TCB turnover are 
consistent with uncoupling of electron transport from substrate oxidation (Chapter 3). As a 
result, reactive oxygen species (ROS) may be released from the active site of CYP1A or 
may attack and inactivate the protein (Chapter 3). ROS attack may be involved in the 
decline in CYP1A seen in vivo. 
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In vitro oxidative inactivation and ROS release are stimulated by several slowly 
metabolized pHAH that are CYP1A substrates, including 2,3,3',4,4'-pentachlorobiphenyl, 
3,3',4,4',5-pentachlorobiphenyl (PeCB) and 3,3',4,4',5,5'-hexachlorobiphenyl (Chapter 
4). Loss of protein induction but not CYP1A mRNA expression following treatment with 
high doses of multiple planar CB congeners suggests that inactivation may occur with 
pHAH generally in vivo, as well (Rodman et al., 1989; Newsted et al., 1995; Lorenzen et 
al., 1997). Recently, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) also has been shown to 
cause suppression of CYP1A1, but not CYP1A2, in mice, in combination with an increase 
in 8-hydroxydeoxyguanosine content (Shertzer et al., 1998). 
We hypothesized from the in vitro data that the coplanar PeCB would suppress 
CYP1A induction in scup liver and induce oxidative stress in vivo. Of the coplanar CB 
congeners, PeCB is the most potent in eliciting toxic effects in fish (Janz and Metcalfe, 
1991; Walker and Peterson, 1991; Newsted et al., 1995) and mammals (Safe, 1990; Tillitt 
et al., 1991). If uncoupling and ROS production are involved in PeCB toxicity, that 
toxicity may be enhanced by the lack of PeCB metabolism (Yoshimura et al., 1987; Koga 
et al., 1990). Although low doses of PeCB (0.01-0.1 mg/kg) potently induced CYP1A 
mRNA, protein and activity in scup liver, a high dose (1 mg/kg) induced only CYP1A 
mRNA and suppressed induction of CYP1A protein and activity. As with TCB, this effect 
appeared to be largely specific to CYP1A. Interestingly, suppression of CYP1A induction 
was organ-dependent, with hepatic CYP1A being most susceptible to inactivation. PeCB 
transiently stimulated anti-oxidant enzyme activity in scup liver in vivo. Furthermore, the 
capacity for hepatic microsomes to produce ROS was correlated with CYP1A activity. The 
results are consistent with the hypothesis that ROS are involved in the in vivo suppression 
of scup liver CYP1A by coplanar CB congeners. 
MATERIALS AND METHODS 
Chemicals: 7-Ethoxyresorufin and dihydroethidium were purchased from 
Molecular Probes (Eugene, OR). 3,3',4,4',5-Pentachlorobiphenyl (IUPAC# 126) was 
purchased from Ultra Scientific (North Kingstown, RI). All other reagents were purchased 
from Sigma (St. Louis, MO). 
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard 
Sound, MAin August, 1996, and experiments were conducted in August, 1997. Fish 
were held in flow-through seawater tanks at 14 oc and maintained on a diet of Purina Trout 
Chow. Experimental animals (mixed sex) were gonadally undeveloped and ranged in size 
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from 136 to 327g. Fish were injected intra-peritoneally with com oil or solutions of 
3,3',4,4',5-pentachlorobiphenyl (0.01, 0.1 or 1 mg/ml, 1 mllkg body weight) in com oil. 
For each dose group, three tanks contained six fish, and at each time point two fish from 
each tank were sampled. Fish were fed once weekly. Untreated fish were killed by 
severing the spinal cord on Day 0. Injected fish were killed 3, 7, and 16 or 18 days 
following dosing. Body and liver weights were recorded and used to calculate the 
Hepatosomatic Index (HSI=the percent of total body weight represented by the liver). 
Sections of liver for RNA preparation were removed and frozen in liquid N2. Immediately 
following dissection of heart, gill, kidney and liver, microsomes and cytosols were 
prepared from sections of each (Stegeman et al., 1979). Microsomal pellets were 
resuspended in buffer (50 mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20% 
glycerol) and frozen in liquid N2 until use. Protein content was determined using the 
bicinchoninic acid method (Smith et al., 1985), using bovine serum albumin as a standard. 
Quantification ofCYPJA mRNA: RNA was prepared using RNA-Stat (Tel-Test 
Inc., Friendswoods, TX) by following the manufacturer's instructions. RNA pellets were 
washed once in 4 M LiCl to remove glycogen, followed by two washes in 95% ethanol. 
Total RNA was quantified by its absorbance at 260 nm on a Shimadzu UV-2401PC 
spectrophotometer. 
Total RNA samples (10 !lg each) were denatured in formamide/formaldehyde and 
separated on a 1% agarose/2.2 M formaldehyde gei, in 20 mM MOPS running buffer. 
RNA was transferred to a positively charged membrane (Chomczynski, 1992). Equal 
loading was assessed from visualization of ethidium bromide staining of ribosomal RNA. 
The dried membrane was pre-hybridized for 2 hr at 42°C, in a buffer composed of 5x 
SSPE, 0.1% SDS, 2x Denhardt's solution, 50% formamide and 100 ~-tg/ml calf thymus 
DNA. 32P-Labeled probe (see below) was added to the pre-hybridization buffer, and the 
membrane was hybridized at 42°C for approximately 12 hrs. The membrane was washed 
two times at 42°C for 30 minutes with 2x SSC, 0.1% SDS and exposed to Kodak X-
OMAT AR film. The relative amount of CYP1A mRNA was determined using 
densitometric analysis of a video image (NIH Image 1.60b5). 
A eDNA probe containing 75% of the scup CYP1A coding region (Morrison et al., 
1995) was used for quantification of CYP1A mRNA. The probe was radiolabeled with [a-
32P]dCTP (Amersham, Arlington Heights, IL) using a Prime-a-Gene labeling kit 
(Promega, Madison, WI). 
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Western blotting for CYP JA quantification: Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). For CYP1A 
determinations, liver microsomal protein was applied to nylon membrane using a slot 
manifold (Kloepper-Sams and Stegeman, 1994). For all other analyses microsomal 
proteins (30-40 f.!g) were resolved on 6-18% SDS-PAGE gels and electrophoretically 
transferred to nylon membrane. The primary antibodies were the mouse monoclonal 
antibody 1-12-3 (Park et al., 1986), against scup P450E (CYP1A; (Morrison et al., 
1995)), the rabbit polyclonal antibody against scup P450B (a CYP2B-like protein) (Gray, 
1988; Stegeman et al., 1990)) and the rabbit polyclonal antibody against scup P450A (a 
CYP3A-like protein) (Celander et al., 1996). The secondary antibodies were alkaline 
phosphatase linked goat anti-mouse IgG and goat anti-rabbit IgG (Schleicher and Schuell, 
Keene, NH). Bands were developed using enhanced chemiluminescence (Tropix, 
Bedford, MA) and quantified by video image analysis (NIH Image 1.60b5) by comparison 
to scup standards of known concentration .. 
Cytochromes b5 and P450 The content of hepatic microsomal P450 was 
determined from the dithionite-difference spectra of CO-treated microsomes (Bonkovsky et 
al., 1984), and cytochrome b5 content was determined from NADH difference spectra 
(Stegeman et al., 1979), as previously described. 
Enzyme assays: Microsomal ethoxyresorufin (EROD) and methoxyresorufin 
(MROD) 0-dealkylation activities were determined fluorometrically by the method of Hahn · 
et al. (1993), using a Cytofluor 2300 (Millipore) multiwell plate reader. Microsomal 
NADPH-cytochrome P450 reductase activity was determined as previously described 
(Stegeman et al., 1982). The activities of catalase (Beutler, 1975), glutathione peroxidase 
(Sies et al., 1979), glutathione reductase (Sies et al., 1979), and superoxide dismutase 
(McCord and Fridovich, 1969) were determined in the cytosols. 
Superoxide formation: 02-. formation was determined using the fluorescent dye, 
dihydroethidium (HE), as described in Chapter 3. Additions included acetone (5 f.!l), 
PeCB (1.7 nmol in acetone) and NADPH (1.4 mM). ROS production stimulated by PCB 
126 was calculated by subtracting the fluorescence in the well containing acetone to that in 
the well containing PeCB. 
Statistics Statistics were calculated using SuperAnova for Macintosh (Abacus 
Concepts, Inc., Berkeley, CA). Nested, one-factor ANOVAs were used to analyze 
differences between treatment groups within sampling days. Tank was not found to be a 
significant factor. Because RNA and extrahepatic tissue samples were pooled per tank, 
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Figure 1. Effect of PeCB on hepatic microsomal cytochrome P450 (A) and cytochrome b5 
(B) content. Cytochrome contents were determined spectrally. Data represent the means± 
SD of measurements on 6 fish per treatment group except for the 0.01 mglkg dose on Day 
18 (n=4) and the 1 mglkg dose on Day H) (n=3). +-Statistically different from control and 
1 mg/kg dose (p<0.05). #-Statistically different from control (p<0.05). The 0.1 mg/kg 
dose was significantly different from control and 1 mglkg dose (p<0.05). 
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Figure 2. Effect ofPeCB on CYP1A mRNA expression in scup liver. A) Northern blot of 
CYP1A mRNA. Lanes 1-2. Control, Day 3. Lanes 3-4. 0.01 mg PeCB/kg, Day 3. 
Lanes 5-6. 1 mg PeCB/kg, Day 3. Lanes 7-8. 0.01 mg PeCB/kg, Day 7. Lanes 9-10. 
0.1 mg PeCB/kg, Day 7. Lanes 11-12. 1 mg PeCB/kg, Day 7. Lanes 13-14. 0.01 mg 
PeCB/kg, Day 18. Lanes 15-16. 1 mg PeCB/kg, Day 16. B) Comparison of CYP1A 
mRNA in liver of scup treated with various doses of PeCB. For each time point, livers 
from fish in the same tank were pooled before RNA preparation. Total RNA (10 J..Lg/lane) 
was separate on agarose gel, transferred to nylon membrane, probed with a 32P-labeled 
eDNA containing 75% of the scup CYP1A coding region, and densitometrically quantified. 
Data represent the means ± SD of measurements on 3 pools per treatment group except for 
the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg dose on Day 16 (n=3). ++-
Statisically different from control and 1 mg/kg dose (p<0.01). #-Statistically different from 
control (p<0.05). ##-Statistically different from control (p<0.01). The 0.1 mg/kg dose 
was significantly different from control and 1 mglkg dose (p<0.01). 
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one-factor ANOV As were to analyze assays using these samples. The Tukey-Kramer 
multiple-comparisons test was used to determine which doses were different. Due to 
deaths in the 1 mg/kg dose group, fish in this group were killed on Day 16 while those in 
the control and 0.01 mglkg dose groups were killed on Day 18. Fish killed on days 16 and 
18 were analyzed together. 
RESULTS 
Gross effects: No change in the Hepatosomatic Index occurred in any dose group 
over the experimental period (data not shown). However, while no deaths due to toxicity 
occurred in the first seven days post-injection, one of the five remaining fish in the 0.01 mg 
PeCB/kg dose group died between Days 7 and 18, and three of the six remaining fish in the 
1 mg PeCB/kg dose group died between Days 7 and 16. 
Hepatic mono-oxygenase components: The content of total spectral P450 in hepatic 
microsomes from control fish decreased over time; however, the change was not 
statistically significant. Although the content of total P450 in hepatic microsomes from 
fished dosed with 0.01 mg PeCB/kg peaked on Day 3, it was not significantly induced 
above controls until Day 7 and remained elevated on Day 18 (Figure 1A). The 0.1 mg 
PeCB/kg dose significantly induced total P450 by Day 7, and the level of total P450 was 
similar to that induced by the 0.01 mg PeCB/kg dose. The 1 mg PeCB/kg dose did not 
significantly induce total P450 until Day 16. The maximal induction of total P450 by the 
0.01 mg PeCB/kg dose was 3-fold, while that by the 1 mg PeCB/kg dose was 2-fold. The 
specific content of b5 was not affected by any of the treatments (Figure 1B). 
CYPIA expression, protein content and activity: Hepatic CYP1A mRNA 
expression was assessed using a eDNA probe containing 75% of the scup CYP1A coding 
region (Figure 2A). Ethidium bromide staining of ribosomal RNA was visualized on the 
membrane to confirm equivalent loading of samples (data not shown). CYP1A mRNA 
expression was significantly elevated by Day 3 in both the 0.01 and 1 mg PeCB/kg dose 
groups and remained elevated through Days 16-18 (Figure 2B). Maximal induction (15-
fold) by the 0.01 mg PeCB/kg dose occurred 18 days post-injection, and maximal 
induction (35-fold) by the 1 mg PeCB/kg dose occurred 7 days post-injection. The 0.1 mg 
PeCB/kg dose significantly induced CYP1A mRNA expression at Day 7 (Figure 2B). 
Induction of CYP1A protein followed a similar pattern to that seen with total P450 
content. Despite being in captivity for one year, the presence of measurable CYPlA in 
controls suggests that these fish were not depurated fully. A peak in CYP1A content 
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occurred on Day 3 following the 0.01 mg PeCB/kg dose; however, CYP1A protein was 
significantly induced only on Days 7 and 18 (Figure 3A). The 0.1 mg PeCB/kg dose 
significantly induced CYP1A protein at Day 7, and the content was similar to that induced 
by the 0.01 mg PeCB/kg dose. The 1 mg PeCB/kg dose did not significantly induce 
CYP1A protein over that seen in controls until Day 16; however, the content of CYP1A 
was still significantly less than that seen in the 0.01 mg PeCB/kg dose group (3-fold vs. 5-
fold, respectively). 
EROD and MROD activity have been attributed to CYP1A1 and CYP1A2 in 
mammals (16). As of yet, a single CYP1A form has been identified in scup, and it is 
hypothesized to be a type ancestral to both mammalian CYP1A1 and CYP1A2 (4,17). 
Scup CYP1A is thought to catalyze both EROD and MROD. EROD activity increased by 
Day 3 in the 0.01 mg PeCB/kg dose group but was not induced significantly above EROD 
in controls until Day 7 (Figure 3B). EROD activity reached maximal induction (4-fold) on 
Day 18 in the 0.01 mg PeCB/kg dosed fish. The 0.1 mg PeCB/kg dose significantly 
induced EROD activity (3-fold) at Day 7. EROD activity was not induced by the 1 mg 
PeCB/kg dose over the course of the experiment. Unlike EROD activity, MROD activity 
peaked at 6-fold induction in the 0.01 mg PeCB/kg dosed fish on Day 3 and declined 
through Day 18 (Figure 3C). MROD activity was induced significantly at Day 7 by the 
0.01 and 0.1 mg PeCB/kg doses. MROD activity was not induced by the 1 mg PeCB/kg 
dose over the course of the experiment. 
Total P450 was correlated strongly with CYP1A throughout the experiment (Figure 
4A). EROD activity also was correlated strongly with CYP1A content; however, on Day 3 
the slope of the correlation decreased, i. e. the turnover number for EROD activity 
decreased (Figure 4B). 
Other CYP proteins : Hepatic microsomes were immunoblotted with antibodies to 
two other major P450 forms expressed in scup liver: P450A, a possible CYP3A 
homologue (Celander et al., 1996) and P450B, a probable CYP2B homologue (Gray, 
1988; Stegeman et al., 1990). The content of P450A was not affected by any· of the 
treatments (Figure 5A). Little change in P450B content occurred with any treatment 
(Figure 5B). However, on Day 7 the 0.01 mg PeCB/kg dose slightly induced P450B, and 
the 1 mg PeCB/kg dose slightly suppressed P450B content. P450B content in the 0.01 mg 
PeCB/kg dose group was only significantly different from the 1 mg PeCB/kg dose group 
on Day 7. 
Oxidative stress: Several studies have suggested that CYP1A produces reactive 
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Figure 3. Effect ofPeCB on hepatic microsomal CYP1A content (A) and catalytic activity 
(EROD - B; MROD - C). Liver microsomal fractions (0.2-4 J..Lg/slot) were applied to nylon 
membrane with a slot blot manifold, and immunoblotted with MAb 1-12-3 against scup 
CYP1A. CYP1A reactive bands were visualized using enhanced chemiluminescence and 
quantified by densitometric analysis. Enzyme activities were determined fluorometrically 
by the method of Hahn et al. (1993). Data represent the means± SD of measurements on 6 
fish per treatment group except for the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mglkg 
dose on Day 16 (n=3). +-Statisically different from control and 1 mglkg dose (p<0.05). 
++-Statisically different from control and 1 mglkg dose (p<0.01). ##-Statistically different 
from control (p<0.01). The 0.1 mg/kg dose was significantly different from control 
(p<0.05). 
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Figure 4. Correlation of CYPlA content with total P450 content and EROD activity. 
A) CYPlA versus total P450. B) CYPlA versus EROD. 
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Figure 5. Effect of PeCB on hepatic microsomal P450A (A) and P450B (B). Liver 
microsomal fractions (30 J-lg/lane) were electrophoresed, transferred to nylon membrane, 
and immunoblotted with polyclonal anti-scup P450A (a CYP3A-like protein) and 
polyclonal anti-scup P450B (a CYP2B-like protein). Reactive bands were visualized using 
enhanced chemiluminescence and quantified by densitometric analysis. Data represent the 
means± SD of measurements on 6 fish per treatment group except for the 0.01 mglkg dose 
on Day 18 (n=4) and the 1 mglkg dose on Day 16 (n=3). +-Statisically different from 
control and 1 mglkg dose (p<0.05). 
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oxygen species during its interaction with pHAHs (DeMatteis et al., 1991; Park et al., 
1996; Chapters 3 and 4). The potential for hepatic microsomes to produce ROS was 
determined by incubating microsomes with PCB 126, NADPH and HE. HE is oxidized to 
the fluorescent product ethidium by superoxide (Robinson et al., 1994). HE oxidation was 
greatest in microsomes from fish treated with the 0.01 mg PeCB/kg dose (Figure 6A). The 
potential to produce ROS was significantly elevated by Day 7 in the 0.01 and 0.1 mg 
PeCB/kg dose groups, and it remained elevated in the 0.01 mg PeCB/kg dose group 
through Day 18. The 1 mg PeCB/kg dose did not significantly affect the potential to 
produce ROS. The potential to produce ROS was highly correlated with EROD activity 
(Figure 6B). 
In vivo oxidative stress was assessed by measuring the activities of several anti-
oxidant enzymes. Similar patterns of induction were seen with all of the anti-oxidant 
enzymes measured, including catalase, glutathione peroxidase, glutathione reductase and 
superoxide dismutase (Figure 7). The activities of all of the enzymes were significantly 
induced by the 0.01 mg PeCB/kg dose at Day 3 and then decreased through Day 18. 
Glutathione peroxidase activity remained significantly elevated on Day 7. The 0.1 and 1 
mg PeCB/kg doses did not significantly alter the activity of any of the anti-oxidant enzymes 
over the course of the experiment. 
Extrahepatic organs: The patterns of CYP1A induction in microsomes from extra-
hepatic tissues differed from that seen liver microsomes. In heart, CYP1A content was 
significantly induced by the 0.01 mg PeCB/kg dose by Day 7 and continued to increase 
over time (Figure 8A). The 1 mg PeCB/kg dose strongly induced CYP1A content in the 
heart by Day 16. In gill, only the 0.01 and 0.1 mg PeCB/kg dose significantly induced 
CYP1A content over that in controls, despite an increase in CYP1A content in the 1 mg 
PeCB/kg dose group on Day 16 (Figure 8B). In thekidney, a significant increase in 
CYP1A content was seen in the 1 mg PeCB/kg dose group by Day 3 (Figure 8C). By Day 
7, all three dose groups had similar induction of renal CYP1A. The CYP1A content 
remained elevated in both the 0.01 and 1 mg PeCB/kg dose groups through Days 16-18. 
EROD induction had a slightly different pattern than that seen with CYP1A content 
in extra-hepatic organs. In heart, EROD activity was significantly induced by 0.01 mg 
PeCB/kg, reaching a maximal level by Day 7 (9-fold induction) which was sustained to the 
end of the experiment (Figure 9A). The 0.1 mg PeCB/kg dose did not induce EROD 
activity significantly in heart. EROD activity was strongly induced by the 1 mg PeCB/kg 
dose at Day 16 (10-fold induction). In gill, the 0.01 mg PeCB/kg dose significantly 
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Figure 6. Effect of PeCB on the potential of hepatic rnicrosomes to produce ROS (A) and 
correlation ofROS production with EROD activity (B). Microsomal protein (0.1 mg) was 
diluted in HBSS containing 7.5 JlM HE (final concentration). Following a 15 minute pre-
incubation at 30°C, either acetone (5 Jll) or PeCB (1.7 nmol in acetone) was added. 
Reactions were initiated with NADPH (1.4 mM), and fluorescence was monitored over 10 
minutes. ROS production stimulated by PCB 126 was calculated by subtracting the 
fluorescence in the well containing acetone to that in the well containing PeCB. Data 
represent the means ± SD of measurements on 6 fish per treatment group except for the 
0.01 mg/kg dose on Day 18 (n=4) and the 1 mglkg dose on Day 16 (n=3). ++-Statisically 
different from control and 1 mg/kg dose (p<0.01). The 0.1 mg/kg dose was significantly 
different from control and 1 mg/kg dose (p<0.05). 
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Figure 7. Effect of PeCB on hepatic cytosolic catalase activity (A), glutathione peroxidase 
activity (B), glutathione reductase activity (C), and superoxide dismutase activity (D). 
Enzyme activities were quantified spectrophotometrically. Data represent the means± SD 
of measurements on 6 fish per treatment group except for the 0.01 mg/kg dose on Day 18 
(n=4) and the 1 mg/kg dose on Day 16 (n=3). +-Statisically different from control and 1 
mg/kg dose (p<0.05). ++-Statisically different from control and 1 mg/kg dose (p<0.01). 
#-Statistically different from control (p<0.05). 
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Figure 8. Effect of PeCB on extra-hepatic microsomal CYP1A content. A) Heart. B) 
Gill. C) Kidney. For each time point, organs from fish in the same tank were pooled 
before microsome preparation. Microsomal fractions (30 ~gllane) were electrophoresed, 
transferred to nylon membrane, and immunoblotted with MAb 1-12-3 against scup 
CYP1A. CYP1A reactive bands were visualized using enhanced chemiluminescence and 
quantified by densitometric analysis. Data represent the means ± SD of measurements on 3 
pools per treatment group. + -Statisically different from control and 1 mg/kg dose 
(p<0.05). #-Statistically different from control (p<0.05). ##-Statistically different from 
control (p<0.01). For gill and kidney, the 0.1 mglkg dose was significantly different from 
control and 1 mglkg dose (p<0.05). 
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Figure 9. Effect ofPeCB on extra-hepatic microsomal CYP1A catalytic activity (EROD). 
A) Heart. B) Gill. C) Kidney. For each time point, organs from fish in the same tank 
were pooled before microsome preparation. EROD activity was determined 
fluorometrically. Data represent the means± SD of measurements on 3 pools per treatment 
group. + -Statisically different from control and 1 mg/kg dose (p<0.05). ++ -Statisically 
different from control and 1 mglkg dose (p<0.01). #-Statistically different from control 
(p<0.05). ##_Statistically different from control (p<0.01). For gill and kidney, the 0.1 
mglkg dose was significantly different from control and 1 mglkg dose (p<0.05). 
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• 0.01 mg/kg 
• 0.1 mg/kg 
1 mg/kg 
induced EROD activity by Day 7, and the activity continued to increase through Day 18 
(14-fold maximal induction)(Figure 9B). At Day 7, EROD activity was greatest in the 0.1 
mg PeCB/kg dose group (9-fold induction). The 1 mg PeCB/kg dose significantly 
increased EROD activity in gill by Day 3 with a slight increase in activity through Day 16. 
Unlike the other extrahepatic organs, while the 0.01 mg PeCB/kg dose strongly induced 
renal EROD activity from Days 7-18, the EROD activity in the 1 mg PeCB/kg dose group 
was suppressed throughout the entire experiment (Figure 9C). The 0.1 mg PeCB/kg dose 
significantly induced renal EROD activity on Day 7. 
DISCUSSION 
Planar HAH can regulate CYP1A via induction, inhibition and inactivation. 
Coplanar CB congeners, including TCB, PeCB and 3,3',4,4',5,5-hexachlorobiphenyl are 
potent inducers of CYP1A (Parkinson et al., 1980; Melancon and Lech, 1983; Parkinson et 
al., 1983; Gooch et al., 1989; Miranda et al., 1990; Monosson and Stegeman, 1991; Palace 
et al., 1996). Presumably all coplanar CBs are competitive inhibitors of CYP1A, as has 
been shown for TCB (Gooch et al., 1989). In vitro studies also have shown that coplanar 
CB congeners oxidatively inactive CYP1A (White et al., 1997a; Chapters 3 and 4). PeCB 
potently induced CYP1A mRNA, protein and catalytic activity at low doses (0.01-0.1 
mglkg) and induced CYP1A mRNA at a high dose (1 mglkg) but suppressed induction of 
CYP1A protein and catalytic activity at that high dose. Suppression of hepatic CYP1A 
content by high doses of TCB (White et al., 1997a) and PeCB may be attributed to the 
same oxidative inactivation seen in vitro. The organ specificity of CYP1A-suppression 
could result simply from a lesser concentration of PeCB or from a reduction in reductase 
activity in extra-hepatic organs (Stegeman et al., 1982). This study and others have 
demonstrated oxidative stress resulting from pHAH exposure, supporting the conclusion 
that CYP1A produces ROS in vivo and that ROS are the in vivo mechanism of CYP1A 
inactivation. 
Comparison of Induction and Suppression of CYP JA by PeCB and TCB: PeCB 
was a more potent inducer of CYP1A than TCB, with maximal induction being reached at a 
dose of 0.01 mg PeCB/kg, as compared to a dose of 0.1 mg TCB/kg (White et al., 1997a). 
The same relationship has been seen in rainbow trout (Newsted et al., 1995) and mammals 
(Safe et al., 1985). At a dose of 0.1 mg/kg PeCB, CYP1A induction was similar to that 
with 0.01 mg PeCB/kg, although there may have been slight inactivation at this dose. In 
absolute values, the low dose of PeCB induced CYP1A protein and activity with similar 
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efficacy as TCB (White et al., 1997a). The fold induction of CYP1A protein and activity 
by PeCB was lower than that seen with TCB; however, this is only a result of the fact that 
the fish used in the current experiment were not depurated as long as those in the TCB 
experiment. 
In vitro studies have suggested that oxidative inactivation of scup CYP1A occurs 
not only with TCB, but also with PeCB, 2,3,3',4,4'-pentachlorobiphenyl, and 
3,3',4,4',5,5'-hexachlorobiphenyl (Chapter 4). In this study, we have demonstrated that 
inactivation of CYP1A by PeCB apparently occurs in vivo. Comparison of nominal doses 
of TCB and PeCB suggests that a similar dose (""' 1 mglkg) is required for PeCB and TCB 
to inactivate CYP1A in vivo. Ki and Kminactivation values for TCB and PeCB are similar; 
however the rate of inactivation of EROD activity was greater with PeCB than with TCB 
(Chapter 4). The loss of suppression by TCB at Day 16 probably resulted from the 
significant decrease in the hepatic TCB concentration (White et al., 1997a). Suppression of 
CYP1A was maintained by the high dose of PeCB despite the dose being 5-fold lower than 
that used previously with TCB; this may result from PeCB being eliminated more slowly 
than TCB (Yoshimura et al., 1987; Koga et al., 1990). Residue analysis of the livers of 
these fish are required to confirm this hypothesis. 
High doses of both TCB and PeCB caused complete suppression of EROD but 
induced CYP1A protein moderately. Loss of catalytic activity following treatment with 
high doses of coplanar CB congeners without the loss of protein occurs in vivo (Melancon 
and Lech, 1983; Voorman and Aust, 1988; Miranda et al., 1990; Monosson and Stegeman, 
1991; Lindstrom-Seppa et al., 1994) and in cultured cells (Sawyer and Safe, 1982; 
Rodman et al., 1989; Hahn et al., 1993; Kennedy et al., 1993; Hahn and Chandran, 1996; 
Lorenzen et al., 1997). This suggests that inhibition may contribute partially to the loss of 
EROD activity (Gooch et al., 1989). However, in in vitro assays, despite the total loss of 
EROD activity and substantial loss of spectral P450 during incubation with TCB and 
NADPH, there is no loss of immunodetectable CYPlA (White et al., 1997a). Thus, the 
inactivated protein may retain the epitope recognized by the antibody, and degradation of 
the protein may occur more slowly than inactivation. A similar lag between loss of catalytic 
activity and loss of protein is seen d,uring the mechanism-based inactivation of CYP1A1 by 
analogues of 3,5-diethoxycarbonyl-1.4-dihydro-2,4,6-trimethylpyridine (Riddick et al., 
1990). 
As with the regulation of CYP1A by TCB, the effects of PeCB appear to be largely 
specific for CYP1A. Heme production was not suppressed generally, as the cytochrome 
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b5 content remained constant' for all treatments over the course of the experiment. 
Significant, sustained protein induction following the low dose PeCB treatment and 
significant suppression of protein induction following the high dose of PeCB only occurred 
with CYP1A and not with P450A or P450B. 
The data also may suggest that another CYP was induced transiently. While the 
relationship between total P450 and CYP1A remained constant throughout the experiment, 
the turnover number for EROD activity decreased on Day 3. Peaks in total P450, CYP1A 
content ~nd MROD activity, but not EROD activity occurred on Day 3. PeCB induces both 
CYP1A1 and CYP1A2 in mammals (Safe et al., 1985). Therefore, one explanation for this 
anomaly may be that a P450 that is recognized by MAb 1-12-3 and catalyzes MROD 
activity was induced on Day 3. However, to date, MAb 1-12-3 has been thought to 
recognize only one protein (Park et al., 1986), and scup have been thought to have only 
one CYP1A (Morrison et al., 1995). Multiple CYP1A genes have been isolated from trout 
treated with 3-methylcholanthrene (Bemdtson and Chen, 1994), and potentially a second 
CYP1A exists in scup. Further, experiments are required to address this issue. 
CYP IA and Oxidative Stress In Vivo: Induction of specific P450 isoforms has 
been correlated with increased oxidase activity in microsomes. Ethanol treatment in rats 
results in induction of CYP2E1, oxidase activity and lipid peroxidation (Ekstrom and 
Ingelman-Sundberg, 1989). Some studies indicate that there is an increase in microsomal 
oxidase activity following treatment with CYP2B inducers; however, results have been 
variable (Auclair et al., 1978; Urquhart and Elder, 1987; Buchmann et al., 1991; Sakai et 
al., 1992). Liver microsomes from mice treated with hexachlorobenzene or 3-
methylcholanthrene (MC) and rats treated with TCB or MC produce elevated amounts of 
ROS (Urquhart and Elder, 1987; Buchmann et al., 1991). However, the results with rats 
also have been contradicted (Sakai et al., 1992). In the experiments performed here, there 
was no increase in oxidase activity without the presence of additional PeCB. Very low 
doses of PeCB were originally administered, therefore much of it may have been removed 
during microsome preparation. Thus, the variable results seen previously with CYP1A 
may be related to the original dose and the removal of the compound during microsome 
preparation. 
A growing body of studies support the conclusion that the pHAH, TCDD, induces 
oxidative stress in vivo. Treatment of female rats with TCDD results in a 600% increase in 
single strand breaks in DNA and a 500% increase in lipid peroxidation in the liver (Stohs et 
al., 1990). Peritoneal lavage cells (PLC) from TCDD treated rats exhibit increased OT• 
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production and single strand DNA breaks (Alsharif et al., 1994). TCDD-stimulated 
toxicity (Poland and Glover, 1980) and oxidative stress both appear to be AhR dependent 
In PLC from AhR-responsive mice a 25-fold lower dose of TCDD is required to stimulate 
02-. production than that required in non-responder mice (Alsharif et al., 1994). TCDD 
exposure induces both CYP1A activity and oxidative DNA damage in Hepa1clc7 cells, but 
induces neither in AhR defective c4 cells (Park et al., 1996). Potentially, H202, OT• and 
OH• all are involved in TCDD-induced oxidative damage (Stohs et al., 1986). 
Treatment with CB mixtures, as well as specific congeners, also promotes oxidative 
stress. Aroclor 1254 treatment stimulates hepatic lipid peroxidation in chickens, rats and 
guinea pigs (Combs and Scott, 1975; Kato et al., 1981; Dogra et al., 1988). Kestrels show 
increased lipid peroxidation following treatment with PeCB (Hoffman et al., 1996). This 
study and others have demonstrated increases in both CYP1A content and antioxidant 
enzyme activity following exposure to TCB and PeCB in fish (Otto and Moon, 1995; Palace 
et al., 1996). Further, iron potentiates 8-hydroxydeoxyguanosine formation, hepato-
carcinogenesis and uroporphyria in AhR responsive mice (C57BL but not DBA/2) exposed 
to Aroclor 1254 (Faux et al., 1992; Smith et al., 1995). Considering that iron can act as a 
Fenton catalyst converting ROS produced in cells to OH• which can attack celluiar 
components, this data suggests that ROS are associated with that toxicity. 
Despite that facts that pHAH-stimulated oxidative stress is apparently AhR 
dependent (Faux et al., 1992; Smith et al., 1995) and that only microsomes with induced 
levels of CYP1A produce ROS (Chapter 3), there may be in vivo sources of ROS other 
than CYP1A. Potential sources of ROS can be narrowed by the fact that hepatic 
microsomal and mitochondrial fractions but not cytosolic fractions from TCDD-treated rats 
can increase the incidence of DNA single strand breaks (Wahba et al., 1989). First, pHAH 
may stimulate xanthine oxidase, peroxisome proliferation or mitochondrial multiplication 
(Stohs, 1990). Polychlorinated biphenyls with 3 or fewer chlorine substitutions can be 
metabolized to redox-cycling quinones (Oakley et al., 1996). Neutrophils can be activated 
by PCBs, but only by ortho-substituted PCBs (Ganey et al., 1993). Finally, NADPH-
cytochrome P450 reductase can be induced by pHAH (Manjunath and Dufresne, 1988) and 
is a known source of ROS (Morehouse et al., 1984). While CYPlA is implicated as the 
source of ROS in in vitro studies, alterations in mitochondrial activities or reductase activity 
may contribute to the oxidative stress stimulated by more highly chlorinated pHAHs in 
vivo. 
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The toxicity of coplanar PCBs is correlated with the AhR and CYPlA induction; 
however, metabolic activation of these congeners is not significant. The production of 
ROS during the interaction of coplanar congeners with CYPlA may explain in part the role 
of CYPlA in the toxicity of pHAHs. One consequence of that ROS production may be 
self-inactivation of CYPlA, as has been shown with several coplanar congeners in vitro 
and with TCB and PeCB in vivo in the fish model scup. The consequences of a loss of 
CYPlA are unknown, but studies have shown a regulatory relationship between CYPlA 
and the AhR which may be perturbed by the loss of CYPlA (Chang and Puga, 1998). The 
multiplying studies which demonstrate oxidative stress following exposure to pHAHs 
supports the in vitro evidence of ROS production by CYPlA. 
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CHAPTER 6 
Characterization of the Reactive Oxygen Sensitive Transcription Factor, 
Nuclear Factor-KB in the Marine Fish Scup (Stenotomus chrysops) and 
Examination of its Activation by Aryl Hydrocarbon Receptor Agonists 
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ABSTRACT 
Members of the Rel family of proteins have been identified in Drosophila, 
Xenopus, birds and mammals, and evidence suggests that xenobiotic compounds may alter 
the activation of nuclear factor-KB (NF-KB). Here we demonstrate that apparent members 
of the Rel protein family also exist in liver, kidney and heart of the marine fish scup 
(Stenotomus chrysops). Using the electrophoretic mobility shift assay, binding of an NF-
KB consensus sequence was evident, but highly variable, in vehicle-treated fish. The 
activation of NF-KB in vehicle-treated fish appeared to decrease over time. Two xenobiotic 
compounds, benzo[a]pyrene (BP) and 3,3',4,4',5-pentachlorobiphenyl (PeCB), were 
tested for the ability to activate NF-KB-DNA binding in scup liver. A 10 mg BP/kg dose 
had no effect on NF-KB-DNA binding either at 3 or 6 days following treatment. Two 
experiments with PeCB gave conflicting results. The first experiment showed a 6-8-fold 
increase in activation 16-18 days following treatment with PeCB (0.01-1 mg/kg); however, 
the second experiment showed no significant activation 14 days following treatment. The 
results appeared to be confounded both by the apparent injection effect and by high 
variability. Nuclear proteins from scup kidney and heart also specifically bound the NF-
KB consensus sequence, but with no dose specific pattern. The specificity and identity of 
the shifted band was confirmed. Scup liver nuclear extracts did not bind to the consensus 
binding sequences of another redox sensitive transcription factor AP-1 or a ubiquitous 
mammalian transcription factor Octl. The binding was specifically competed by 
oligonucleotides containing various sequences of NF-KB binding regions; however, an 
oligonucleotide containing the aryl hydrocarbon receptor dioxin response element did not 
inhibit the band-shift. A DNA-protein crosslinking technique demonstrated that 3 proteins 
bound the NF-KB consensus sequence in scup liver, kidney and heart, 2 of which 
potentially correspond to the mouse p50 and RelA (p65) proteins as well as a smaller 
protein of approximately 30 kD. Antibodies to mammalian p50 primarily 
immunoprecipitated the apparent 50 kD protein in scup liver, kidney and heart. The data 
indicate that the Rel family of proteins is present in fish and represented by at least a p50 
homologue. Activation of NF-KB by aryl hydrocarbon receptor agonists remains a 
question, however. 
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INTRODUCTION 
NF-KB is a multisubunit transcription factor that can rapidly activate genes 
encoding cytokines, cell surface receptors, cell adhesion molecules and acute phase 
proteins (Baeuerle, 1991). NF-KB subunits are members of the Rel homology family of 
proteins. The Rel homology domain is a 300-amino acid region which contains a DNA-
binding region, a dimerization domain, a nuclear translocation signal and a region of 
interaction with proteins of the IKB family (Miyamoto and Verma, 1995; Verma et al., 
1995). In mammals, the Rel family is represented by RelA, RelB, cRel, NF-KB 1 
(p52/p100) and NF-KB2 (p50/p105) (see (Huguet et al., 1997)). The Rel family is 
represented by dorsal, dif and relish in Drosophila (Steward, 1987; Ip et al., 1993; Dushay 
et al., 1996). Homologs of NF-KB1, RelA, RelB and cRel have been sequenced from 
Xenopus (Kao and Hopwood, 1991; Suzuki et al., 1995; Tannahill and Wardle, 1995; 
Suzuki et al., 1998), and homologs of NF-KB1, NF-KB2, RelA and cRel have been 
sequenced from birds (Wilhelmsen et al., 1984; Capobianco et al., 1990; Capobianco et 
al., 1992; Ikeda et al., 1993; Sif and Gilmore, 1993). RelA, RelB and cRel are 
synthesized "ready-to-use" and contain a transactivating domain, while p50 and p52 are 
proteolytically matured and do not contain a transactivating domain. Multiple homo- and 
heterodimers may by formed, the classic NF-KB dimer being p50/RelA. Different KB 
binding sites in gene promoters have different affinities for dimers, and thus the identity of 
the subunits in the dimer confer specificity to gene activation (Miyamoto and Verma, 1995; 
Muller et al., 1996). 
Usually, NF-KB dimers are sequestered in the cytoplasm by an inhibitor, IKB. 
Upon stimulation by cytokines, mitogens, viral infection, UV irradiation or reactive oxygen 
species (ROS), the inhibitor is phosphorylated, ubiquinated and digested by a proteosome, 
allowing NF-KB to translocate to the nucleus and bind DNA (Baldwin, 1996). In many 
cases, ROS are used as second messengers to initiate degradation of IKB, as antioxidants 
block NF-KB activation by potent activators such as tumor necrosis factor-a, interlukin-1, 
phorbol 12-myristate 13-acetate, lipopolysaccharide and okadaic acid (Schreck et al., 
1991). 
Recent studies have shown that xenobiotic compounds also may activate NF-KB 
binding. 2,3, 7,8-Tetrachlorodibenzo-p-dioxin (TCDD) transiently stimulates NF-KB 
binding in rat thymocytes (Olnes et al., 1994), and TCDD-mediated activation of 
expression of a chloramphenicol acetyltransferase (cat) reporter gene linked to the promoter 
sequence of the human immunodeficiency virus type 1 (HIV-1) requires NF-KB activation 
137 
(Yao et al., 1995). Two polynuclear aromatic hydrocarbons, 7,12-dimethylbenz[a]-
anthracene (DMBA) and benzo[a]pyrene (BP), transiently stimulate NF-KB binding in 
murine hepatoma cells (Shneider et al., submitted) and murine stromal cells (K. K. Mann, 
unpublished results). A more sustained activation of NF-KB binding is seen following 
treatment of HepG2 cells with quinones, including menadione and tert-butylhydroquinone 
(Pinkus et al., 1996; Chen and Cederbaum, 1997). In vivo, phenobarbital, ciprofibrate 
and carbon tetrachloride all have been shown to activate NF-KB binding in rat liver 
(Gruebele et al., 1996; Li et al., 1996; Li et al., 1996). ROS have been suggested to be a 
second messenger in the activation of NF-KB by xenobiotic compounds. 
Aryl hydrocarbon receptor (AhR) mediated pathways may be contributing to the 
activation of NF-KB. DMBA- and BP-mediated NF-KB activation have been shown to be 
AhR dependent (Shneider et al., submitted). The AhR regulates the expression of drug 
metabolizing enzymes, including cytochromes P450 lAs (CYPlA), and genes involved in 
cell growth control (Hankinson? 1995). Studies have produced conflicting results as to 
whether AhR-mediated NF-KB activation is dependent upon CYPlA (Yao et al., 1995; 
Shneider et al., submitted). AhR agonists may activate NF-KB through CYPlA by 
stimulating its production of ROS. CYPlA might contribute to the production of ROS by 
forming redox cycling metabolites or by abortive reduction. In this study we investigated 
the effects of two AhR agonists on NF-KB activation in the marine fish scup (Stenotomus 
chrysops). BP is metabolized to 3 redox cycling quinones in mammals and fish (Lorentzen 
and Ts'o, 1977; Stegeman, 1981; Klotz et al., 1983), and the coplanar polychlorinated 
biphenyl 3,3',4,4',5-pentachlorobiphenyl (PeCB) stimulates ROS production by 
uncoupling the CYPlA catalytic cycle (Chapter 4). 
Here we demonstrate for the first time that members of the Rel family of proteins 
are present in a teleost. An NF-KB consensus sequence bound at least 3 proteins in scup 
liver, kidney and heart, two of which potentially correspond with mammalian p50 and 
RelA. An antibody to mammalian p50 immunoprecipitated the =50 kD binding protein in 
all 3 organs. An NF-KB consensus sequence was bound by nuclear proteins from 
untreated scup. BP did not increase the activation of NF-KB, and PeCB activated NF-KB 
in only 1 of 2 experiments. While, we have confirmed the presence of the Rel family of 
proteins in a teleost, their regulation by AhR agonists is still a question. 
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MATERIALS AND METHODS 
Chemicals: 3,3',4,4',5-Pentachlorobiphenyl (IUPAC# 126) was purchased from 
Ultra Scientific (North Kingstown, RI). Poly [di-dC], pNd6 and 5-bromo-2'deoxyuridine 
were purchased from Boehringer Mannheim (Indianapolis, IN). [y-32p]ATP and [a-
32p]CTP were purchased from Amersham (Arlington Heights, IL). All other chemical 
reagents were purchased from Sigma (St. Louis, MO). 
Animals: Scup (Stenotomus chrysops ) were caught by trapping in Vineyard 
Sound,~ in August, 1996 and the experiment conducted in August, 1997 or were caught 
in August, 1995 and the experiment conducted in June, 1998. Fish were held in flow-
through seawater tanks at 14°C and maintained on a diet of Purina Trout Chow. Treatment 
of fish in the August, 1997 experiment was described in Chapter 5. For the June, 1998 
experiments, fish (mixed sex) were gonadally undeveloped. For the BP experiment, fish 
ranged in size from 90 to 252 g. Fish were injected intra-peritoneally (1ml/kg body 
weight) with com oil or a solution of BP (10 mg/ml) in com oil. For each dose group, 3 
tanks contained 3 fish each. At day 3 following injection one fish from each tank was 
sampled, at a day 6 the remaining fish were sampled. For the PeCB experiment, fish 
ranged in size from 39 to 107 g. Fish were injected intra-peritoneally (1ml/kg body 
weight) with com oil or solutions of PeCB (0.01 or 1 mg/ml) in com oil. For each dose 
group, fish were split between 3 tanks. The control tanks contained 2 fish/tank. The low 
dose tanks contained 3 fish/tank. The high dose tanks contained 4 fish/tank. Fish were fed 
Purina Trout Chow once weekly and were sampled 14 days following treatment. Two of 
the high dose fish died prior to the completion of the experiment. Immediately following 
dissection, sections of liver, heart and kidney were frozen in liquid N2. Microsomes were 
prepared from portions of liver immediately following dissection. 
Microsome preparation and analysis of CYP JA: Microsomes were prepared by 
differential centrifugation (Stegeman et al., 1979). Pellets were resuspended in buffer (50 
mM TRIS, pH 7 .4, 1 mM dithiothrietol, 1 mM EDTA, 20% glycerol) and frozen in liquid 
N2 until use. Protein content was determined using the bicinchoninic acid method (Smith 
et al., 1985), with bovine serum albumin standards. Microsomal ethoxyresorufin 0-
deethylation (EROD) was determined fluorometrically (Hahn et al., 1993), using a 
Cytofluor 2300 (Millipore) multiwell plate reader. Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal 
proteins (0.5-15 J...lg/lane) were resolved on 6-18% SDS-PAGE gels and electrophoretically 
transferred to 0.05 f...lm nitrocellulose membrane. The primary antibody was the mouse 
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monoclonal antibody 1-12-3 (Park et al., 1986). The secondary antibody was a 
horseradish peroxidase-linked sheep anti-mouse IgG (Amersham). The immunoreactive 
bands were visualized using enhanced chemiluminescence (Amersham) and quantified by 
video image analysis (NIH Image 1.60b5) by comparison to scup standards of known 
concentration. 
Nuclear extract preparation: Crude nuclear extracts were prepared from tissues by 
the method of Deryckere and Gannon (1994). All manipulations were carried out at 4°C. 
Tissues (100-300 mg) were ground in liquid N2 and added to a 15 ml centrifuge tube with 
5 ml of isolation buffer (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM 
EGTA, 1 mM dithiothrietol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF)) that 
contained 0.6% IGEPAL. The ground tissues were homogenized with five strokes of 
pestle B in a Dounce homogenizer. Homogenates were spun at 500 g in a Sorval 
centrifuge for 30 seconds to remove unbroken tissue. The supernatant was transferred to 
another 15 ml centrifuge tube, incubated for 5 minutes on ice and centrifuged for 5 minutes 
at 3000 g. The supernatant was removed and the nuclear pellet transferred to a micro 
centrifuge tube. The pellet was resuspended in 50-100 Ill of extraction buffer (20 mM 
HEPES pH 7.9, 400 mM NaCl, 1.2 mM MgC12, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM 
PMSF and 5 !lg/ml of each protease inhibitor (leupeptin, aprotinin, and pepstatin)) and 
incubated for 20 minutes. The supernatant was cleared by centrifuging at maximum speed 
in a microcentrifuge for 5 minutes. Protein content was determined using the bicinchoninic 
acid method (Smith et al., 1985), using bovine serum albumin as a standard. Supernatants 
were collected and stored at -80°C. 
Gel-shift analysis of NF-KB activation: For analysis of NF-KB activation, the 
double-stranded oligonucleotide 5'-AGTTGAGGGGACTTTCCCAGGC-3' (Promega, 
Madison, WI)) was used. The DNA probe was end-labeled using T4 polynucleotide 
kinase (Promega) and [y-32p]ATP and was purified using a Centrispin-20 column 
(Princeton Separations, Adelphia, NJ). The electrophoretic mobility shift assay (EMSA) 
was performed as follows: the 32P-labeled DNA ( -0.5 ng, 50,000 cpm) and 2 !lg of 
nuclear extract were combined with buffer (Final concentrations: 10 mM TRIS-HCl pH 
7.5, 1 mM EDTA, 40 mM KCl, 0.5 mM MgCl2, 1 mM DTT, 10% glycerol) and poly di-
dC (1 !lg) in a final volume of 20 IlL The mixture was incubated at room temperature for 
30 minutes. Polyacrylamide gels (6%) were pre-run at 80V for 1 hour. Mixtures were 
electrophoresed at 80V for 1.5 hours in 0.25x TBE (Final concentrations: 22 mM TRIS-
base pH 8, 22 mM boric acid, 0.4 mM EDTA). The gels were dried and exposed to film 
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(Kodak X-OMAT AR). Shifted bands were quantified by video image analysis. EMSAs 
also were performed with 32P-labeled probes containing the AP-1 (Santa Cruz 
Biotechnology, Santa Cruz, CA) or Oct1 (Promega) consensus binding sequences. 
Specificity of shifted bands was determined by including 50-100x cold specific (NF-KB 
consensus sequences) and non-specific (AhR DRE 5'-GATCCGGC-
TCCGGCTCTICTCACGCAACTCCGAGCTCAAAAA-3') oligonucleotides. 
Identification of specific subunits: To identify specific NF-KB/Rel subunits, DNA-
protein crosslinking studies were used (Ballard et al., 1989; Ballard et al., 1990). The 
photoreactive 32P-labeled oligonucleotide was prepared as follows. The oligonucleotide 
(5'-CAACGGCAGGGGAATICCCCTCTCCTT-3') was annealed with the primer (5'-
AAGGAGAGGG-3') and filled in using the larg~ fragment of DNA polymerase 
(Promega). The labeling mixture contained annealed oligonucleotide probe (5 pmol), [a-
32p]CTP (50 J.!Ci), Klenow (2 units), BSA (2 mg) and buffer (Final concentrations: 20 
mM HEPES 6.6, 2 mM MgCl2, 0.2 mM DTT, 100 J..LM each dATP, dGTP, dTTP, 100 
J.!M 5'bromo-2'deoxyuridine). The labeling reaction was performed at 16°C for 4 hours, 
chased with 0.4 mM cold dCTP at room temperature for 30 minutes and purified using a 
Centrispin-20 column. The binding reaction was performed as follows: 5-20 Jlg of 
nuclear extract were combined with buffer (Final concentrations: 20 mM HEPES pH 7.9, 1 
mM DTT, 1 mM EDTA, 5% glycerol), poly di-dC (1 J.!g), BSA (5 J..Lg), pdN6 (1 J..Lg) in a 
final volume of 20 J.!l. The mixture was incubated at room temperature for 5 minutes. The 
32P-labeled DNA (-2.5-5 ng, 200,000-500,000 cpm) was added, and the mixture was 
incubated for 15 minutes at room temperature. The mixture was then incubated for 15 
minutes under UV. At this point, some samples were boiled with sample treatment buffer 
and frozen at -20°C. Or, reaction mixtures were immunoprecipitated with antibodies to 
specific NF-KB/Rel subunits (Santa Cruz Biotechnology). To immunoprecipitate, a 
reaction mixture was combined with 180 Jll of RIPA buffer (10 mM TRIS pH 7.5, 150 
mM NaCl, 1 mM EDTA, 1% Triton x-100, 0.1% SDS) to which 0.5 mM PMSF and 5 
J..lg/ml of each protease inhibitor (leupeptin, pepstatin, and sodium orthovanadate) were 
added). An antibody was added and the mixture incubated on ice for 1 hour. Protein A-
sepharose (25 J.!l of a 50% slurry) was added and the mixture rotated for 1 hour at 4 °C. 
The mixture was quickly spun to remove the supernatant. The pellet was washed twice in 
RIP A containing 0.5 mM PMSF. Sample treatment buffer was added to the mixture, and it 
was boiled for 5 minutes. All samples then were loaded on a 10% SDS polyacrylamide gel 
and electrophoresed at 10-14 mAmps. The portion of the gel containing free probe was 
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removed. The gel was fixed in MeOH (5%)/acetic acid (5%) for 30 minutes, dried and 
exposed to film. 
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc., 
Redmond, WA) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA). 
The Student's t-test was used to determine differences from control values in the BP 
experiment. Nested, one-factor ANOV As with the Tukey-Kramer multiple comparisons 
test were used to analyze differences between treatment groups within sampling days for 
the PeCB experiments. 
RESULTS 
Fish treated with two AhR agonists, BP and PeCB, were examined for activation of 
the AhR and of NF-KB-DNA binding. BP strongly induced CYP1A protein and catalytic 
activity 3 and 6 days post-treatment (Figure 1). Binding of an NF-KB consensus sequence 
was determined with an EMSA. Hepatic nuclear proteins from both control and BP-treated 
scup bound an NF-KB consensus sequence (Figure 2). NF-KB activation decreased in the 
controls over time: however, no change in NF-KB activation occurred following BP 
treatment. CYP1A protein and catalytic activity were strongly induced by a low dose (0.01 
mg/kg) of PeCB; while they were suppressed by treatment with a high dose of PeCB 
(Chapter 5, Figure 3). Like was seen in the BP experiment, hepatic nuclear proteins from 
both control and PeCB-treated scup bound an NF-KB consensus sequence (Figure 4). NF-
KB activation decreased over time in the controls. In the initial experiment, there was no 
significant increase in activation of NF-KB until days 16-18 at which time there was a 6-
fold increase in activation with the low dose and an 8-fold increase with the high dose. In 
the second experiment, a slight increase in activation occurred with the low dose at day 14; 
however, the variability was very large (Figure 4). 
In order to confirm further that a Rei family protein was responsible for the band-
shift of the NF-KB binding oligonucleotide, competition, crosslinking and 
immunoprecipitation studies were performed. First, liver nuclear extracts from control or 
treated fish did not bind to the consensus binding sequences of AP-1, another redox 
sensitive transcription factor (Meyer et al., 1994), or Octl, a ubiquitous mammalian 
transcription factor (Pfisterer et al., 1994) (Figure 5). When a 50-100 fold excess of 
unlabeled oligonucleotides containing various sequences of NF-KB binding regions, the 
band-shift was eliminated (Figure 6). However, a 50-100 fold excess of unlabeled 
oligonucleotide containing the aryl hydrocarbon receptor dioxin response element (DRE) 
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Figure 1. Effect of BP on scup hepatic microsomal CYPlA content (A) and catalytic 
activity (EROD - B). Scup were injected IP with com oil or 10 mg BP/kg and killed 3 or 6 
days post-injection. Liver microsomal fractions (0.5-15 f..Lg/lane) were electrophoresed, 
transferred to nitrocellulose, immunoblotted with MAb 1-12-3 against scup CYPlA, 
visualized using enhanced chemiluminescence and quantified by densitometric analysis. 
EROD was determined fluorometrically. Data represent the means± SD of measurements 
on 3 to 6 fish per treatment group. #-Statisically different from control (p<0.05, Student's 
t-test). ##-Statistically different from control (p<O.Ol, Student's t-test). 
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Figure 2. Binding of an NF-KB consensus sequence to liver nuclear proteins from control 
and BP-treated scup. Scup were injected IP with com oil or 10 mg BP/kg and killed 3 or 6 
days post-injection. Nuclear extracts were prepared from livers from fish killed on Day 3 
(A) and Day 6 (B) and analyzed by electrophoretic mobility shift assay for 32P-labeled NF-
KB oligonucleotide binding. C) Band intensity was quantified using video image analysis. 
*-Significantly different from day 3 (p<0.03, Student's t-test) . 
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Figure 3. Effect of PeCB on hepatic microsomal CYP1A content (A) and catalytic activity 
(EROD- B). Scup were injected IP with com oil, 0.01 mg PeCB/kg or 1 mg PeCB/kg and 
killed 14 days post-injection. CYP1A content and activity in liver microsomes were 
determined as described in Figure 1. Data represent the means ± SD of measurements on 
6-10 fish per treatment group. +- Significantly different from control and 1 mg/kg dose 
groups (p<0.01, Tukey-Kramer). 
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Figure 4. Quantification of NF-KB activation in liver of control and PeCB-treated scup. 
Nuclear extracts were prepared from livers and analyzed by electrophoretic mobility shift 
assay for 32P-labeled NF-KB oligonucleotide binding. Band intensity was quantified 
using video image analysis. A- Experiment 1. Scup were injected IP with corn oil, 0.01 
mg PeCB/kg, 0.1 mg PeCB/kg or 1 mg PeCB/kg and killed 3,7,16,or 18 days post-
injection. Data represent the means ± SD of measurements on 6 fish per treatment group 
except for the 0.01 mg/kg dose on Day 18 (n=4) and the 1 mg/kg dose on Day 16 (n=3). 
#-Statisically different from control (p<0.01). B -Experiment 2. Scup were injected IP 
with corn oil, 0.01 mg PeCB/kg or 1 mg PeCB/kg and killed 14 days post-injection. Data 
represent the means + SD of measurements on 6-10 fish per treatment group. 
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Figure 5. Nuclear proteins from scup liver bound an NF-KB consensus sequence but not 
AP-1 or Octl consensus sequences. Nuclear extracts were prepared from fish 3 days 
post-injection of 10 mg BP/kg and analyzed by electrophoretic mobility shift assay for 32p_ 
labeled NF-KB, AP-1 or Octl oligonucleotide binding. 
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did not inhibit the band-shift (Figure 6). The NF-KB consensus binding sequence was 
bound by hepatic nuclear proteins corresponding to mouse p50 and RelA (p65) and a 
smaller protein of approximately 30 kD (Figure 7). The middle band could be 
immunoprecipitated with an antibody to mammalian p50 (Figure 7), but none of the bands 
was recognized by antibodies to mammalian p52, RelA, cRel or RelB (data not shown). 
Nuclear proteins from scup kidney and heart also specifically bound the NF-KB 
consensus sequence, but with no dose specific pattern (Figure 8). Similar to liver, 3 
nuclear proteins from scup heart and kidney bound the NF-KB consensus sequence (Figure 
9). One of these proteins (=50 kD) was recognized by an antibody to mammalian p50 
(Figure 9). 
DISCUSSION 
The Rei family of proteins has been identified and characterized in Drosophila, 
Xenopus, birds and mammals. ROS are responsible for the activation of nuclear 
translocation and DNA binding of NF-KB, a transcription factor comprised of dimers of 
members of the Rei protein family. Previous work has shown that a number of xenobiotic 
compounds activate NF-KB and that this activation may occur through the stimulation of 
ROS production (Olnes et al., 1994; Gruebele et al., 1996; Li et al., 1996; Li et al., 1996; 
Pinkus et al., 1996; Chen and Cederbaum, 1997; Shneider et al., submitted). Here we 
have demonstrated the presence of the Rei protein family in a teleost, scup. Attempts to 
activate NF-KB DNA binding by treatment with AhR agonists gave conflicting results, 
however. While, we have confirmed the presence of the Rei family of proteins in a teleost, 
the regulation of NF-KB activation by AhR agonists is still a question. 
A large gap exists in the knowledge of the evolution of Rei family proteins. While 
these proteins have been characterized in Drosophila (Steward, 1987; Ip et al., 1993; 
Dushay et al., 1996), the next higher animal in which they have been identified is an 
amphibian (Kao and Hopwood, 1991; Suzuki et al., 1995; Tannahill and Wardle, 1995; 
Suzuki et al., 1998). Considering the important function of Rei family proteins during 
development and in the immune system (Steward, 1987; Ip et al., 1993; Baeuerle and 
Henkel, 1994; Tannahill and Wardle, 1995), these proteins presumably should occur in 
teleosts, as well. Here we provide biochemical evidence for the presence of multiple Rei 
family proteins in the teleost scup. 1) An oligonucleotide containing an NF-KB consensus 
binding sequence forms a band shift in EMSAs with nuclear proteins from multiple scup 
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Figure 6. Specific competition of binding of an NF-KB consensus sequence to scup liver 
nuclear proteins. Nuclear extracts were prepared from fish 3 days post-injection of 10 mg 
BP/kg and analyzed by electrophoretic mobility shift assay for 32P-labeled NF-KB 
oligonucleotide binding. The specificity of NF-KB binding activity was tested by the 
addition of 50-100-fold molar excess of unlabeled NF-KB binding oligonucleotide or the 
aryl hydrocarbon receptor dioxin response element (DRE). Lanes 4,6,8,10- 50-fold 
excess. Lanes 2,3,5,7 ,9- 100-fold excess. 
150 
Competitor 
No NF-kB ORE 
1 2 3 4 5 6 7 8 9 10 
NF-kB 
... 
Free 
Probe 
... 
Competitors: 
Lane 2. s·-AGT TGA GGG GAC TIT CCC AGG C-3· 
Lanes 3-4. s·-CGG CAG GGG AAT TCC CCT CTC C-3· 
Lanes 5-6. s·-CGG CAG GGC AAT TCC CCT CTC C-3· 
Lanes 7-8. s·-ccG CTG GGG ACT TTC CAG GC-3• 
Lanes 9-10. s·-GAT CCG CTC CGG CTC TTC TCA CGC 
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Figure 7. Binding of an NF-KB consensus sequence to at least 3 scup liver nuclear 
proteins. Nuclear extracts were prepared from fish 3 days post-injection of 10 mg BP!kg 
or nuclear extracts from preB lymphocyte (BU-ll) cells were incubated with a 5-bromo-2'-
deoxyuridine-substituted 32P-labeled NF-KB oligonucleotide probe and crosslinked by UV 
irradiation. The resultant labeled DNA-protein complexes also were immunoprecipitated 
with antibodies to specific NF-KB subunits. All were resolved on a 10% polyacrylamide 
gel. Results shown are different exposures of the same gel. Lanes 1&5. No 
immunoprecipitation. Lane 2&6. Immunoprecipitation with p50 antibody. Lane 3. 
Immunoprecipitation with RelA antibody. Lane 4. Molecular weight standards 
corresponding to 250, 98, 64, 50, 36, 30 and 16 kD. 
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Figure 8. Specific binding of an NF-KB consensus sequence to scup kidney (A) and heart 
(B) nuclear proteins. Nuclear extracts were prepared from kidney or heart from scup 3 
days post-injection of 10 mg BP/kg and analyzed by electrophoretic mobility shift assay for 
32P-labeled NF-KB oligonucleotide binding. The specificity of NF-KB binding activity 
was tested by the addition of 100-fold molar excess of unlabeled NF-KB binding 
oligonucleotide or the aryl hydrocarbon receptor DRE. Lanes 1-3. No competitor. Lane 
4. 100-fold excess specific competitor. Lane 5. 100-fold excess of non-specific 
competitor. 
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Figure 9. Binding of an NF-KB consensus sequence to at least 3 scup kidney (A) and heart 
(B) nuclear proteins. Nuclear extracts from kidney and heart from scup 3 days post-
injection of 10 mg BP/kg were incubated with a 5-bromo-2'-deoxyuridine-substituted 32p_ 
labeled NF-KB oligonucleotide probe and crosslinked by UV irradiation. The resultant 
labeled DNA-protein complexes also were immunoprecipitated with antibodies to specific 
NF-KB subunits. All were resolved on a 10% polyacrylamide gel. Results shown are 
different exposures of the same gel. Lane 1. Molecular weight standards corresponding to 
250, 98, 64, 50, 36, 30 and 16 kD. Lanes 2-3. No immunoprecipitation. Lane 4. 
Immunoprecipitation with p50 antibody. 
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organs. 2) The oligonucleotide binding could be specifically competed. 3). Protein/DNA 
crosslinking studies demonstrated 2 proteins which appeared to correspond with murine 
p50 and RelA. 4 ). The ::::50 kD binding protein in multiple organs was recognized by an 
antibody to mammalian p50. The NF-KB 1 and NF-KB2 genes have been found to evolve 
at the slowest rate of the Rei proteins (Huguet et al., 1997), thus the p50 antibody was 
most likely to recognize the teleost protein. Alignment analyses suggest that all Rel/NF-KB 
and IKB proteins truly belong to a superfamily of genes whose precursor contained both a 
Rei homology domain and an ankyrin repeat area (Huguet et al., 1997). Therefore, it is not 
surprising that these proteins would be present in fish as they are present in insects. 
Furthermore, an NF-KB binding site has been identified in the promoter of mitogen-
activated protein kinase kinase 1 of carp (Leu et al., 1996). 
A number of xenobiotic compounds have been shown to activate NF-KB-DNA 
binding. Redox cycling quinones activate NF-KB in HepG2 cells, apparently as a 
protective mechanism (Pinkus et al., 1996; Chen and Cederbaum, 1997). Phenobarbital 
and ciprofibrate have been shown to activate NF-KB-DNA binding in rat liver (Li et al., 
1996; Li et al., 1996). Phenobarbital induces CYP2B1/2B2, which was suggested to 
produce ROSas a metaboiic by-product. Ciprofibrate, a peroxisome proliferator, induces 
enzymes in the peroxisomal 13-oxidation pathway which also produce ROS as a by-
product. However, phenobarbital and ciprofibrate apparently activate different Rei 
proteins, suggesting that they activate NF-KB through different pathways (Li et al., 1996; 
Li et al., 1996). 
AhR agonists also have been shown to activate NF-KB. DMBA- and BP-mediated 
NF-KB activation have been shown to be AhR dependent, but CYP1A1 independent 
(Shneider et al., submitted). Activation of NF-KB by BP and DMBA occurs within an 
hour of treatment, a time too short for CYP1A induction, and activation occurs in Hepa 
cells with a functional AhR but deficient in CYP1A (Shneider et al., submitted). The effect 
of an antioxidant was not examined. In contrast, TCDD-mediated activation of expression 
of a cat reporter containing an NF-KB binding sequence occurred 24 hours post-treatment, 
could be blocked by anti-oxidants and required a functional CYP1A1 (Yao et al., 1995). It 
was hypothesized that the lgK light chain enhancer and the HIV -1 long terminal repeat are 
regulated differentially by NF-KB, though the NF-KB subunits involved in each case have 
not been identified (Yao et al., 1995; Shneider et al., submitted). It also is possible that 
there is a direct interaction between the AhR and RelA. RelA can be coimmunoprecipitated 
with AhR in cytosol or nuclear fractions of TCDD-treated COS cells that are cotransfected 
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with AhR and RelA, and TCDD down-regulates NF-KB mediated gene expression in these 
cells (Tian et al., 1998). 
Both BP and PeCB are AhR agonists and are capable of stimulating ROS 
production. BP is metabolized to 3 redox cycling quinones in scup (Klotz et al., 1983), 
and the coplanar polychlorinated biphenyl PeCB stimulates ROS production by uncoupling 
the CYP1A catalytic cycle (Chapter 4). Liver should be an appropriate site to analyze NF-
KB activation, as NF-KB is an important mediator of hepatocyte proliferation. NF-KB is 
rapidly activated following partial hepatectomy (Cressman et al., 1994), and livers ofRelA 
knockout mice undergo massive apoptosis early in gestation (Beg et al., 1995). However, 
treatment of scup with BP and TCDD did not cause a consistent effect on hepatic NF-KB 
activation. Undeniably, the results were confounded by the fact that injection alone 
appeared to activate NF-KB. Why this occurred is unknown. One can only speculate that 
the stress of injection stimulated one of the many activators of NF-KB. It does not appear 
that AhR agonists activate NF-KB simply by activating the AhR. If this were the case then 
both BP and PeCB would have activated NF-KB. Although, activation was not analyzed at 
very early time points, as the results in cell culture suggest is necessary to observe this 
phenomenon. The suppression of injection-induced NF-KB activation by BP at Day 3, is 
reminiscent of the results seen with COS cells (Tian et al., 1998), although this 
suppression was not seen with PeCB treatment. In at least one of the experiments with 
PeCB there appeared to be activation of NF-KB at late time points. This is unlike results 
with other xenobiotics which cause activation within 3-6 days of treatment (Li and Furness, 
1991; Li et al., 1996; Li et al., 1996). The delay might have been caused by the type of 
ROS that were being produced. During CYP1A uncoupling in vitro, CBs appear to 
stimulate OT• production to a greater extent than H202 production (Chapter 3). Studies 
have suggested that 02-• is only indirectly involved in a NF-KB activation, as a source of 
H202 (Schmidt et al., 1995). In the end, these experiments have raised more questions 
than they have answered. 
NF-KB could play an important role in the defense against the effects of 
xenobiotics. First, the AhR regulates genes involved in the antioxidant response. AhR 
agonists can induce glutathione S-transferase Y a and NADPH:quinone oxidoreductase via 
the AhR as well as via an antioxidant response element (Rushmore et al., 1991; 
Hankinson, 1995). Proteins that are involved in the antioxidant response are also induced 
following NF-KB activation, suggesting that NF-KB may regulate their expression. These 
proteins include Mn-SOD (Pang et al., 1992), NADPH-oxidoreductase (Yao and 
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O'Dwyer, 1995), inducible nitric oxide (Xie et al., 1994), and ferritin H (Kwak et al., 
1995). NF-KB activation was suggested to be the mechanism by which HepG2 cells are 
protected from oxidative stress-induced cytotoxicity (Chen and Cederbaum, 1997). 
Second, an NF-kB consensus binding sequences has been identified in the promoter of the 
P-glycoprotein gene (Zhou and Kuo, 1997). P-glycoprotein can be induced by TCDD 
(Schuetz et al., 1995), and xenobiotics may be removed from cells via the P-glycoprotein 
transporter (Yeh et al., 1992). Therefore, it is important to continue to investigate the 
apparently complicated relationship between the AhR and NF-KB and the contribution of 
NF-KB to the defense against xenobiotic induced effects. 
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CHAPTER 7 
Tissue Distribution of and Induction of Cytochrome P4501A by Model Aryl 
Hydrocarbon Receptor (AhR) Agonists in the American Eel and 
Investigation of the Effect of Endothelial CYPlA on AhR Agonist 
Pharmacokinetics 
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ABSTRACT 
We investigated both the dose-dependent response of hepatic cytochrome P4501A 
(CYP1A) in relation to inducer distribution and the in vivo dose-dependent response of 
endothelial CYP1A in a fish model, American eel (Anguilla rostrata). First, injection 
studies were used to determine the distribution of different doses of two radio labeled model 
aryl hydrocarbon receptor (AhR) agonists, benzo[a]pyrene (BP), a polynuclear aromatic 
hydrocarbon, and 3,3',4,4'-tetrachlorobiphenyl (TCB), a planar halogenated aromatic 
hydrocarbon. Concentrations of BP and TCB were greatest in bile, liver, gut and kidney 
and were dose-dependent in bile, gill, gut, liver, muscle and rete mirabile. Second, 
increasing doses of B-naphthoflavone (BNF) (0.1, 1, 5, 10, and 100 mg/kg), BP (0.1, 1 
and 10 mglkg), and TCB (0.1, 1, 10 and 20 mglkg) all produced dose-dependent induction 
of CYP1A content and catalytic activity. Using the liver microsomal EROD data, BP, BNF 
and TCB all had EDsos of approximately 5 mg/kg. However, BNF and BP had greater 
efficacy than TCB in eliciting hepatic CYP1A induction. Hepatic inducer concentration and 
CYP1A levels were correlated significantly. Third, previous studies have shown that 
endothelium is a major site of induction of CYP1A in vertebrates and have suggested that 
CYP1A induction in peripheral vasculature may be related to inducer dose (Drug Metab. 
Dispo. 19, 113-123 (1991)). Biochemical analysis of microsomes from heart and rete 
mirabile, organs in which CYP1A induction occurs predom_inantly in endothelial cells, 
showed an increase in CYP1A content and EROD activity following treatment with BP, 
BNF or TCB. CYP1A content and activity also were elevated in heart and rete mirabile in 
eels from a notably polluted site. Immunohistochemical (IHC) analysis with MAb 1-12-3 
revealed increasing induction of CYP1A in the endothelium of the heart, gill, kidney and 
rete mirabile with increasing dose of BNF, BP and TCB. In the rete mirabile, greater 
doses of inducers were associated with increasing penetration of induction. In addition, a 
transition from endothelial to epithelial staining occurred in the gill, heart and kidney at high 
doses of BNF. We conclude not only that the penetration of endothelial cell CYP1A 
expression in the vessels of the rete mirabile reflects greater concentrations of inducer 
reaching the distal circulation, but also that endothelial CYPlA induction may limit the local 
distribution of inducers. The results are consistent with the hypothesis that endothelial 
CYP1A may participate in removal of AhR agonist/CYP1A substrates from the circulation. 
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INTRODUCTION 
Endothelial cells make up the lining of all blood and lymphatic vessels. The 
functions of endothelium are diverse, including providing a physical lining, maintaining 
blood vessel tone, controlling microvascular permeability, regulating platelet clumping, 
clotting and lymphocyte traffic, repairing damaged blood vessels and initiating 
. angiogenesis (Pearson, 1991). Thus endothelium may be a site that is particularly sensitive 
to xenobiotic toxicity. For instance, activation of promutagens in endothelium may play a 
role in atherosclerosis (Juchau et al., 1976). Edema is a symptom of a syndrome common 
among developing fish, birds and mammals exposed to planar halogenated aromatic 
hydrocarbons (pHAH) (Peterson et al., 1993). Finally, both polynuclear aromatic 
hydrocarbons (P AH) and pHAH have been shown to alter endogenous arachidonic acid 
(AA) metabolism (Schlezinger et al., 1998); these metabolites can affect a number of 
endothelial cell functions (Schwartzman et al., 1987; Ohnishi et al., 1992; Harder et al., 
1995; Campbell e~ al., 1996). 
P AH and pHAH induce the expression of a number of genes, including cytochrome 
P4501A (CYP1A), through their interaction with the aryl hydrocarbon receptor (AhR) 
(Hankinson, 1995). The toxicity of PAH and pHAH may be mediated in part by their 
interaction with CYP1A. Liver is the major site of CYP1A induction (Goldstein and 
Linko, 1984); however, CYP1A can be induced in a variety of organs and cells types 
(Goldstein and Linko, 1984; Smolowitz et al., 1991). Human umbilical vein endothelial 
cells express CYP1A1 mRNA at a low constitutive level and at an increased level following 
polychlorinated biphenyl (PCB) or 13-naphthoflavone (BNF) exposure (Farin et al., 1994). 
3-Methylcholanthrene (MC) induces CYP1A protein in rat and rabbit aorta (Thirman et al., 
1994; Stegeman et al., 1995), and TCDD induces an endothelial CYP, presumably 
CYP1A, in rabbit kidney and lung (Dees et al., 1982). 
Strong induction of CYP1A has been seen in the endothelium of fish exposed to 
AhR agonists. Initially observed in the heart of scup (Stegeman et al., 1989), induction of 
CYP1A has been seen in endothelium in the liver, heart, gill, kidney, gut, gonad, spleen, 
red muscle and brain of fish exposed to BNF, 3,3',4,4'-tetrachlorobiphenyl (TCB), and 
2,3,7,8-tetrachlorodibenzofuran (TCDF) (Miller et al., 1989; Stegeman et al., 1989; 
Smolowitz et al., 1991). By calculation, CYP1A could account for as much as 25% of the 
endothelial microsomal protein in the heart of BNF-treated fish (Stegeman et al., 1982; 
Stegeman et al., 1989). In scup dosed with the potent CYP1A agonist TCDF given at 3 
jlg/kg and TCB, as less potent inducer, given at 1 mglkg, similar CYP1A induction occurs 
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in liver and sites proximal to large vessels. However, in scup dosed with TCB, CYP1A 
induction also was seen in distal regions of the fish (Smolowitz et al., 1991). It was 
hypothesized that induction of endothelial CYP1A could influence the local concentration of 
inducer, both limiting the amount that could penetrate to the underlying tissue and the 
spread of the inducer to distal areas of the organism (Stegeman et al., 1995). 
The extent to which endothelial CYP1A is catalytically active is not clear. In rabbit 
lung, CYP1A was ultrastructurally localized to endothelial cells, but cytochrome P450 
reductase (CPR) was not detected (Overby et al., 1992). However, studies of porcine 
aorta endothelial cells (P ABC) confirm the presence of CPR in both catalytic and 
immunoblot assays (Stegeman et al., 1995). Bovine aorta endothelial cells and cardiac 
microsomes from scup produce metabolites of BP indicative of CYP1A metabolism (Baird 
et al., 1980; Stegeman et al., 1982). Mouse heart and kidney also have a BNF-inducible, 
metabolically active P450 in the endothelium (Brittebo, 1994). However, the catalytic 
activity of endothelial CYP1A is lower than that of equivalent amounts of hepatic CYP1A 
(e.g. (Stegeman et al., 1982)). The full significance of endothelial CYP1A remains a 
question because despite its low catalytic activity, its induction correlates with the toxicity 
ofTCDD to embryos (Guiney et al., 1997). 
In this study we investigated both induction of CYP1A in liver in relation to inducer 
distribution and induction of endothelial CYP1A in relation to its effect on AhR agonist 
pharmacokinetics. American eels (Anguilla rostrata) were exposed to model AhR 
agonists/CYP1A substrates. We demonstrated that liver CYP1A responds to BP, BNF and 
TCB in a dose-dependent fashion and that this induction correlates with hepatic inducer 
concentration. Eels may be particularly useful for the study of in vivo induction of 
endothelial CYP1A because they have a rete mirabile, a counter-current vascular structure, 
composed entirely of capillaries, which increases the partial pressure of oxygen to aid its 
secretion into the swim bladder (Krogh, 1959). We show that endothelial CYP1A is 
inducible in a number of organs and is metabolically active, albeit at low levels. We 
addressed the hypothesis that substrates might remain "bound" to endothelial CYP1A, 
limiting their distribution; CYP1A2 already is recognized as a binding protein in 
mammalian liver (Diliberto, 1997). In the rete mirabile, penetration of endothelial CYP1A 
induction increased with increasing dose of AhR agonists, corresponding with an increase 
in inducer concentration. In addition, a transition from endothelial to epithelial staining 
occurred in the gill, heart and kidney at high doses of BNF. Endothelial CYP1A may both 
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enhance and ameliorate the toxicity of AhR agonists by holding them in a sensitive cell type 
but also by slowing their spread to underlying tissues and distal areas. 
MATERIALS AND METHODS 
Chemicals: Benzo[a]pyrene and P-naphthoflavone were purchased from Aldrich 
(Milwaukee, WI). Benzo[a]pyrene (3H, 55 Ci/mmol) was purchased from Amersham 
(Arlington Heights, IL). Soluble was purchased from Dupont!NEN (Boston, MA). 7-
Ethoxyresorufin was purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
Tetrachlorobiphenyl (IUPAC# 77), and 3,3',4,4'-tetrachlorobiphenyl-Ring-UL-14C (52.1 
mCi/mmol) were purchased from Pathfinder (St. Louis, MO). MS 222 was the generous 
gift of Dr. Adria Elskus, but can be purchased from Sigma (St. Louis, MO). All other 
reagents were purchased from Sigma. 
Animals used in experimental exposures: One hundred and twelve American eels, 
Anguilla rostrata, were purchased from Marine Resources at the Marine Biological 
Laboratory, Woods Hole, MA. All of the eels were females. For the first experiment the 
eels were kept at 20°C. For all other experiments, the eels were kept for at least 3 days at 
lOOC in flow-through tanks until treated. 
Animals from environmental collections: Eels were collected from three sites near 
Woods Hole, MA. Traps baited with horseshoe crab meat were used to collect the eels. 
Eighteen eels were collected from New Bedford Harbor, MA at the Aerovox site. Eight 
eels were collected from Marion Harbor, MA. Eleven eels were collected from Vineyard 
Sound, MA. Eels were killed and dissected immediately upon return to the lab as described 
below. 
Treatment for chemical distribution: The eels were anesthetized in a solution of MS 
222 (6g/4L sea water) and injected intra-peritoneally (IP) with corn oil or varying 
concentrations of 3H-BP (1 and 10 mglkg) and 14C-TCB (1 and 10 mg/kg) in corn oil. 
Eight days following injection, each eels was anesthetized in a solution of MS 222, and the 
spinal cord severed. Portions of freshly dissected organs (0.1-0.25 g each of liver, heart, 
gill, spleen, gut, kidney and muscle or 0.03-0.13 g of rete mirabile) were removed, 
weighed, rinsed with water, blotted and placed in 20 ml scintillation vials. Bile was 
collected via syringe, and blood was collected from the caudal vein via syringe. Both were 
placed in 20 ml scintillation vials. 
Chemical distribution analysis: Soluble (1 ml) was added to organs in the 
scintillation vials. The organs were minced with scissors and placed in a 50oC oven until 
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dissolved (12-48 hours). A mixture of ethanol:Soluble (1:2) was added to the blood, and 
the vials were warmed to 50°C for 1 hour. H202 (30%, 0.75 ml) was added to all vials 
except those containing gut and muscle. All samples containing Soluble were acidified 
with 200 J..ll of 6N HCL. Scintiverse (15 ml) was added to the vials and the samples were 
allowed to quench overnight before counting them on a Beckman LS5000TD scintillation 
counter. To calculate the concentration of BP and TCB in each organ, the radioactivity in 
control organs was subtracted from that in organs from treated eels. The remaining 
radioactivity was converted into J..lg. 
Treatment for dose response The eels were anesthetized in a solution of MS 222 
and injected IP with com oil or varying amounts of B-naphthoflavone (BNF) (0.1, 1, 5, 
10, and 100 mg/kg), benzo[a]pyrene (BP) (0.1, 1 and 10 mg/kg), or 3,3',4,4':-
tetrachlorobiphenyl (TCB) (0.1, 1, and 10 mglkg) in com oil. Each dose group consisted 
of at least 3 eels. Eels were kept in flow-through tanks at 20°C for experiment 1 and at 
10°C for experiments 2-7. They were not fed. Eels were killed on day 5 (Expt. 1) or day 
8 (Expts. 2-7). Eels were killed as described above. Portions of heart, gill, kidney, rete 
mirabile and liver were preserved in 10% neutral buffered formalin. Liver, heart and rete 
mirabile also were collected for microsome preparation. 
Microsome preparation and assays: Freshly dissected livers were immediately 
homogenized in cold homogenization buffer (0.15M KCl, 0.05M TRIS, pH 7.2). Hearts 
and rete mirabile were frozen in liquid N2 before homogenization. Microsomes were 
prepared as previously described (Stegeman et al., 1979). Protein content was determined 
using the bicinchoninic acid method (Smith et al., 1985), using bovine serum albumin 
standards. Microsomal ethoxyresorufin 0-deethylase (EROD) activity was determined 
fluorometrically by the method of Hahn et al. (1993) using a Cytofluor 2300 (Millipore) 
multiwell plate reader. NADPH-cytochrome P450 reductase activity in rete microsomes 
was determined as previously described (Stegeman et al., 1982), using a Shimadzu 210 
difference spectrophotometer. Microsomal P-450 content was determined using dithionite-
difference spectra of CO-treated samples (Bonkovsky et al., 1984). Cytochrome b5 was 
determined using NADH difference spectra as previously described (Stegeman et al., 
1979). 
Western blotting for CYPIA quantification Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal 
proteins (10-80 J..lg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically 
transferred to nylon or nitrocellulose (1 J..lm) membrane. The primary antibody was the 
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mouse monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E 
(CYP1A; (Morrison et al., 1995)). The secondary antibody was alkaline phosphatase 
linked goat anti-mouse IgG (Biorad, Hercules, CA). The immunoreactive proteins on 
nitrocellulose membrane were visualized using nitro blue tetrazolium and 5-bromo-4-
chloro-3-indoyl-phosphate (NBT/BCIP). The immunoreactive proteins on nylon 
membranes were visualized using enhanced chemiluminescence (Tropix, Bedford, MA). 
CYP1A content was quantified by densitometric analysis of video images (NIH Image, 
1.60b5). The CYP1A values are relative, reported as scup CYP1A equivalents. 
Immunohistochemical analysis: Preserved organs (liver, heart, kidney, gill and rete 
mirabile) were embedded in paraffin by Pathology Services, Inc., Cambridge, MA or by 
the Laboratory of Aquatic Animal Medicine and Pathology at the Marine Biological 
Laboratory, Woods Hole, MA. Tissue sections were cut to a thickness of 5 J..tm and 
mounted on Fisher Superfrost Plus slides. Prior to staining, the sections were 
deparaffinated and hydrated in 1% PBS/BSA. While being hydrated the sections were 
incubated in 3% H202 in water to block the activity of endogenous peroxidases. The 
hydrated sections were stained using an indirect peroxidase stain (Universal 
Immunoperoxidase Staining Kit (Murine), Signet Lab, Dedham, MA). The antibodies 
used were the monoclonal antibody MAb 1-12-3 and a peroxidase labeled goat anti-mouse 
secondary antibody. The staining procedure used was as described by Smolowitz et al. 
(1991). Staining of CYP1A was scored for intensity of staining (O=no stain, 1=mild stain, 
2=moderate stain, 3=strong stain, 4=very strong stain) and for occurrence of staining 
(O=no cells, 1=rare cells , 2=some cells, 3=many cells, 4=all cells staining). The stain 
index was computed by multiplying the intensity and occurrence scores for a scale from 0-
16. 
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc., 
Redmond, W A) and SuperAnova for Macintosh (Abacus Concepts, Inc., Berkeley, CA). 
A Student's t-test was used to test differences between the dose groups in the chemical 
distribution experiments. A one-factor ANOVA in combination with the Tukey-Kramer or 
Dunnett's multiple-comparisons tests was used to analyze all other data. 
RESULTS 
Chemical distribution analysis: First, the patterns of distribution of BP and TCB 
following IP injection into eels were examined (Figure 1) so that the distribution of the 
inducers might be compared with induction of CYP1A. Two doses (1 and 10 mg/kg) of 
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Figure 1. Distributions of 3H-BP and 14C-TCB in eels injected IP. A) lmglkg dose B) 
10 mglkg dose C) Bile. Eels were injected IP with BP or TCB at the doses indicated and 
killed 8 days post-injection. Portions of freshly dissected organs were removed, weighed, 
rinsed with water, blotted and digested with Soluble. The organs were minced with 
scissors and placed in a 50°C oven until dissolved. Bile was collected via syringe. Blood 
was collected from the caudal vein via syringe and then added to ethanol:Soluble (1:2). 
H202 was added to all vials except those containing gut and muscle. All samples 
containing Soluble were acidified with HCL. Scintiverse was added to the vials, and the 
samples were allowed to quench overnight before counting. Data are means ± SD of 3-6 
individuals. a- Significantly greater than 1 mg!kg dose (p<0.05, Student's t-test) b-
Significantly greater than blood (p<0.05, Dunnett's). 
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BP and TCB were tested, and tissues were sampled eight days after treatment. 
Concentrations of BP and TCB were found to be dose-dependent in gill, gut, liver, muscle 
and rete mirabile. In all cases bile contained the highest concentration of BP and TCB, and 
the concentrations of both chemicals were similar. Of the organs, liver contained the 
greatest concentration of BP and TCB. The other excretory organs, gut and kidney, also 
had comparatively high concentrations of BP and TCB. The chemical concentrations in the 
gill, heart, and rete mirabile were higher than that seen in blood, though variability in the 
results prevented the differences from being significant. 
Liver 
Experimental exposure: We assessed CYP1A induction in liver to determine the 
responsiveness of CYP1A in eels to induction by model AhR agonists. MAb 1-12-3 
reacted with one band in eel liver microsomes (Figure 2). Control eels had low basal levels 
of total P450 content, CYP1A content and ethoxyresorufin 0-deethylase (EROD) activity 
(Table I, Figure 3). 
Treatment with BNF, BP and TCB resulted in minimal effects on total P450 and b5 
content (Table I). Significant increases in total P450 occurred only at the 10 mglkg dose of 
BNF andBP. 
Induction of CYP1A protein and activity in liver microsomes varied with inducer 
(BNF, BP or TCB) and dose (Figure 3). CYP1A content was induced significantly by 
doses greater than 1 mg BNF/kg, and CYP1A content in the 10 and 100 mg BNF/kg 
groups was significantly greater than in all other groups. Doses greater than 5 mg BNF/kg 
resulted in EROD activities significantly greater than in control eels. EROD activity in the 
100 mg BNF/kg group was significantly different from that in all other groups. Both the 1 
and 10 mg BP/kg doses elicited significant CYP1A protein induction The 10 mg BP/kg 
group had significantly greater CYP1A protein and activity than all other doses. Doses 
greater than 5 mg TCB/kg resulted in significant increases in CYP1A content and EROD 
activity compared to the control group. However, the 20 mg TCB/kg dose did not 
significantly induce CYP1A content or EROD activity above that in eels receiving 10 mg 
TCB/kg. Treatment with TCB resulted in a lesser induction of CYP1A protein and activity 
than was seen with BNF and BP (Table II), at comparable doses. 
The results as described above refer to nominal or administered dose. Induction of 
CYP1A content and catalytic activity was assessed in livers of eels used in the chemical 
distribution studies to relate responses to tissue dose. For both BP and TCB, CYP1A 
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Figure 2. CYP1A protein expression in liver microsomes from eels treated with BNF, BP 
and TCB. Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8 
days post-injection. Liver microsomal fractions were electrophoresed, transferred to 
nitrocellulose, immunoblotted with MAb 1-12-3 against scup CYP1A and visualized using 
NBT-BCIP. Lane 1: Scup CYP1A. Lanes 2-3: Control (80 J,.tg). Lanes 4-5: BNF-
treated (5 & 10 J,.tg) Lanes 6-7: TCB-treated (5 & 10 J,.tg). Lanes 8-9: BP-treated (10 J,.tg). 
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TABLE I 
Total spectral P450 and cytochrome b5 content in eels treated with BNF, BP and TCB 
Treatment Dose n b5 Total P450 
(mglkg) (nmoUmg) (nmoUmg) 
Com Oil Control 24 0.07 ± 0.03 0.28 ± 0.08 
TCB 0.1 6 0.09 ± 0.03 0.34 ± 0.10 
1 8 0.05 ± 0.01 0.32 ± 0.03 
5 3 0.12 ± 0.03 0.43 ± 0.11 
10 18 0.08 ± 0.03 0.34 ± 0.15 
20 3 0.11 ± 0.02 0.38 ± 0.101 
BNF 0.1 3 0.08 ± 0.05 0.31 ± 0.06 
1 3 0.10 ± 0.02 0.30 ± 0.03 
5 3 0.10 ± 0.03 0.24 ± 0.04 
10 9 0.13 ± 0.04 0.42 ± 0.15* 
100 3 0.18 + 0.03 0.42 + 0.09 
BP 0.1 4 0.07 ± 0.02 0.22 ± 0.04 
1 13 0.08 ± 0.02 0.31 ± 0.07 
10 12 0.11 + 0.03 0.38 + o.o8* 
Eel liver microsomal cytochrome P450 and b5 contents were determined spectrally as 
described in Methods. Values are means± SD. 
* - Significantly different from control (p<0.05, Tukey-Kramer). 
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Figure 3. Quantification of liver CYPlA protein and activity in eels treated with BNF, BP 
and TCB. A) EROD activity. B) CYPlA content. Eels were injected IP with BNF, BP 
or TCB at the doses indicated and killed 8 days post-injection. Microsomal EROD activity 
was determined fluorometrically Immunoblot analysis was performed as described in 
Figure 2, and quantified by densitometric analysis. a_ Significantly different from control 
(p<0.05, Tukey-Kramer). b-Significantly different from all doses (p<0.05, Tukey-
Kramer). 
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TABLE II 
Comparison of the efficacy of BNF, BP and TCB in inducing CYPlA in eel liver 
Treatment Dose CYP1A EROD Activity 
Corn Oil 
BNF 
BP 
TCB 
BNF 
BP 
TCB 
(mg/kg) 
Control 
1 
10 
(pmol/mg) 
2±3 
58± 12* 
43 ± 32* 
12 ± 4 
156 ± 37** 
122 ± 34** 
65 ± 27 
(pmol/min/mg) 
81 ± 47 
661 ± 194** 
422 ± 234* 
193 ± 70 
1115 ± 901* 
1312 ± 600** 
502 + 191 
Eel liver microsomal CYPlA content and EROD activity were determined as described in 
Methods. Values are means± SD. 
* -Significantly different from TCB (p<0.05). 
** -Significantly different from TCB (p<O.Ol). 
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content and activity were correlated strongly with the inducer concentrations in the liver 
(Figure 4). 
Environmental exposure: Three sites were chosen for sampling of eels exposed to 
AhR agonists in the environment. PCB, dioxin and PAR concentrations in sediment were 
2100, 8, 170 ug/g dry weight in New Bedford Harbor, MA (Pruell et al., 1990). This led 
to concentrations of PCBs as high as 1400 ~g/g dry weight in F. heteroclitus and 700 ~g/g 
dry weight (i.e. approximately 70 mglkg wet weight) in A. rostrata (Lake et al., 1995). 
Marion Harbor, MA is an enclosed body of water with substantial boat traffic. Vineyard 
Sound is an open body of water where eels used in the experimental exposures were 
caught. Total P450 and b5 contents as well as CYP1A protein and EROD activity were 
significantly greater in liver of eels from New Bedford Harbor (NBH) than in those from 
Marion Harbor or Vineyard Sound (Table ill). 
Endothelium 
Biochemical analysis: Heart and rete mirabile microsomes were biochemically 
analyzed to examine the induction of CYP1A in endothelial cells. Endothelium represents 
as much as 8-9% of the mass of the teleost heart (Stegeman et al., 1989), and the rete 
mirabile is composed almost solely of endotheliai ceils (Krogh, 1959). In heart, CYPlA 
protein and activity increased with increasing doses of BP and TCB (Table IV). As in 
liver, similar CYP1A induction occurred with BNF and BP, while TCB treatment resulted 
in a lesser CYP1A induction. Not only was CYP1A protein detectable in rete mirabile 
(Figure 5), but EROD and CPR activity also were measurable (Table IV). Furthermore, in 
eels collected from variously polluted sites, endothelial CYP1A content and activity was 
elevated significantly in eels collected from NBH (Table V). 
Immunohistochemical analysis: Immunohistochemical analyses were performed in 
order to determine the dose-dependence of endothelial CYP1A induction in a variety of 
organs. Across experiments, control eels which received com oil had at most mild staining 
of CYP1A in gill pillar cells, heart endothelial cells, and kidney endothelial cells (Figure 6). 
No staining was observed in gill epithelium of control eels. 
CYP1A was induced in endothelium in heart, kidney and gill by treatment with 
BNF, BP or TCB, although the p~ttem of induction varied with the inducer (Figure 6). 
Both BP and TCB induced dose-dependent increases in endothelial staining in gill, heart, 
and kidney. Doses greater than 10 mglkg of BP or TCB resulted in significant CYP1A 
induction compared to that in controls. At 20 mg TCB/kg, CYP1A immunostaining also 
was significantly greater than that in eels receiving 0.1 mg TCB/kg. CYP1A 
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Figure 4. Correlation of BP and TCB concentration in eel liver with CYPlA induction. A) 
Inducer concentration vs. EROD activity B) Inducer concentration vs. CYPlA content. 
Inducer concentrations were determined as described in Figure 1. EROD activity and 
CYPlA content were determined as described in Figure 3. All of the relationships shown 
are correlated significantly (p<O.OOl). 
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TABlE Ill 
Characterization of CYPlA protein and activity in liver microsomes from eels collected 
from differentially polluted sites 
Site 
New Bedford (n=16) 
Marion Harbor (n=8) 
EROD Activity 
(pmoUmin/mg) 
321 ± 119** 
116 ± 28 
CYP1A 
(pmoUmg) 
190 ± 92** 
13 ± 3 
Total P450 b5 
(nmoUmg) (nmoUmg) 
0.55 ± 0.10* 0.36 ± 0.11 ** 
0.35 ± 0.08 0.14 ± 0.03 
VineyardSound(n=10) 77 + 32 1 + 1 0.41 + 0.07 0.14 + 0.12 
Eel liver microsomes from eels collected in New Bedford Harbor, Marion Harbor and 
Vineyard Sound were characterized for their cytochrome P450, b5 and CYPlA contents, 
and CYPlA catalytic activity (EROD) as described under Methods. Values are means± 
SD. 
* - Significantly different from all other sites (p<0.05, Tukey-Kramer). 
** -Significantly different from all other sites (p<O.Ol, Tukey-Kramer). 
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TABLEN 
Quantification of CYPlA content and activity in eel heart and rete mirabile following 
treatment with model AhR agonists 
Heart Rete mirabile 
Treatment CYP1Aa EROD CYP1Ac EROD Reductase 
Activityb Activityd Activitye 
Control ND 2±2 ND 0.1 8.9 
BP 0.1 mg/kg ND 4±2 0.2 0.2 18.0 
BP 1 mg/kg 23 ± 23 4 ±2 1.4 0.5 11.3 
BP 10 mg/kg 255 ± 143 13 ± 12 5.8 0.9 14.5 
BNF 10mglkg 49 ± 49 9±6 3.9 0.9 5.6 
TCB 10 mglkg 22 + 14 3 + 3 0.7 0.4 33.8 
Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8 days post-
injection. Eel heart and rete mirabile were characterized for their CYPlA content and 
catalytic activity (EROD) as described under Methods. For heart, values are means ± SD 
from 3-6 pools of 2-3 individual organs. For rete mirabile, each value is from a pool of 2-
3 individual organs. 
a- Integrated density/mg microsomal protein. 
b - Pmol resorufin formedlmin/mg microsomal protein. 
c - Integrated density measured in 80 J..Lg of post-mitochondrial supernatant protein. 
d- Pmol resorufin formedlmin/mg post-mitochondrial supernatant protein. 
e - Nmol/min/mg post-mitochondrial supernatant protein. 
ND- Not detectable. 
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Lane 
1 2 3 4 5 6 7 
Figure 5. Immunodetection of CYP1A in rete mirabile microsomes from eels treated with 
BNF, BP and TCB. Eels were injected IP with BNF, BP or TCB at the doses indicated and 
killed 8 days post-injection. Immunoblot analysis was performed as described in Figure 2, 
with the exceptions of being transferred to nylon and visualized using enhanced 
chemiluminescence. Lane 1: Scup CYP1A standard. Lane 2: Control. Lane 3: 1 mg 
BP/kg. Lane 4: 0.01 mg BP/kg. Lane 5: 10 mg BP/kg. Lane 6: 10 mg TCB/kg. Lane 7: 
10 mg BNF/kg. 
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TABlEV 
Characterization of CYPlA protein and activity in heart and rete mirabile microsomes from 
eels collected from differentially polluted sites 
Site Organ EROD Activity CYP1A Endothelial CYP1A 
(pmollmin/mg) (pmollmg) (Stain Index) 
New Bedford Heart 5.8 ± 2.8* 4.5 ± 1.7 10.1 ± 3.5* 
n=ll Rete 1.9 ± 1.2* <.Oo1a Irl 
Marion Harbor Heart 1.0 ± 0.4 <.001 1.3 ± 1.8 
n=5 Rete 0.2 + 0.1 <.001 Irl 
Vineyard Sound Heart 0.6 ± 0.5 <.001 0.2 ± 0.4 
n=8 Rete 0.3 ± 0.1 <.001 Irl 
Eel heart and rete mirabile microsomes from eels collected in New Bedford Harbor, Marion 
Harbor and Vineyard Sound were characterized for their CYPlA content and CYPlA 
catalytic activity (EROD) as described under Methods. Values are means± SD. 
*-Significantly different from all other sites (p<O.Ol, Tukey-Kramer). 
a - Bands corresponding to CYPlA were visible in two samples, but were unquantifiable. 
nd - Not determined 
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immunostaining in BNF treated eels peaked at intermediate doses, which differed from that 
resulting from BP or TCB treatment where staining increased to the highest dose. 
Endothelial staining peaked at 1 mg BNF/kg in gill pillar cells and 5 mg BNF/kg in 
ventricular and kidney endothelial cells. 
Gill epithelial cells also were inducible for CYP1A; however, the response was 
dependent upon the inducer (Figure 6). In BP and TCB-treated eels, gill epithelial staining 
remained mild, even at the highest doses. While gill endothelial staining in eels treated with 
doses greater than 5 mg BNF/kg decreased, the gill epithelial staining was induced and 
continued to increase significantly with increasing dose. 
CYP JA immunostaining in the rete mirabile: Immunohistochemical analysis of 
CYP1A showed a dose-dependent induction in the endothelial cells of the rete mirabile 
(Figure 7). All control and dosed fish showed significant positive staining in the pre-rete 
arteries; however, the extent of penetration of staining into the rete itself differed with 
inducer and dose. Rete from control fish had mild to strong staining in endothelial cells of 
the pre-rete arteries only. BNF was most effective at inducing CYP1A in the endothelium 
of the rete (Table VI). There was a dose-dependent increase in the CYP1A stain index in 
the pre-rete arteries, with maximal staining reached by the 1 mg BNF/kg dose. Similarly, 
the intensity of CYPlA staining in the heart-pole endothelium was dose-dependent. Doses 
greater than 1 mg BNF/kg resulted in penetration of CYP1A staining into the mid-rete 
region, and doses greater than 5 mg BNF/kg resulted in extension of penetration of 
endothelial CYP1A staining into the vessels of the bladder pole. In BP-treated eels, the 
CYP1A stain index in the pre-rete arteries was dose-dependent. Doses greater than 0.1 mg 
BP/kg resulted in CYPlA staining in heart-pole endothelium, and the intensity of staining 
increased with dose. A dose of 10 mg BP/kg resulted in CYPlA induction in the mid-rete. 
While the CYP1A stain index in TCB-treated eels was dose-dependent, maximal staining 
(i.e. a score of 16) was not reached in these eels. Doses greater than 1 mg/kg TCB resulted 
in CYP1A staining in the heart-pole endothelium, and the intensity increased with dose. 
TCB did not induce CYP1A staining in the mid-rete. With all of the inducers as the dose 
increased, the proportion of eels with staining of retial CYP1A increased, evident most 
clearly in the heart pole. 
DISCUSSION 
Previous studies have suggested that eels may be useful in biomonitoring of aquatic 
pollution (van der Oost et al., 1996). However, the direct response of CYPlA in eels 
179 
Figure 6. Immunohistochemical analysis of CYPlA protein in endothelium of eels treated 
with BNF, BP and TCB. A) BNF-treated eels (n=3-10). B) BP-treated eels (n=4-8). C) 
TCB-treated eels (n=3-15). Eels were injected IP with BNF, BP or TCB at the doses 
indicated and killed 8 days post-injection. Tissues were dissected, embedded, sectioned and 
immunohistochemically analyzed for CYPlA as described under Methods. Staining of 
CYPlA was scored for intensity of staining (O=no stain, l=mild stain, 2=moderate stain, 
3=strong stain, 4=very strong stain) and for occurrence of staining (O=no cells, 1=rare 
cells, 2=some cells, 3=many cells, 4=all cells staining). The stain index was computed by 
multiplying the intensity and occurrence scores for a scale from 0-16. *-Significantly 
different from control. a-Significantly different from control and 0.1 mg/kg. b_ 
Significantly different from control, 0.1 and 1 mg/kg. C-Significantly different from 1 
mg/kg. d-Significantly different from 5 mg/kg. Significance was determined as p<0.05 
(Tukey-Kramer). 
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Figure 7. CYP1A immunostained sections of rete mirabile from eels treated with BNF. 
Eels were injected IP with BNF at the doses indicated and killed 8 days post-injection. A) 
Control (heart pole). B) 0.1 mg/kg (heart pole). C) 1 mg/kg (heart pole). D) 5 mg/kg 
(heart pole). E) 5 mg/kg (bladder pole). The immunostaining procedure used is as 
described by Smolowitz et al. (1991). 
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TABLE VI 
Immunohistochemical analysis of CYPlA induction following treatment with BNF, BP 
and TCB in the rete mirabile of eels 
Pre-rete Heart Pole Mid-rete Bladder Pole 
Endothelium Endothelium Endothelium Endothelium 
Chemical Dose Stain +/total* Intensity +/total +/total +/total 
~mg/kg1 Index 
BNF 0 10 ± 4 3/3 0 0/3 0/3 0/3 
0.1 13 ± 2 3/3 1 ± 1 1/3 0/3 0/3 
1 16 ± 0 3/3 3 ±1 2/3 113 0/3 
5 16 ± 0 3/3 4±1 3/3 3/3 2/3 
10 16 ± 0 9/9 3±0 9/9 1/9 1/9 
100 16 + 0 3/3 3+0 3/3 3/3 2/3 
BP 0 10± 6 7/12 0±0 4112 0112 0112 
0.1 10± 2 4/4 1 ± 1 3/4 0/4 0/4 
1 15 ± 2 617 1 ± 1 617 017 017 
10 16 + 0 6/6 2+1 6/6 2/6 116 
TCB 0 10 ± 4 5/5 0±0 0/5 015 0/5 
0.1 6±3 3/3 0 0/3 0/3 0/3 
1 14 ± 3 3/3 2±0 3/3 0/3 0/3 
10 15 ± 3 12/12 1 ± 1 12/12 0/12 0/12 
20 11 ± 7 3/3 2±0 3/3 0/3 0/3 
Eels were injected IP with BNF, BP or TCB at the doses indicated and killed 8 days post-
injection. Rete mirabile were dissected, embedded, sectioned and immunohistochemically 
analyzed for CYPlA as described under Methods. Staining of CYPlA was scored for 
intensity of staining (O=no stain, l=mild stain, 2=moderate stain, 3=strong stain, 4=very 
strong stain) and for occurrence of staining (O=no cells, l=rare cells , 2=some cells, 
3=many cells, 4=all cells staining). The stain index in computed by multiplying the 
intensity and occurrence scores for a scale from 0-16. 
* - Number of rete with positive staining over the total number analyzed. 
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following treatment of AhR agonists has not been addressed. CYPlA in liver was 
significantly induced by both halogenated and non-halogenated AhR agonists. 
Furthermore, CYP1A induction in liver was correlated strongly with agonist concentration, 
whether PAH (BP) or pHAH (TCB). In comparison with other species, eels are 
moderately sensitive to CYP1A induction by AhR agonists. 
CYP1A induction in endothelium could have multiple consequences. Previous 
studies have suggested that endothelial CYP1A induction may alter the pharmacokinetics of 
AhR agonists/CYP1A substrates (Smolowitz et al., 1991), affect vascular function (Pinto 
et al., 1986; Pinto et al., 1987), and stimulate toxicity (Guiney et al., 1997). In this study 
we evaluated the possible relationship between CYPlA induction in endothelium and the 
pharmacokinetics of AhR agonists. CYP1A in endothelium responded in a dose-dependent 
manner to treatment with AhR agonists and was highly inducible in heart, gill and kidney. 
The rete mirabile was examined for CYPlA induction because it is an organ that is 
composed almost solely of endothelial cells and may be a unique site in which to investigate 
the response of endothelial CYP1A to AhR agonists in vivo. Induction of CYPlA in rete 
mirabile could be observed in both immunohistochemical and biochemical assays .. The 
patterns of induction in this vascular bed are consistent with the extent of penetration of 
inducer being limited at lower doses possibly by induction of CYPlA. The results also 
confirm that capillary endothelial CYPlA is metabolically active. 
Liver 
Tissue Distribution of BP and TCB: Previously, studies determined that the tissue 
distribution of highly lipophilic compounds, including pHAHs, is species specific. Cod 
injected with 2,3,3',4,4'-pentachlorobiphenyl or 2,3,7,8-tetrachlorodibenzo-p-dioxin have 
much greater concentrations of these chemicals in the liver than similarly treated rainbow 
trout (Bernhoft et al., 1994; Hektoen et al., 1994). This difference has been attributed to 
the fact that the main lipid store in cod is the liver, while in rainbow trout there are 
peritoneal and subcutaneous lipid stores. In the present study, eels tended to have low 
concentrations of both TCB and BP in the liver, though the liver did have greater 
concentrations of both BP and TCB than any other organ examined. The low 
concentrations of BP and TCB may be related to abundant peritoneal fat in these animals 
(personal observation), which could limit the amount distributed to other organs. The 
similarity in the concentrations of BP and TCB in most organs suggests that the 
pharmacokinetics of these chemicals are similar in eels. 
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Induction and Suppression of Eel Liver CYP JA: BP and BNF are model non-
halogenated AhR agonists, and TCB is a model halogenated AhR agonist. CYP1A can be 
induced in a variety of fish by these AhR agonists (Gooch and Matsumura, 1983; 
Melancon and Lech, 1983; Beyer et al., 1997; White et al., 1997a). In eels, an ED50 for 
EROD activity of approximately 5 mglkg for BNF, BP and TCB can be estimated from the 
dose-response curves. Furthermore, both EROD activity and CYP1A content were highly 
correlated with concentrations of BP and TCB in the liver. In comparison, the ED 50 for 
administered doses of TCB has been estimated at 0.03 mglkg in chicken embryo (Poland 
and Glover, 1977), 0.1 to 0.7 mg/kg in rainbow trout (Oncorhynchus mykiss) (Janz and 
Metcalfe, 1991; Newsted et al., 1995), 5.8 mglkg in C57BL/6J mice (Poland and Glover, 
1977), and 150 mglkg in Wistar rats (Leece et al., 1985). In comparison to other species, 
eels are moderately sensitive to CYP1A induction by model AhR agonists. 
BNF and BP had greater efficacy in inducing CYP1A than TCB. The induction of 
hepatic microsomal CYP1A content and catalytic activity was 2 to 3-fold greater in eels 
dosed with BNF or BP than in those dosed with TCB, compared at a 10 mglkg dose. 
While TCB induced CYP1A in liver, a dose of 20 mglkg did not produce a greater level of 
induction than did a 10 mglkg dose. Increasing doses of BNF or BP resulted in increased 
induction of CYP1A in hepatic microsomes, with no decline in induction at administered 
doses that far exceeded doses of TCB. The reason for this greater efficacy is not known 
but might result from differences in pharmacokinetic distribution; however, the distribution 
studies demonstrate that the concentrations of BP and TCB were similar in all organs but 
spleen. The plateau in induction of CYP1A activity following treatment with high doses of 
TCB also may result from inhibition of CYP1A, as TCB is a competitive inhibitor of 
EROD activity (Gooch et al., 1989). However, there is a plateau in induction of both 
protein and activity at the 20 mglkg dose, suggesting that catalytic inhibition is not the only 
contributing factor. 
While TCB and other planar PCBs generally induce CYP1A, the rate of CYP1A 
activity and the content of CYP1A protein decline sharply following in vivo exposure to 
high doses of TCB, 3,3',4,4',5-pentachlorobiphenyl and 3,3',4,4',5,5'-
hexachlorobiphenyl in several species (Gooch et al., 1989; Sinclair et al., 1989; Newsted et 
al., 1995; Stegeman et al., 1995). In the fish model, scup (Stenotomus chrysops), the 
decline was shown to be largely specific for CYP1A, resulting from a loss of CYP1A 
protein following transcription (White et al., 1997a). The mechanism was determined to be 
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oxidative inactivation (Chapter 3). Inactivation of CYP1A during the metabolism ofTCB 
may explain in part the lack of increase in induction at the highest dose (See Appendix A). 
Use of Eels as Biomonitoring Species: A previous study demonstrated the use of 
feral eels (Anguilla anguilla) in biomonitoring aquatic pollution (van der Oost et al., 1996). 
CYP1A content and activity were the most sensitive to environmental xenobiotics (van der 
Oost et al., 1996) and were correlated with tissue levels of PCBs and organochlorine 
pesticides (van der Oost et al., 1995). Although the relationship between AhR agonist 
concentration and CYP1A induction is species dependent (Bemhoft et al., 1994; Hektoen et 
al., 1994), in this study both BP and TCB concentrations were correlated with hepatic 
CYP1A induction. In addition, eels collected from NBH, an EPA Superfund site, had 
significantly elevated CYP1A levels compared to eels collected from other sites in the area. 
These results suggest that the eel is a good candidate for use as a biomonitoring species. 
Endothelium 
CYP JA Induction in Endothelium: In most extra-hepatic organs, CYP1A can be 
strongly induced in endothelium by AhR agonists (Smolowitz et al., 1991). In eels, the 
immunohistochemical CYP1A signal was as strong in endothelial cells as in hepatocytes. 
In other species it has been estimated that CYP1A could account for as much as 25% of the 
endothelial cell microsomal protein in heart (Stegeman et al., 1982; Stegeman et al., 1989). 
In this study, we observed a dose-dependent increase in endothelial CYP1A induction 
following treatment ofBNF, BP and TCB. 
Investigation of endothelial CYP1A induction in vivo is complicated by two factors. 
Most organs have multiple cell types which are inducible for CYP1A, and endothelial cells 
represent a very small proportion of the mass of most organs. Fish heart has been used as 
a model for CYP1A induction in endothelial cells. Although endothelium represents as 
much as 8-9% of the mass of the teleost heart (Stegeman et al., 1989), that proportion is 
less than in the rete mirabile, an organ composed almost solely of endothelial cells (Krogh, 
1959). Thus, we deduced that the rete may be a unique site in which to study induction of 
CYP1A in endothelial cells in vivo. Both experimental and environmental exposure to AhR 
agonists resulted in induction of CYP1A in rete endothelial cells, detectable both 
immunohistochemically and biochemically. Both CYP1A catalytic activity and reductase 
activity were quantifiable in the rete, supporting conclusions that endothelial CYP1A is 
catalytically active (Overby et al., 1992; Brittebo, 1994; Stegeman et al., 1995). We have 
demonstrated that endothelial cells exposed to CYP1A inducers in vivo responded with 
increasing CYP1A content and activity. 
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Although immunohistochemical studies have suggested that CYP1A may be as 
highly induced in endothelium as in hepatocytes, the catalytic activity of endothelial CYP1A 
is very low in comparison to that in liver. As has been found for P ABC (Stegeman et al., 
1995), EROD rates in endothelial cells from induced eels are lower than that in liver of 
uninduced eels. In comparison, the maximum EROD rate quantified in eel rete mirabile 
was 3 pmollmin/mg microsomal protein and in P ABC was 25 pmollmin/mg total protein 
(Stegeman et al., 1995). The low activity may result from a deficiency of CPR in 
endothelial cells (Stegeman et al., 1982; Overby et al., 1992; Stegeman et al., 1995). 
Augmentation with rat reductase increased the CYP1A catalytic rate in P ABC, suggesting 
that there is not enough reductase to fully support the catalytic capacity of endothelial 
CYP1A (Stegeman et al., 1995). 
Significance of Endothelial CYP lA Induction: The limited catalytic capacity of 
endothelial CYP1A raises the question of what significance CYP1A induction in 
endothelium might have. Endothelium is thought to act as a protective barrier, and 
induction of a metabolically inefficient CYP1A might contribute to the barrier function by 
holding substrates in the active site rather than metabolizing them. CYP1A2 strongly binds 
TCDD (Poland et al., 1989; Poland et al., 1989) and was shown to be responsible for the 
sequestration of TCDD in rat liver (Diliberto, 1997). Binding of TCB to CYP1A also may 
be inferred from inhibition studies using scup hepatic microsomes in which a Ki of 18-22 
nM at low protein concentrations (Hahn and Stegeman, 1994) and a Ki of 0.2-0.3 J..tM at 
high protei~ concentrations (Gooch et al., 1989; Chapter 3) were measured. 
Slowly metabolized substrates might be effectively "bound" to endothelial CYP1A, 
resulting in sequestration in the endothelium that could limit the amount of inducer that can 
penetrate to underlying tissues or distal regions (Stegeman et al., 1995). Results from this 
study support the hypothesis that endothelial CYP1A might influence the pharmacokinetics 
of AhR agonists. First, concentrations of BP and TCB in the rete mirabile were dose-
dependent and were greater than in the blood. Second, as the agonist dose increased, 
penetration of CYP1A immunostaining into the rete increased. Third, CYP1A staining was 
never seen in efferent rete vessels. The correlation of AhR agonist concentration with 
endothelial CYP1A induction suggests that the AhR agonist is responsible for the 
endothelial CYP1A induction. However, concentration of AhR agonists from the blood 
and lack of efferent CYP1A induction suggest that endothelial CYP1A can effectively 
remove the agonists from the circulation. In humans, placental endothelium taken from 
smokers has elevated aryl hydrocarbon hydroxylase (AHH) activity, however the umbilical 
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vein does not (Manchester et al., 1984). This suggests that the placental endothelium may 
remove inducers from the blood, and as CYP1A2 induction in extra-hepatic tissues is 
limited (Goldstein and Linko, 1984), the elevated AHH activity may indicate that CYP1A1 
is responsible for that removal. In addition to controlling distal distribution of AhR 
agonists, endothelial CYP1A may influence passage of AhR agonists to underlying tissues 
as seen in the transition of CYP1A immunostaining from within the endothelial cells to 
staining in cells underlying the endothelium high doses of BNF. Endothelial CYP1A may 
limit the spread of AhR agonists following low dose exposures. 
Despite the relatively low catalytic activity of endothelial CYP1A, its induction has 
been correlated with overt toxicity. Guiney et al. (1997) found that the strongest CYP1A 
induction occurs in the vascular endothelium of lake trout embryos exposed to TCDD, and 
that this induction correlated with the toxic effects, culminating in mortality. Two potential 
routes to this toxicity may be alteration in arachidonic acid (AA) metabolism and production 
of reactive oxygen species (ROS). First, AA metabolites produced by P450s influence 
vascular function by altering endothelial cell permeability (Ohnishi et al., 1992), vascular 
tone (Harder et al., 1995), and cellular ion flux (Schwartzman et al., 1987; Campbell et al., 
1996), and stimulating angiogenesis (Harder et al., 1995). BNF and MC treatment of 
canine coronary and rabbit pulmonary arteries leads to dose-dependent increases in AA 
induced endothelium-dependent relaxations (Pinto et al., 1986; Pinto et al., 1987), which 
can be reversed in the presence of general P450 inhibitors (Pinto et al., 1986) and 7-
ethoxyresorufin (Fulton et al., 1992; Fulton et al., 1995). Second, CYP1A binding of 
slowly metabolized substrates and resulting release of ROS during catalytic uncoupling 
(Chapters 3 and 4) in endothelium could be a mechanism of toxicity. Piperonyl butoxide, a 
general CYP inhibitor, and N-acetylcysteine, an antioxidant, can protect against TCDD-
induced mortality in fish embryos (Cantrell et al., 1996). Furthermore, porcine pulmonary 
endothelial cells respond to TCB treatment with increased CYP1A1 content and activity, as 
well as ROS production and lipid peroxidation (Toborek et al., 1995). 
We have demonstrated that American eels respond to both PAHs and a pHAH with 
induction of hepatic and endothelial CYP1A. Liver CYP1A can be induced significantly by 
multiple model AhR agonists, and in comparison with other species, eels are moderately 
sensitive to CYP1A induction. That CYP1A induction is correlated strongly with inducer 
concentration supports the conclusion that eels can be a useful biomonitor. Endothelial 
CYP1A in eels is highly inducible and can respond to AhR agonists in a dose-dependent 
manner. Further, induction of CYP1A in endothelium appears to be strong in eels collected 
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from a notably polluted site. Our results support the hypothesis that endothelial CYPlA 
can potentially sequester AhR agonists thereby modifying their pharmacokinetics. The 
results of this study suggest that the rete mirabile can be used a model for the study of 
CYPlA expression in endothelial cells in vivo and its role in the toxicity of AhR agonists. 
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CHAPTER 8 
Summary and Conclusions 
191 
Arachidonic Acid Metabolism 
The goal of these studies was to investigate cytochrome P450-related changes in a 
process that is important to the function of endothelial cells. Only one previous preliminary 
study had addressed CYP-mediated AA metabolism in fish (Zacharewski et al., 1996). 
Scup liver microsomes produced all possible types ofP450-derived AA metabolites: BETs, 
DHETs, mid-chain HETEs and w-terminal HETEs. While liver microsomes from females 
and males produced identical metabolite profiles, gravid females had much lower rates of 
total AA metabolism. In fish, several CYP, including CYP1A, CYP2B, CYP2K and 
CYP3A, have been shown to be hormonally regulated (Pajor et al., 1990; Gray et al., 
1991; Buhler et al., 1994), suggesting that these CYP might contribute to basal hepatic AA 
metabolism. Antibodies against scup CYP1A and a scup CYP2B-like protein inhibited 
liver microsomal AA metabolism, also suggesting that multiple CYP contribute to hepatic 
AA metabolism. These studies provide the first evidence of BETs and DHETs as 
endogenous constituents in teleost liver. Treatment of scup with the CYP1A inducer BP 
increased both liver microsomal AA metabolism and endogenous hepatic EET content, with 
a shift in BET regio- and enantioselectivity. While TCDD treatment did not significantly 
affect liver microsomal AA metabolism, it did increase endogenous EET content and alter 
EET regioselectivity. Kidney, gill and heart microsomes all metabolized AA, at rates 10 to 
30-fold less than with liver. BP treatment did not alter total BET content in heart and 
kidney; however there was a shift in favor of 14,15-EET. The predominant CYPs in 
mammalian kidney are the CYP2Cs (Capdevila et al., 1992), and CYP2N2 is highly 
expressed in heart of some fish (Oleksiak et al., 1998b). Therefore, CYP1A induction may 
not significantly alter the CYP compliment in these organs. However, other studies have 
shown that CYP1A-mediated AA metabolites can alter vasoactivity in blood vessels, as will 
be discussed below. Thus, scup liver and extrahepatic organs metabolize AA via multiple 
CYP forms to eicosanoids in vitro and in vivo. While AhR agonists alter metabolism of 
AA in early diverging vertebrates expressing both CYP1A and AhR, the magnitude of 
effects may depend upon the type of inducer. 
Induction of CYP1A was correlated with changes in the regio- and stereochemistry 
of endogenous BETs, suggesting that CYP1A-mediated metabolism of AA is regio- and 
enantiospecific. Expressed CYP2P and CYP2N from F. heteroclitus also metabolize AA in 
a regio- and stereospecific fashion (Oleksiak et al., 1998a; Oleksiak et al., 1998b). 
Metabolism of AA by expressed or purified scup CYP1A is required to confirm the actual 
metabolites produced by this CYP. 
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Marine fish contain less AA and greater amounts of n-3 fatty acids (e.g. 
eicosapentaenoic acid) than do mammals or freshwater fish, presumably due to differences 
in diet and in ability to elongate fatty acids (Weber, 1990). In comparison to mammals, 
amounts of endogenous AA metabolites and rates of microsomal AA metabolism were low 
in scup. Fish oils are rich in eicosapentaenoic (EPA) and docosahexaenoic acids; thus 
these fatty acids may be more readily available for metabolism in fish. Rat hepatic 
microsomes metabolize n-3 fatty acids to products with regiochemistry similar to P450-
derived AA metabolites (VanRollins et al., 1984; VanRollins et al., 1988; VanRollins, 
1990). EPA has been implicated in regulation of tight junction permeability, gene 
expression and nitric oxide production (Achard et al., 1997; Okuda et al., 1997; Jiang et 
al., 1998). Even though EPA metabolites appear to be less biologically active than their 
AA-counterparts, they appear to contribute significantly to the maintenance of the 
cardiovascular system in mammals (Weber, 1990). Investigation of the metabolism of 
EPA by fish and the role of CYP-derived AA and EPA metabolites in cardiovascular, renal 
and hepatic function in fish is required. 
This is the first study to demonstrate alteration of endogenous AA metabolites 
following treatment with a CYP inducer. Rifkind et al (1990) have raised the issue as to 
whether TCDD-induced changes in AA metabolism exacerbate or ameliorate the toxicity of 
TCDD. Rifkind et al (1994) argue that the effects of the AA metabolites produced by 
CYP1As are compatible with the syndrome of TCDD toxicity (i.e. alterations in hormonal 
regulation, fluid homeostasis, cell growth, and intermediary metabolism and increased 
intracellular ca2+). However, it is also pointed out that some CYP-derived AA metabolites 
could protect against TCDD toxicity through anti-mitogenic and edema-inhibition pathways 
(Rifkind et al., 1990). Now that there is evidence for alterations in AA metabolism by AhR 
agonists in vivo, an examination of how predominant CYP1A-derived metabolites might 
contribute to pHAH toxicity is necessary. 
PHAH-Simulated-CYP JA Inactivation 
Previous studies in fish, birds and mammals have demonstrated induction, 
inhibition and suppression of CYP1A by TCB. Here we defined the mechanism of CB-
stimulated CYP1A inactivation. In vitro inactivation of scup CYP1A activity by TCB was 
time-dependent, NADPH-dependent, oxygen-dependent and irreversible. TCB increased 
microsomal NADPH oxidation rates, and CYP1A inactivation was lessened by adding 
cytochrome c. CYP1A inactivation was accompanied by loss of spectral P450 and variable 
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loss of heme and/or appearance of P420. Rates of TCB metabolism were too slow to 
support the rate of inactivation. Non-heme iron chelators, anti-oxidant enzymes, and ROS 
scavengers had no influence on inactivation. Adding H202 enhanced TCB-dependent 
inactivation, but only the enhancement was reversed by catalase. Inactivation was 
accelerated by azide but not by hydroxylamine or aminotriazole, suggesting that the azide 
effect is not dependent upon catalase. TCB also inactivated rat liver microsomal CYP1A; 
although the rate of inactivation was slower than that seen with scup CYP1A. The results 
indicate that TCB uncouples the catalytic cycle of CYP1A, ostensibly CYP1A1, resulting in 
formation of ROS within the active site. Furthermore, we hypothesized that the attacking 
species is OH•, formed by the interaction of the reduced heme iron with H202. The 
inactivation of CYP1A was stimulated by CBs that are AhR agonists and possibly CYP1A 
substrates, i.e. CBs i26 and 169. The mono-ortho CB 105 was less effective at 
stimulating inactivation of CYP1A. The non-ortho CB 52 and the rapidly metabolized 
CYP1A substrate BP did not stimulate inactivation. Inactivation of CYP1A was species-
specific and was correlated with the rate of TCB metabolism. Based on in vitro data, we 
hypothesized that CB 126 would suppress CYP1A induction in vivo. CB 126 potently 
induced CYP1A mRNA, protein and catalytic activity at low doses (0.01-0.1 mglkg) and 
induced CYP1A mRNA at a high dose (1 mglkg) but suppressed induction of CYP1A 
protein and catalytic activity at that high dose. The suppression of CYP1A induction was 
organ-dependent, with hepatic CYP1A being most susceptible to inactivation. 
Species differences in TCB metabolism and CYP1A inactivation suggest 
differences in the topology of the substrate access channel or the active site of homologous 
CYPlAs. Such differences may favor metabolism ofTCB by rat CYP1A1 and retention of 
ROS by scup CYP1A. Structural differences between scup CYP1A and rat CYP1A1 have 
been suggested by results from antibody studies. Only 1 of 9 antibodies raised against 
scup CYP1A recognize rat CYP1A1, and 2 of 10 antibodies raised against rat CYP1A1 
recognize scup CYP1A (Klotz et al., 1986). In addition, even though polyclonal 
antibodies raised against scup CYP1A inhibit EROD activity in teleost microsomes, they do 
not inhibit EROD activity in BNF-treated rat liver microsomes (Stegeman et al., 1985). 
Modeling studies are planned to det~rmine ifTCB "fits" differently into CYP1A active sites 
from various species. Aligned amino acid sequences show both similarities and differences 
in residues in the vicinity of the CYP1A active site and considered involved in substrate 
binding (Figure 1) (Lewis and Lake, 1996). Only a small change in molecular size allows 
the binding and metabolism of BP but prevents the binding of benzo[e]pyrene (Lewis et 
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al., 1994). This sieve effect has· been attributed two phenylalanine residues (Phe 201 and 
Phe 243, using P450cam nomenclature) that have a coplanar orientation (Lewis et al., 
1994); this may be a site important to determining differences between the scup and rat 
proteins. 
The consequences of suppression of CYP1A are unknown at this time. Studies of 
a CYP1A-deficient animal model are required, but this tool has not been developed as of 
yet. However, studies are beginning to recognize the regulation of AhR activation by 
CYP1A1 in a mammalian system. Studies in Hepa-1 cells have shown that the c37 mutant, 
which lacks CYP1A1 activity, has a constitutively activated AhR (Chang and Puga, 1998). 
Similarly, inhibition of CYP1A1 activity by ANF in the wild-type Hepa-1 also results in 
activation of the AhR. Chang and Puga (Chang and Puga, 1998) have hypothesized that an 
endogenous CYP1A substrate is responsible for the constitutive activation of the AhR. 
Metabolism of the substrate converts it to an inactive product; therefore, if CYP1A is not 
present or is inhibited the substrate will remain active resulting in the constitutive activation 
of the AhR. The endogenous ligands of the AhR have been suggested to be eicosanoids, 
compounds which also can be metabolized by CYP1A (Capdevila et al., 1990; Nebert, 
1994). Thus, it is possible that the suppression of CYPlA resulting from inactivation 
mediated by coplanar PCBs may alter the homeostasis of the AhR. Considering that the 
AhR now is recognized to participate in control of cell cycle progression (Ma and Whitlock, 
1996; Weiss et al., 1996), perturbation of AhR homeostasis may have physiologically 
important consequences. 
PHAH-Stimulated ROS Production 
Adding TCB to scup or rat liver microsomes containing CYP1A, but not control 
microsomes, stimulated formation ofROS; formation rates correlated with native CYP1A 
content. Use of multiple techniques confirmed that both 02-· and H202 were produced by 
scup CYP1A. Expressed human CYP1As differed in their production of ROS. In the 
presence of NADPH alone, CYP1A2 microsomes oxidized DCDFDA and HE at rates 5-
fold greater than the rates obtained with CYP1A1 microsomes. Considering that CYP1A2 
has been shown to be reduced in the absence of substrate (Guengerich and Johnson, 
1997), this result is not surprising. However, another recent study reported that NADPH-
stimulated ROS production by human CYP1A1 was greater than that by CYP1A2 
(Puntarulo and Cederbaum, 1998). Addition of TCB+NADPH stimulated ROS production 
by the human CYP1A1 microsomes, but decreased ROS production by the CYP1A2 
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Figure 1. . An alignment between CYPlA sequences demonstrating similarities and 
differences between amino acids in the vicinity of the CYPlA active site. A, B, C -
involved in hydrogen bonding. D -Involved in limiting the size of the substrate binding 
site. E - Involved in 1t-1t stacking with aromatic rings on substrates. F - Involved in 
hydrogen bonding by CYPlAl. G- Involved in hydrogen bonding by CYP1A2. H-
Possibly involved in discrimination of CYPlAl and CYP1A2 substrates. I -Possibly 
involved in 1t-1t stacking with substrates and limiting the size of the substrate binding site. 
J - Possibly involved in substrate binding interactions or in limiting the size of the binding 
site. K - Involved in 1t-1t stacking with aromatic rings on substrates. Designations of 
active site amino acids are from (Lewis and Lake, 1996). Sequences were retrieved by 
GenBank accession numbers K03191 (human CYPlAl), Y00071 (mouse CYPlAl), 
K02246 (rat CYPlAl), U14162 (scup CYPlA), M21310 (trout CYPlAl), and X99453 
(chicken CYP1A4). 
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microsomes. Therefore, the data suggest that pHAH-stimulated ROS production is a result 
of the interaction with CYP1A1 in mammals. ROS formed by uncoupling of CYP1A could 
attack any member of the cellular machinery, including proteins (Davies, 1987; Stadtman 
and Berlett, 1991), lipids (Girotti, 1985) and nucleotides (Breen and Murphy, 1995). CBs 
have been shown to stimulate oxidative stress in this study as well as others (Stohs et al., 
1990; Buchmann et al., 1991; Toborek et al., 1995; Park et al., 1996), and ROS 
production was shown to be both AhR-dependent (Faux et al., 1992; Alsharif et al., 1994; 
Park et al., 1996) and limited to microsomal and mitochondrial sources (Wahba et al., 
1989). Uncoupling of CYP1A fits the criteria for the source of pHAH-stimulated ROS 
production. 
Beyond inactivating CYP1A protein, oxygen and ROS may be important regulators 
of CYP1A. Oxidative stress has been shown to downregulate CYPs. While BNF 
substantially induced CYP1A1 and CYP1A2 mRNA expression in hepatocytes isolated 
from rats, co-treatment with H202 reduced transcription rates by 50% and 70%, 
respectively (Barker et al., 1994). Oxidizing conditions decrease DNA binding of purified 
AhR (Ireland et al., 1995). Unlike other redox-sensitive transcriptions factors, the AhR 
does not contain conserved cysteines in its basic regions; however both the AhR and 
ARNT contain conserved cys-arg motifs in the PAS domain. In contrast, hyperoxia has 
been found to induce CYP1A expression in both mice (Gonder et al., 1985) and sheep 
(Hazinski et al., 1995). On the other hand, hypoxia also may influence CYPlA induction. 
Activated hypoxia inducible factor-1a out competes dioxin-activated AhR for binding of 
ARNT, resulting in reduced AhR-DNA binding (Gradin et al., 1996). A greater 
understanding of the regulation of the AhR and CYP1A by oxygen is required. 
NF-KB in a Teleost 
The goal of these studies was develop an assay with which we could analyze the 
physiological effect of the production of ROS during the uncoupling of CYP1A by pHAH. 
Even though analysis of antioxidant enzymes and oxidative damage are difficult to 
interpret, I initially attempted to measure an oxidative DNA adduct 8-hydroxy-
deoxyguanosine. This was abandoned due to the difficult nature of isolating DNA from 
scup. I turned to looking for a redox sensitive transcription factor whose activation I could 
use as a sensitive indicator of oxidative stress. First, this required finding a probe that 
would recognize such a protein in fish and then confirming its specificity. Thus, I have 
demonstrated for the first time that members of the Rel family of proteins are present in a 
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teleost. An NF-KB consensus sequence bound at least 3 proteins in scup liver, kidney and 
heart, two of which potentially correspond with mammalian p50 and RelA. An antibody to 
mammalian p50 immunoprecipitated the ==50 kD binding protein in all 3 organs. In EMSAs 
the band-shifts were specifically competed by NF-KB binding oligonucleotides and not by 
the AhR DRE. Second, I attempted to use activation of NF-kB/DNA binding as an 
indicator of oxidative stress following treatment with two AhR agonists. An NF-kB 
consensus sequence was bound by nuclear proteins from untreated scup. BP did not 
increase the activation of NF-kB, and PeCB activated NF-KB in only 1 of 2 experiments. 
While, we have confirmed the presence of the Rel family of proteins in a teleost, 
interpretation of the effects of AhR agonists on NF-KB activation is difficult. This is not 
necessarily surprising considering the conflicting results seen in cell culture (Yao et al., 
1995; Tian et al., 1998; Shneider et al., submitted). Sequencing of members of the Rel 
family of proteins from scup is occurring as I write. This will confirm further the 
biochemical results which show that this family of proteins is present in a teleost. The 
identification, the distributions, the regulation and the functions of Rel family proteins in 
te1eosts, as we11 as determJning the relationshJp of teleost Rei proteins to mammalian, avian 
and amphibian Rel proteins, all remain questions for another thesis. Use of primary cell 
culture or the Hepa-expressed SCl,lp CYP1A system may reduce the confounding effects 
seen in vivo. 
CYP JA in Endothelium 
Endothelial cells may be a particularly sensitive target for PAHs and pHAHs. We 
have shown that CYP1A can be strongly induced in this cell type by several model AhR 
agonists. Induction of endothelial CYP1A is dose-dependent in multiple organs, and both 
cardiac endothelial CYP1A in microvascular endothelial CYP1A were metabolically active. 
In the rete mirabile, greater doses of inducers were associated with increasing penetration 
of induction. In addition, a transition from endothelial to epithelial staining occurred in the 
gill, heart and kidney at high doses of BNF. We conclude that the penetration of 
endothelial cell CYP1A expression in the vessels of the rete mirabile reflects greater 
concentrations of inducer reaching the distal circulation. The results are consistent with the 
hypothesis that endothelial cell CYP1A may participate in removal of AhR agonist/CYP1A 
substrates from the circulation. 
We have shown that AA metabolism is altered by AhR agonists, and others have 
shown that P450-derived AA metabolites can affect endothelial cell function. Even though 
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endothelial cells represent up to 8-9% of the mass of the teleost heart (Stegeman et al., 
1989), changes in CYPlA status may not have changed the CYP compliment of the heart 
as a whole, and thus we saw little change in AA metabolism following BP treatment. 
However, considering that CYPlA can represent up to 25% of endothelial microsomal 
protein (Stegeman et al., 1982) and the ability of CYPlA-induction to alter AA metabolism 
in an CYPlA-rich organ (i.e. liver), it is likely that changes in CYPlA-content in 
endothelial cells may have a profound effect on AA metabolism. For instance, BNF and 
MC treatment of canine coronary and rabbit pulmonary arteries leads to dose-dependent 
increases in AA induced endothelium-dependent relaxations (Pinto et al., 1986; Pinto et al., 
1987). Studies on AA metabolism in cultured endothelial cells treated with AhR agonists 
would be required to answer this question definitively. 
ROS play an important role in the normal physiology of endothelial cells, as well as 
participate in endothelial cell pathology. Endothelial cells produce nitric oxide (NO) as a 
paracrine factor which stimulates relaxation in vascular smooth muscle cells, and ROS are 
second messengers in shear flow induced gene expression (Chien et al., 1998; Hsieh et al., 
1998). Endothelial cells also commonly encounter ROS produced by activated neutrophils 
(Baboir, 1978). However, ROS also have been implicated in atherosclerosis. 
Peroxidation of low density lipoproteins has been suggested to attract adhering monocytes 
(Halliwell, 1993), and ROS induce the transcription of vascular cell adhesion molecule-! 
whose promoter contains an NF-KB consensus binding sequence (Weber et al., 1994; 
Alexander, 1995). Treatment of endothelial cells with ROS can result in alterations of 
many physiological process including stimulation of release of intracellular ca+2 stores, 
release of polyunsaturated fatty acids via activation of phospholipases A2, C and D, 
platelet-activating factor, protein phosphorylation and prostanoid synthesis, inhibition of 
agonist induced Ca+2 flux and inositol triphosphate liberation, depletion of ATP, NAD+ 
and reduced glutathione, accumulation of lysophopholipids, induction of c-myc and c-fos 
expression and alteration of vascular barrier function (Vane et al., 1990; Vercellotti et al., 
1991; Elliot et al., 1992; Schilling and Elliot, 1992; Barchowsky et al., 1994; Natarajan, 
1995). Considering the substantial potential for CYPlA induction in endothelial cells 
(Stegeman et al., 1982), the production of ROS during CYPlA uncoupling, the evidence 
of oxidative stress following CB treatment in culture (Toborek et al., 1995) and the 
correlation of early life-stage mortality stimulated by TCDD with endothelial CYP and ROS 
(Cantrell et al., 1996), ROS production stimulated by pHAHs may be an important initiator 
of endothelial cell pathology. 
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Appendix A 
3,31 ,4,4 1- Tetrachlorobiphenyl Metabolism in Fish, Bird and Reptile 
Species and its Relationship with Cytochrome P4501A Inactivation and 
Reactive Oxygen Production 
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ABSTRACT 
Previous work in the fish model scup (Stenotomus chrysops) demonstrated that 
during the association of planar polychlorinated biphenyls with the CYPlA active site, 
reactive oxygen species (ROS) are produced as a result of catalytic uncoupling, culminating 
in oxidative inactivation of the enzyme. Here, we investigated 3,3',4',4-tetrachloro-
biphenyl (TCB) metabolism and its relationship to CYPlA catalytic activity, CYPlA 
inactivation and ROS production liver microsomes from a series of fish (Anguilla rostrata, 
Fundulus heteroclitus, Psuedopleuronectes americanus, and Raja erinacea), bird (Gallus 
domesticus, Larus argentatus and Phalacrocorax auritus) and reptile (Chrysemys picta) 
species. For all species examined, TCB metabolism represented a very small proportion of 
the CYPlA catalytic activity, ethoxyresorufin 0-deethylation (EROD); however, it was 
correlated strongly with EROD activity in all species except flounder. The rate of CYPlA 
inactivation varied between species. Chicken hepatic CYPlA was most susceptible to 
inactivation; however eel, flounder, killifish and cormorant liver microsomes all had 
significant decreases in EROD activity following incubation with TCB and NADPH. 
Inactivation was correlated negatively with TCB metabolism in the bird species (r2=0.992, 
p<0.05). ROS production by liver microsomes also was species dependent. In chicken 
and turtle liver microsomes, NADPH alone stimulated a high rate of ROS production, both 
H202 and OT•. In both fish and bird species, NADPH-stimulated ROS production was 
correlated positively with EROD activity (r2=0.770~0.845, p<0.05 and r2=0.952-0.959, 
p<0.05, resl?ectively). TCB stimulated H202 production in liver microsomes of flounder, 
cormorant and gull; however, TCB decreased H202 production in the chicken liver 
microsomes. TCB stimulated 02-. production in liver microsomes of flounder, killifish, 
cormorant and gull. Compared to the model species scup, only chicken had rates of ROS 
production and CYPlA inactivation as high. CYPlA inactivation appears to be dependent 
in part on the rate at which species metabolize TCB. 
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INTRODUCTION 
Polychlorinated biphenyls are ubiquitous in the global environment and present in 
tissues of fish, birds and mammals (see (Risebrough et al., 1968; McFarland and Clark, 
1989)). Congeners that lack substitution at ortho sites (e.g. 3,3',4,4'-tetrachlorobiphenyl) 
can achieve a planar conformation similar to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) (Safe et al., 1985). These planar halogenated aromatic hydrocarbons (pHAH) 
promote hepatocellular carcinoma, immunotoxicity, wasting syndrome and reproductive, 
endocrine and developmental toxicity (as reviewed in (Safe, 1994)). PHAH alter the 
expression of a number of genes, including cytochrome P4501A (CYP1A) genes, by 
activating the aryl hydrocarbon receptor (AhR) (Hankinson, 1995). 
3,3',4'4,-Tetrachlorobiphenyl (TCB) induces CYP1A in a wide range of fish 
(Franklin et al., 1980; Melancon and Lech, 1983; Gooch et al., 1989; Monosson and 
Stegeman, 1991; Tyle et al., 1991; Lindstrom-Seppa et al., 1994; Newsted et al., 1995; 
Otto and Moon, 1995; Huuskonen et al., 1996; Sleiderlink and Boon, 1996; White et al., 
1997a), bird (Dubois et al., 1995; Kennedy et al., 1996; Lorenzen et al., 1997), reptile 
(Schwen and Mannering, 1982; Jewell et al., 1989; Yawetz et al., 1998) and amphibian 
(Marty et al., 1992) species; however sensitivity to induction is species specific. In 
comparison, the ED50 calculated from 7-ethoxyresorufin 0-deethylation (EROD) induction 
for administered doses of TCB has been estimated at 0.03 mglkg in chicken embryo (Poland 
and Glover, 1977), 0.1 to 0.7 mglkg in rainbow trout (Oncorhynchus mykiss) (Janz and 
Metcalfe, 1991; Newsted et al., 1995), 5 mglkg in American eel (Anguilla rostrata) (Chapter 
7), 5.8 mglkg in C57BU6J mice (Poland and Glover, 1977), and 150 mglkg in Wistar rats 
(Leece et al., 1985). The EC5os for EROD induction by TCB in hepatocytes cultured from 
a number of bird species range over 4 orders of magnitude (Dubois et al., 1995; Kennedy et 
al., 1996; Lorenzen et al., 1997). Furthermore, in bird species, the susceptibility to CYP1A 
induction has been correlated with susceptibility to toxicity (Brunstrom and Reutergardh, 
1986; Brunstrom, 1988; Brunstrom and Lund, 1988; Dubois et al., 1995; Kennedy et al., 
1996; Lorenzen et al., 1997). 
One possible route to toxicity is the metabolic activation of CYP1A substrates to 
reactive derivatives. That CYP1A1 is responsible for the metabolism of TCB has been 
established in rats (Ishida et al., 1991). Correlations of CYP1A catalytic activity and TCB 
metabolism support the conclusion that CYP1A4 metabolizes TCB in birds (Murk et al., 
1994) and CYP1A metabolizes TCB in a fish (White et al., 1997b). Although rates of 
microsomal TCB metabolism in birds approach that seen in mammals, TCB metabolism is 
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extremely slow in fish (Borlakoglu and Wilkins, 1993; Murk et al., 1994; White et al., 
1997b). However, whether efficiently metabolized or not, bioactivation has not been 
found to be a significant avenue to pHAH toxicity (Safe, 1992). 
Another route to toxicity may be stimulation of oxygen activation. TCB significantly 
increases the rate of ROS production by hepatic CYP1A in the fish model scup (Stenotomus 
chrysops) (Chapter 3). We have hypothesized that the production of ROS during catalytic 
uncoupling by TCB results in the formation and attack of OH•, leading to the inactivation of 
CYP1A (Chapter 3). This may be the mechanism by which pHAH stimulate oxidative 
stress (Faux et al., 1992; Alsharif et al., 1994; Park et al., 1996), as well as the mechanism 
of CYP1A protein loss following exposure to high doses of TCB seen in vivo in fish 
(Gooch et al., 1989; Newsted et al., 1995; White et al., 1997a) and in cultured hepatocytes 
of chickens and endothelial cells of pigs (Lambrecht et al., 1988; Sinclair et al., 1989; 
Stegeman et al., 1995). 
Previous work has demonstrated a disparity in both TCB metabolism and TCB-
stimulated inactivation of CYP1A in scup and rats (Chapter 3), which suggested that the 
rate of inactivation may be related to the rate of TCB metabolism. Therefore, we 
investigated the relationship between TCB metabolism and inactivation of CYP1A in vitro, 
in a variety of fish, bird and reptile species. In addition, the potential for ROS production 
by liver microsomes of these species was examined. Within species groups, inactivation of 
CYP1A appears to be correlated negatively with the rate of TCB metabolism. The potential 
to produce ROS was correlated positively with CYP1A catalytic activity. 
MATERIALS AND METHODS 
Chemicals: 2',7'-Dichlorodihydrofluorescein diacetate, 7-ethoxyresorufin, and 
dihydroethidium were purchased from Molecular Probes (Eugene, OR). 3,3',4,4'-
Tetrachlorobiphenyl and 2,3,7,8-tetrachlorodibenzofuran were purchased from Ultra 
Scientific (N. Providence, Rl). 3,3',4,4'-tetrachlorobiphenyl-Ring-UL-14c (52.1 
mCi/mmol) was purchased from Pathfinder (St. Louis, MO). Analysis of the 14c_ 
3,3',4,4'-TCB by GC/ECD and GC/MS revealed no hydrophobic contaminants (>99% 
pure); small amounts of polar contaminants were removed by dissolving the TCB in hexane 
and extracting twice with NaOH. All other reagents were purchased from Sigma (St. 
Louis, MO). 
Animals: Killifish (Fundulus heteroclitus) were caught in Scorton Creek, MA, in 
June, 1996 and used in experiments in July, 1996. Killifish were held in flow-through 
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seawater tanks at 14 oc and maintained on a diet of TetraMin large flake food. Killifish 
ranged in size from 9 to 21 g. Eight fish each were injected intraperitoneally with corn oil 
or a solution of 2,3,7,8-tetrachlorodibenzofuran (10 nmollkg), a potent CYP1A inducer. 
Seven days following injection the fish were killed by decapitation. Livers were removed, 
and microsomes were made immediately. In each dose group, livers were pooled in twos 
to form 4 samples per group. Liver microsomes from benzo[a]pyrene treated eels 
(Anguilla rostrata) were prepared and characterized previously (Chapter 7). Flounder 
(Pseudopleuronectes americanus) and skate (Raja erinacea) liver samples were from 
animals environmentally exposed to halogenated and non-halogenated aromatic pollutants 
in Boston Harbor, MA. Chicken (Gallus domesticus), double crested cormorant 
(Phalacrocorax auritus), and herring gull (Larus argentatus) livers, both control and 
3,3',4,4',5-pentachlorobiphenyl-treated, were generous gifts of Lori Feyk (Michigan State 
University). Microsomes from TCB- and 13-naphthoflavone-treated turtles (Chrysemys 
picta) were prepared and characterized previously (Yawetz et·al., 1998). 
Microsome preparation: Microsomes were prepared from livers by differential 
centrifugation as before (Stegeman et al., 1979). Pellets were resuspended in buffer (50 
mM TRIS, pH 7.4, 1 mM dithiothrietol, 1 mM EDTA, 20% glycerol) and frozen in liquid 
N2 until use. Protein content was determined using the bicinchoninic acid method (Smith 
et al., 1985), using bovine serum albumin as a standard. 
Western blotting for CYP JA quantification: Immunoblotting procedures were 
modified from those previously described (Kloepper-Sams et al., 1987). Microsomal 
proteins (10-80 f..lg/lane) were resolved on 12% SDS-PAGE gels and electrophoretically 
transferred to nylon or nitrocellulose (1 f..Lm) membrane. The primary antibody was the 
mouse monoclonal antibody 1-12-3 (Park et al., 1986), raised against scup P450E 
(CYP1A; (Morrison et al., 1995)). MAb 1-12-3 is highly specific for CYP1A in fish and 
CYP1A1 in mammals but recognizes both CYP1A4 and CYP1A5 in chicken. The 
secondary antibody was alkaline phosphatase linked goat anti-mouse IgG (Biorad, 
Hercules, CA). The immunoreactive proteins on nitrocellulose membrane were visualized 
using nitro blue tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate (NBT/BCIP). The 
immunoreactive proteins on nylon membranes were visualized using enhanced 
chemiluminescence (Tropix, Bedford, MA). CYP1A content was quantified by 
densitometric analysis of video images (NIH Image, 1.60b5). Where appropriate, the 
CYP1A values are relative, reported as scup CYP1A equivalents. 
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Enzyme assays: Microsomal ethoxyresorufin 0-deethylation (EROD) was 
determined fluorometrically as before (Hahn et al., 1993), using a Cytofluor 2300 
(Millipore) multiwell plate reader. TCB metabolism was assessed using the assay of 
Schnellman et al. (Schnellman et al., 1983), as modified by White et al., (1997b). 
Radioactivity was determined by liquid scintillation counting on a Beckman LS5000TD 
counter. 
In vitro studies of CYP IA inactivation: The procedure was as described in Chapter 
3 except that 0.1-0.3 mg of microsomal protein was used in each reaction mixture. 
Inactivation was calculated by comparing EROD activity at 30 minutes in reaction mixtures 
containing TCB alone to that in reaction mixtures containing TCB+NADPH. 
Peroxide and superoxide formation: H202 and OT• formation were determined as 
described in Chapter 3. 
Statistics: Statistics were calculated using Microsoft Excel (Microsoft, Inc., 
Redmond, W A) and Stat-View for Macintosh (Abacus Concepts, Inc., Berkeley, CA). A 
Student's t-test was used to analyze inactivation (TCB vs. TCB+NADPH) and ROS 
production (NADPH vs. TCB+NADPH). To examine correlations between EROD 
activity, TCB metabolism, inactivation and ROS production, linear regression analyses 
were performed. 
RESULTS 
CYP1A content, EROD activity and TCB metabolism were determined in liver 
microsomes from bird, fish and reptile species in order to examine their relationship. The 
rate of TCB metabolism was very low in all species, compared to the rate of EROD (Table 
1). When TCB metabolism was represented as a percentage of EROD activity, species 
varied widely in their rates of TCB metabolism. In the bird and turtle species, TCB 
metabolism represented a greater proportion of EROD activity than it did in fish (Table 1 ). 
However, in all species but flounder, the rate of TCB metabolism was correlated strongly 
with EROD activity (Table 1). 
We examined the same fish, bird and reptile species for TCB-stimulated inactivation 
of CYP1A which has been described in the marine fish scup (White et al., 1997a; Chapter 
3). To determine the level of inactivation, the rate of EROD activity in hepatic microsomal 
reaction mixtures containing TCB+NADPH was compared to that in reaction mixtures 
containing only TCB following a 30 minute incubation. CYP1A inactivation was highly 
variable between species (Figure 1). Of the fish species, no one had as great a loss of 
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TABLE 1 
ComEarison of CYPIA content, EROD activit~ and TCB metaboliism in liver microsorhes from bird, fish and reEtile SEecies 
Species n Treatment CYPIA EROD TCB Metabolism TCB Metabolism TCB Metabolism 
Activity as a% ofEROD vs. EROD 
~Qmol/mg~ (Qmol/min/mg) (pmol/min/mg) r2 P< 
Fish 
Eel (A. rostrata)a 4 Control 1 ± 1 59± 26 0.12 ± 0.03 0.2 ± 0.1 0.930 0.001 
4 Induced 51± 7 466 ± 194 0.65 ± 0.12 
Flounder (P.americanus) 5 Environment 22 ± 7 112 ±: 21 0.14 ± 0.02 0.1 ± 0.0 0.000 
Killifish (F.heteroclitus) 4 Control 3 ± 1 566 ± 240 0.12 ± 0.02 0.0 ± 0.0 0.915 0.001 
N 4 Induced 21 ± 8 1385 ± 290 0.23 ± 0.07 
0 
'-1 Scup (S. chrysops)b 7 Induced 380 ± 150 4837 ± 924 0.34 ± 0.08 0.0 ± 0.0 
Skate ~R. erinacea ~ 3-4 Environment 5 ± 1 201 ± 84 0.09 ± 0.04 0.1 ± 0.1 1.000 0.05 
Birds 
Chicken (G. domesticus) 2 Control 1 • 2 131 • 480 0.4 • 0.7 0.3 ± 0.1 0.840 0.005 
7 Induced 19 ± 5 3658 ± 1568 10.9 ± 2.9 
Cormorant (P. auritus) 4 Control 3± 1 182 ± 64 2.2 ± 2.1 0.9 ± 0.6 0.922 0.001 
3 Induced 28 ± 3 1734 ± 729 12.8 ± 8.0 
Gull (Largentatus) 3-6 Control 3 ± 1 65 ± 44 0.5 ± 0.2 1.3 ± 0.5 0.978 0.001 
Induced 25 ± 2 337 ± 114 5.8 ± 2.5 
Reptile 
Turtle {C. eJcta~ c 4 Induced 463 + 171 80 + 23 2.5 + 0.7 3.2 + 0.4 0.861 0.05 
a- CYPIA content and activity data from Chapter 7. b- All data from Chapter 3. c- CYPlA content and activity data from (Yawetz et al., in press). 
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Figure 1. TCB-stimulated inactivation of hepatic microsomal CYPlA (EROD activity). 
Microsomes were incubated at 2 mg/ml in buffer (50 rnM TRIS, 0.1 rnM EDTA, pH 7.6) 
with combinations of the following additions: acetone (5 J...ll), NADPH (1.8 rnM), and TCB 
(1.7 J..!M). Aliquots were removed from reaction mixtures at times zero, 10, 20 and 30 
minutes and assayed for EROD fluorometrically over 5 minutes. Data shown here are from 
the 30 minute time point. EROD was constant in microsomes incubated with acetone or 
NADPH. Following an initial loss of EROD upon addition of TCB, EROD remained 
constant. There were linear losses of EROD during incubation with NADPH and TCB. 
Data are means ± SD. 3-8 sets of microsomes. *Statistically different from the 
corresponding TCB incubation analyzed at 30 minutes (Student t-Test, p<O.Ol). 
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activity due to inactivation as the model species scup; although there were statistically 
significant losses of EROD activity in eel, flounder and killifish liver microsomes (Figure 
1). Of the bird species, chicken appeared to be highly sensitive to CYP1A inactivation 
(Figure 1). There was no inactivation of CYP1A in turtle liver microsomes (Figure 1). 
There was no significant relationship between the rate of TCB metabolism normalized for 
EROD activity and competitive inhibition of EROD activity by TCB (data not shown). 
However, both fish and bird species demonstrated a negative relationship between 
inactivation and TCB metabolism, with the relationship in the bird species being statistically 
significant (Figure 2). 
Previous results in scup have demonstrated that TCB stimulates the production of 
ROSin liver microsomes, and it was hypothesized that those ROS may attack the protein 
resulting in inactivation (Chapter 3). Therefore, we examined ROS production in liver 
microsomes from the species analyzed in the inactivation assays. H202 and oz-· 
production were measured by monitoring the oxidation of 2',7'-dichlorodihydrofluorescein 
diacetate (DCDFDA) to dichlorofluorescein (DCF) and dihydroethidium (HE) to ethidium, 
respectively. DCDFDA and HE oxidation were stimulated significantly by NADPH alone 
in chicken and turtle liver microsomes (Figure 3). In both fish and bird species, NADPH 
stimulated ROS production was correlated positively with EROD activity (Figure 4). TCB 
stimulated H202 production in flounder, cormorant and gull liver microsomes; however, 
TCB decreased H202 production in chicken liver ·microsomes. TCB increased Oz-· 
production ~n the flounder, killifish, cormorant and gull liver microsomes. These increases 
in ROS production were not of the same magnitude as was seen in scup (Figure 3). 
DISCUSSION 
Planar HAHs are ubiquitous environmental contaminants that are known to be 
highly toxic (Safe, 1994). TCB both induces and suppresses the induction of CYP1A in 
several species (Lambrecht et al., 1988; Sinclair et al., 1989; Newsted et al., 1995; 
Stegeman et al., 1995; White et al., 1997a). Loss of CYP1A during incubation of scup 
liver microsomes with TCB+NADPH has been attributed to the formation and attack of 
ROS and may be involved in the decline in CYP1A seen in vivo (Chapter 3). In these 
studies we examined the inactivation of CYP1A and its relationship to TCB metabolism and 
ROS production in a variety of fish, bird, and reptile species. For all species examined, 
TCB metabolism represented a very small proportion of the CYP1A catalytic activity; 
however, it was correlated strongly with EROD activity, except in flounder. Susceptibility 
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Figure 2. Correlation of TCB metabolism with inactivation of CYPlA catalytic activity. 
A) Fish liver microsomes. B) Bird liver microsomes. TCB metabolism has been 
normalized to the EROD activity in the microsomes. 
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to inactivation varied among species with chicken being most sensitive but with eel, 
flounder, killifish and cormorant also having significant inactivation. Inactivation appeared 
to be negatively correlated with TCB metabolism. In both fish and bird species, NADPH-
stimulated ROS production was positively correlated with EROD activity. TCB further 
stimulated ROS production in liver microsomes of flounder, killifish, cormorant and gull; 
however, TCB decreased ROS production in the chicken liver microsomes. Compared to 
scup, only chicken had rates ofROS production and CYP1A inactivation as high. CYP1A 
inactivation appear to be dependent in part on the rate at which species metabolize TCB. 
TCB Metabolism: This study and others have shown that fish do not metabolize 
chlorobiphenyls (CB) as readily as birds or mammals. A recent study confirmed that TCB 
is metabolized by the marine fish scup both in vivo and in vitro (White et al., 1997b). 
Here, all species of fish examined metabolized TCB at a rate of less than 1 pmollmin/mg 
which represented between 0.01 and 0.2% of the EROD activity in these species. These 
very low rates of metabolism may be the reason why some studies have failed to detect CB 
metabolism in fish (Hutzinger et al., 1972; Herbst et al., 1978; Murk et al., 1994). 
However, selective loss of CB congeners in fish species indicated that biotransformation 
occurs in fish; selective loss of coplanar congeners TCB and 3,3',4,4',5-
pentachlorobiphenyl (Niimi and Oliver, 1983; de Boer et al., 1993) and non-coplanar 
congeners 2,2',5,5'-tetrachlorobiphenyl, 2,2',4,5,5'-pentachlorobiphenyl and 
2,2',3,5,5',6-hexachlorobiphenyl (Boon et al., 1989; Elskus et al., 1994) has been 
described. Furthermore, trace amounts of metabolites of di- to pentachlorobiphenyls have 
been detected in several fish species (Metcalf et al., 1975; Sanborn et al., 1975; Melancon 
and Lech, 1976; Hinz and Matsumura, 1977; Herbst et al., 1978). Birds have been shown 
to metabolize a number of di- to pentachlorobiphenyls both in vitro (Borlakoglu and 
Wilkins, 1993) and by the selective loss of specific congeners (Borlakoglu et al., 1990). 
Analysis of congener composition following either environmental or experimental exposure 
to complex CB mixtures suggested that only congeners with at least one pair of adjacent 
unsubstituted meta-para carbons were metabolized by birds (Borlakoglu et al., 1990; 
Rozemeijer et al., 1991). However, liver microsomes from eider duck (Somateria 
mollissima) and common tern (Sterna hirundo) metabolize TCB at significant rates (0.6-1.4 
and 21-47 pmol/min/mg, representing 2.9 and 4.0% of EROD activity) (Murk et al., 
1994). Furthermore, all of the bird species in this study metabolized TCB at rates between 
0.4 and 12.8 pmol/min/mg which represented 0.3 to 1.3% of the EROD activity in these 
samples. TCB metabolism in liver microsomes from rats induced for CYP1A ranged from 
211 
Figure 3. TCB-stimulated ROS production in liver microsomes. A) H202 production as 
assessed by oxidation of DCDFDA to DCF. B) OT• production as assessed by oxidation 
of HE to ethidium. In a 48-well plate, approximately 0.1 mg of microsomal protein was 
diluted to 160 ~l with HBSS containing 5 ~M DCDFDA and 7.5 ~M HE (final 
concentrations). Some reaction mixtures contained 200 units SOD. Following a fifteen 
minute incubation at 30°C, 1.7 nmol TCB in acetone or 5 ~l acetone was added. Reactions 
were initiated with NADPH (1.7 mM). The rates of DCF and ethidium production were 
monitored fluorometrically over 5 minutes. Calculations were made using DCF and 
ethidium bromide as standards. Data are the means± S.D. from 3-8 sets of microsomes. 
*Statistically different from the corresponding NADPH+acetone incubation (p<0.05, 
Student's t-Test). 
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18-91 pmollmin/mg, representing 4% of EROD activity (Ishida et al., 1991; Murk et al., 
1994). 
Previous studies have determined the metabolite profiles of TCB in various species. 
In scup treated with 0.1 mg TCB/kg, 5-hydroxy-3,3',4,4'-tetrachlorobiphenyl (5-0H-
TCB) is the predominant metabolite in bile, constituting 85% of all metabolites, while 4-
hydroxy-3,3',4',5-tetrachlorobiphenyl (4-0H-TCB) constitutes 13% of the total (White et 
al., 1997b). This distribution appears to be dependent upon dose ofTCB, with a dose of 5 
mg TCB/kg resulting in a profile with similar amounts of 4-0H-TCB and 5-0H-TCB 
(White et al., 1997b). 5-0H-TCB is the predominant metabolite in bile of chickens 
(Klasson Wehler et al., 1990) and is the predominant metabolite produced by liver 
microsomes of the common tern and eider duck (Murk et al., 1994). In feces of mice and 
rats, 4-0H-TCB and 5~0H-TCB occur in nearly equal amounts (Yoshimura et al., 1987; 
Klasson Wehler et al., 1989). 
CYP1As appear to be responsible for the metabolism ofTCB. For most species in 
this study, TCB metabolism was correlated strongly with EROD activity. EROD activity is 
associated with CYP1A in fish (Klotz et al., 1983), CYP1A4 in birds (Rifkind et al., 
1994), and CYP1A1 in mammals (Nerurkar et al., 1993). Induction and inhibition studies 
in scup have suggested that CYP1A is responsible for TCB metabolism in the fish scup 
(White et al., 1997b). Interestingly, the flounder showed no relationship between EROD 
activity and TCB metabolism. This may have resulted in part from the fact that a small 
number of samples with very similar TCB metabolism rates were analyzed. However, 
other studies have demonstrated a lack of CYP1A-like metabolism of CB congeners in 
flounder (Brown, 1992; Elskus et al., 1994). Along with the chicken, cormorant and gull 
examined in this study, positive correlation of EROD activity and TCB metabolism also has 
been demonstrated for the common tern and eider duck (Murk et al., 1994). In rats it is 
known that CYP1A1 metabolizes congeners with adjacent, unsubstituted ortho-meta 
carbons (Ishida et al., 1991). 
TCB-Stimulated CYP JA Inactivation: TCB-mediated inactivation of CYP1A was 
described first in scup, where the phenomenon is quite strong (White et al., 1997a). 
Uncoupling of electron transfer and oxygen activation from mono-oxygenation during the 
interaction of TCB with CYP1A results in the release of ROS, either H202 and 02-•, from 
the heme iron. H202 can be converted to the extremely reactive OH• by the Fenton 
reaction with the reduced heme iron acting as the catalyst. That OH• can attack the protein 
and disable it (Chapter 3. This oxidative mechanism of inactivation is hypothesized to 
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occur during the in vitro metabolism of TCB and to be responsible for the loss of CYP1A 
protein in scup following exposure to a high dose of TCB (White et al., 1997a). 
Furthermore, in vitro oxidative inactivationis stimulated by several slowly metabolized CB 
congeners that are CYP1A substrates, including 2,3,3',4,4'-pentachlorobiphenyl, 
3,3',4,4',5-pentachlorobiphenyl (PeCB) and 3,3',4,4',5,5'-hexachlorobiphenyl (Chapter 
4). 
Results from this study and others suggest that pHAH stimulated oxidative 
inactivat~on may occl:lf in species other than scup. While CYP1A rnRNA remains elevated 
in rainbow trout exposed to high doses of PeCB, CYP1A activity and protein both decrease 
at high doses (Newsted et al., 1995). Similarly, studies of cultured cells have 
demonstrated that chick embryo hepatocytes and porcine aorta endothelial cells exposed to 
high doses of TCB show losses of both EROD activity and CYP1A protein (Lambrecht et 
al., 1988; Sinclair et al., 1989; Stegeman et al., 1995). Studies of inactivation of CYP1A 
in liver microsomes of fish and birds show that the extent of TCB-mediated inactivation of 
CYP1A is species specific and may be related to the rate at which TCB is metabolized. A 
greater rate of TCB metabolism was correlated with a lesser rate of inactivation and a lesser 
rate of ROS production. A greater rate of TCB metabolism may reduce the extent of 
catalytic uncoupling thereby reducing the rate of production of ROS which could attack the 
protein. 
However, data from the chicken do not fit this explanation entirely. Chickens have 
a greater concentration of AhR, are more sensitive to CYP1A induction and are more 
susceptible to CB toxicity than other bird species (Brunstrom, 1988; Brunstrom and Lund, 
1988; Dubois et al., 1995; Kennedy et al., 1996). While chicken liver microsomes had 
both one of the lowest rates of TCB metabolism and the greatest rate of inactivation, TCB 
did not enhance the production of ROS. Chicken liver microsomes had high levels of ROS 
production in the presence of NADPH alone with a slight reduction in the presence of 
TCB. Similarly, human CYP1A2 produced ROS at a high rate with NADPH alone, and 
the rate decreased substantially in the presence of TCB (Chapter 3). Unlike mammalian 
CYP1A1 and CYP1A2 (Dragnev et al., 1995), chicken CYP1A4 and CYP1A5 are induced 
in almost equal amounts by pHAH (Sinclair et al., 1997). As CYP1A5 possesses 
characteristics more like CYP1A2, then it may contribute more to the general production of 
ROS seen with NADPH alone. However, ROS production decreases only slightly in the 
presence of TCB in the chicken microsomes. While ROS production by CYP1A5 may 
decrease in the presence of TCB, the interaction of CYP1A4 with TCB may increase ROS 
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production, finally resulting in the inactivation of CYP1A4. Studies with purified chicken 
CYP1As would be required to support this hypothesis. 
PCB-Stimulated ROS Production: Evidence from studies in fish, birds and 
mammals indicate that CBs stimulate oxidative stress. Aroclor 1254 treatment stimulates 
hepatic lipid peroxidation in chickens, rats and guinea pigs (Combs and Scott, 1975; Kato 
et al., 1981; Dogra et al., 1988). Studies in fish have demonstrated an increase in 
antioxidant enzyme activity following exposure to TCB and PeCB (Otto and Moon, 1995; 
Palace et al., 1996). PeCB stimulates lipid peroxidation in kestrels (Hoffman et al., 1996), 
and TCB increases ROS production and lipid peroxidation in porcine pulmonary 
endothelial cells (Toborek et al., 1995). 
Results from in vitro studies supports the hypothesis that pHAH stimulate ROS 
production through their interaction with CYP1A. While the extent of stimulation varied, 
TCB stimulated ROS production in a number of the species examined here. Previously, 
CYP1A from scup and rat were shown to produce ROS during their interaction with planar 
CB congeners (Chapter 4). Oxidation of bilirubin in chicken and rat liver microsomes was 
suggested to occur as a result of ROS formed during uncoupling of the CYP1A catalytic 
cycle by non-ortho CB congeners (Sinclair et al., 1986; DeMatteis et al., 1989). In rats, 
bilirubin oxidation has been shown to be catalyzed by CYP1A1 (DeMatteis et al., 1991). 
Thus, the correlation of CYP1A induction and oxidative stress may indicate that CYP1A 
induced through the AhR could be the immediate source of ROS in vivo. 
Reptiles and Cytochromes P450: Information on CYP induction and CB 
metabolism in reptiles is scare. In both turtles and alligators, two bands are recognized by 
a polyclonal anti-mouse or anti-rat CYP1A1 (Jewell et al., 1989; Yawetz et al., 1998). 3-
Methylcholanthrene induced the slower migrating band in alligators (Jewell et al., 1989) 
and induced total P450, benzo[a]pyrene hydroxylase activity, and p-nitrophenetol 0-
deethylase activity in snakes (Schwen and Mannering, 1982). In the turtle, BNF, TCB and 
2,3,3',4,4'-pentachlorobiphenyl also induced the slower migrating band (Yawetz et al., 
1998). While EROD activities were low, they were correlated with the content of MAb-1-
12-3 cross-reactive protein (Jewell et al., 1989; Yawetz et al., 1998). Furthermore, aryl 
hydrocarbon hydroxylase rates were substantial. We show here that a turtle species can 
metabolize TCB at rates comparable to those seen in birds. This study is the first to 
demonstrate a correlation between EROD activity and TCB metabolism in a reptile. Similar 
to the chicken, the oxidase activity in turtle liver microsomes was substantial. 
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Initial studies in scup and rat suggested that not all species are equally susceptible to 
TCB mediated CYP1A inactivation. Here, we examined the relationship of the TCB 
metabolism to TCB-mediated inactivation of CYP1A and ROS production in a variety of 
species. Within groups of species, CYP1A inactivation appears to be negatively correlated 
with TCB metabolism. This supports earlier conclusions that TCB-mediated inactivation 
results from catalytic uncoupling and formation and attack of ROS. The results also 
demonstrate that ROS are produced by a variety of species. Formation of ROS by CYP1A 
may be linked to overt toxicity though damage to membranes (Bagchi et al., 1989; 
Simonian and Coyle, 1996), proteins (Davies, 1987; Kyle et al., 1989), and nuclei acids 
(Floyd et al., 1988; Simonian and Coyle, 1996) and through modification of the regulation 
of genes involved in several signal transduction pathways (Flohe et al., 1997). The 
stimulation of ROS production by pHAH may represent a pathway of toxicity that is 
common among diverse species. 
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